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ABSTRACT 
Autoimmune diseases affect 5 % of the population but the mechanisms of onset 
remain unresolved. This thesis work investigates the immunopathology of 
autoimmunity by studying the APECED disease and the AIRE gene. APECED 
(autoimmune polyendocrinopathy-candidiasis ectodermal dystrophy) is one of the 
few monogenic autoimmune diseases. The APECED disease phenotype consists of a 
multitude of different disease components affecting especially the endocrine glands. 
The gene mutated in APECED has been identified and is called AIRE (from 
autoimmune regulator). AIRE plays a role in central tolerance in the control of 
expression of tissue specific antigens (TSAs) to developing T cells. T cells reactive 
to these TSAs are eliminated in the establishment of immunological tolerance. AIRE 
also seems to have a function in peripheral tolerance.  
In APECED, a specific set of autoantigens is the target of autoantibodies causing 
immune destruction. A mouse model of APECED, in which the mouse homologue 
of AIRE, Aire, is knocked out, has been previously constructed and characterized 
preliminarily. Using this mouse model, this study established that the Aire deficient 
mice do not produce autoantibodies against the murine homologues of the human 
APECED autoantigens. Thus, Aire may have a different immunopathogenic 
mechanism than AIRE, and care must be taken when interpreting data from this 
mouse model. The role of AIRE in peripheral tolerance in dendritic cells (DCs) was 
also a subject of study. APECED patient derived DCs showed decreased cytokine 
production and analyses of transcript profiles showed differences compared to 
healthy controls, with reductions in immunologically relevant pathways in APECED 
DCs. These results show that AIRE does affect DCs and confirms that AIRE is 
involved in peripheral tolerance, in addition to central tolerance. AIRE affects the 
development of the major T cell subset, αβ T cells. However, whether AIRE is 
involved in γδ T cell development is not known. The γδ T cells from Aire deficient 
mice and APECED patients were analysed and compared to wt mice and healthy 
controls, respectively. The analyses showed no significant differences in the γδ T 
cells in absence of AIRE/Aire. Therefore, AIRE/Aire does not affect γδ T cells and 
further, this T cell subset does not seem to be involved in the loss of tolerance 
causing autoimmunity in APECED. 
  
This thesis work showed that autoimmunity in Aire deficient mice differs from that 
seen in APECED patients, as the mouse autoantibodies target different autoantigens. 
AIRE deficient DCs are defective, but AIRE/Aire does not affect the γδ T cell subset 
in mice or men.  
 
Keywords: APECED, APS-1, AIRE, autoimmunity, tolerance, gamma delta T cell, 
dendritic cell, autoantibody, mouse model 
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TIIVISTELMÄ 
Autoimmuunitauteja sairastaa 5% maailman väestöstä, mutta tautien 
syntymekanismi on tuntematon. Tässä väitöskirjatutkimuksessa selvitetään 
autoimmuniteetin immunopatologiaa tutkimalla APECED-tautia ja AIRE-geeniä. 
APECED (autoimmune polyendocrinopathy-candidiasis ectodermal dystrophy) on 
yksi harvoista monogeenisista autoimmuunisairauksista. APECEDin taudinkuva 
koostuu monista eri tautikomponenteista, jotka vaikuttavat erityisesti 
hormonirauhasiin. APECED-taudin tiedetään johtuvan mutaatioista AIRE-geenissä 
(autoimmune regulator). AIRE toimii sentraalisessa toleranssissa ja kontrolloi 
monien kudos-spesifisten geenien esittelyä kehittyville T-soluille. T-solut jotka 
reagoivat omia kudosmolekyylejä vastaan poistetaan immunologisen toleranssin 
kehittyessä. AIRElla on ilmeisesti funktio myös perifeerisessä toleranssissa.  
Autoimmuunitaudit johtuvat autovasta-aineista jotka aiheuttavat kudostuhoa ja 
APECEDissa esiintyy autovasta-aineita tiettyjä kohdeaineita vastaan. Aire-
poistogeenistä APECEDin hiirimallia on tutkittu alustavasti. Tässä väitöskirjatyössä 
tutkittiin muodostuuko kyseisellä hiirimallilla autovasta-aineita samoille kohteille 
kuin ihmisten APECED-autovasta-aineet. Mallissa ei muodostunut autovasta-aineita 
samoja kohteita vastaan kuin APECED-potilailla. Aire aiheuttaa autoimmuuniteettiä 
ehkä eri mekanismilla hiirissä kuin ihmisissä, joten tämän hiirimallin tulosten 
tulkinnassa on syytä noudattaa varovaisuutta. Väitöskirjatyössä tutkittiin myös 
AIREn tehtävää perifeerisessä toleranssissa dendriittisoluissa. APECED-potilaista 
tuotetut dendriittisolut tuottivat vähemmän sytokiinejä ja genominlaajuinen 
ekspressioanalyysi näytti, että immunologisesti tärkeiden geenien ilmentyminen oli 
erilainen kuin terveiden verrokkien. Immunologisesti tärkeitä geenejä tuotettiin 
potilassoluissa vähemmän kuin verrokkien dendriittisoluissa. Tulokset osoittavat, 
että AIRE vaikuttaa dendriittisoluihin ja tukee aiempia löydöksiä siitä, että AIRE 
toimii sentraalisen toleranssin lisäksi myös perifeerisen toleranssin säätelyssä. AIRE 
vaikuttaa T-solujen kehitykseen. Tähän mennessä on tutkittu vain αβ-T-soluja. Vielä 
ei kuitenkaan tiedetä vaikuttaako AIRE myös γδ-T-soluihin. Työssä tutkittiin γδ-T-
solupopulaatiota Aire-poistogeenisissä hiirissä ja APECED-potilaissa ja verrattiin 
niitä viilityypin hiirin sekä terveisiin verrokkeihin. Tuloksissa ei näkynyt 
  
merkitseviä eroja γδ-T-soluissa AIREn/Airen puuttuessa. AIRE/Aire ei täten vaikuta 
γδ-T-solujen kehitykseen eivätkä γδ-T-solut aiheuta myöskään autoimmuuniteettiä 
joka ilmenee APECEDissa. 
Tässä väitöskirjassa havaittiin että autoimmuuniteetti Aire-poistogeenisissa hiirissä 
eroaa APECED-potilaiden autoimmuuniteetista, sillä hiirten vasta-aineet 
kohdistuvat eri autoantigeeneihin kuin potilaiden autovasta-aineet. AIREn 
puuttuessa dendriittisolut toimivat heikosti, mutta sen sijaan AIRE/Aire ei vaikuta 
γδ-T-soluihin hiirissä eikä ihmisissä.  
 
 
Avainsanat: APECED, APS-1, AIRE, autoimmuuniteetti, toleranssi, gamma delta T 
solu, dendriittisolu, autovasta-aine, hiirimalli 
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ABBREVIATIONS 
AA  alopecia areata 
AADC  aromatic L-amino acid decarboxylase 
AIRE  autoimmune regulator 
ALPS  autoimmune lymphoproliferative syndrome 
ANA  anti-nuclear antibody 
APC  antigen presenting cell 
APECED autoimmune polyendocrinopathy-candidiasis-
ectodermal dystrophy 
APS autoimmune polyendocrine syndrome 
cDNA complementary DNA 
CTLA cytotoxic T lymphocyte antigen 
CMC chronic mucocutaneous candidiasis 
CXCL chemokine ligand 
DC dendritic cell 
EAE experimental autoimmune encephalomyelitis 
FACS fluorescence activated cell sorter 
FoxP3 forkhead box p3 transcription factor 
GAD glutamic acid decarboxylase 
gld generalized lymphoproliferative disease 
GM-CSF granulocyte-macrophage colony stimulating factor 
GO gene ontology 
HLA human leukocyte antigen 
IA-2  islet cell antigen-2 
ICA  islet cell antigen 
IFN interferon 
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Ig immunoglobin 
IL interleukin 
IFN interferon 
IPEX immunodysregulation, polyendocrinopathy, and 
enteropathy, X-linked 
kb kilobase 
kDa kiloDalton 
LPS  lipopolysaccharide 
lpr lymphoproliferation 
MHC major histocompatibility complex 
mAb monoclonal antibody 
moDC monocyte-derived dendritic cell 
mTEC thymic medullary epithelial cell 
mRNA messenger ribonucleic acid 
NALP  NACHT leucine-rich-repeat protein 
NF-κB nuclear factor kappa B 
NK cell natural killer cell 
NOD non-obese diabetic 
OMIM online Mendelian inheritance in man 
PAH  phenylalanine hydroxylase 
PBL  peripheral blood leukocyte 
PBMC peripheral blood mononuclear cells 
P450c17 steroid 17-α-hydroxylase 
P450c21 steroid 21-hydroxylase 
P450scc cholesterol side-chain cleavage enzyme 
PCR polymerase chain reaction 
Q-RT-PCR quantitative, reverse transcriptase-PCR 
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SLE systemic lupus erythematosus 
SNP single nucleotide polymorphism  
SOX  Sry-related HMG-Box 
SS Sjögren’s syndrome 
T1D type 1 diabetes 
TCR T cell receptor 
TG  thyroglobulin 
TH tyrosine hydroxylase 
TNF tumor necrosis factor 
TPH tryptophan hydroxylase 
TPO thyroid peroxidase 
Treg regulatory T cell 
TSLP thymic stromal lymphopoietin 
VCAM vascular cell adhesion molecule 
wt wild-type 
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INTRODUCTION 
The immune system protects organisms against foreign invaders such as bacteria, 
viruses, and parasites. However, what is foreign and what is part of self is an 
important distinction to be able to make in order to protect self while fighting off 
non-self. 
Cells of the immune system are taught to learn the difference between self and non-
self molecules. Being able to distinguish between these two is termed 
immunological tolerance. If this process, or education, goes wrong, the immune 
system can attack its own tissue and cause destruction resulting in autoimmune 
diseases (AID). Different autoimmune diseases exist and comprise sustained attack 
against different targets such as certain molecules expressed only in certain tissues, 
or more systemic targets present in several locations of the body. How tolerance is 
established is still unknown. It has been a “conundrum, which has irritated 
immunologists for years“ (Hollander 2007). 
APECED is an autoimmune disease which is caused by mutations in the AIRE gene. 
How “malfunction” of one gene can cause such a large variety of symptoms is 
bewildering and still not fully understood. 
The aim of this study has been to shed light on how APECED and further, how 
autoimmune diseases in general, arise. This question has been attacked by several 
different approaches. Recent studies have shown that autoimmune regulator (AIRE), 
the gene mutated in APECED, which is involved in central tolerance, may also play 
a role in the periphery. First, we have studied whether AIRE affects the development 
of γδ T cells in the thymus, since it is known AIRE is important for αβ T cell 
development. Second, we examined the role of AIRE in peripheral monocyte-
derived dendritic cells. Third, we have analyzed the autoantigens produced by Aire 
deficient mice. Aire deficient mice are a murine model of APECED and a valuable 
tool for studying disease mechanism. We have studied the autoantibodies in order to 
further characterize the mouse model, to find out whether the same set of genes are 
targeted by autoantibodies in mice and men, and whether the immunopathology is 
equivalent in these two species. 
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REVIEW OF THE LITERATURE 
1 THE IMMUNE SYSTEM 
“Immunology is the study of the body’s defence against infection” (Janeway et al. 
2008). The immune system has evolved to take care of the defence against a wide 
range of invading pathogens and micro-organisms. In multicellular organisms it is a 
very complex system of immune cells and molecules whose functions are to protect 
the organism, or host from harmful pathogens and the damage they cause. 
The first layer of the immune system is the surface of an organism, such as skin or 
mucosa. If an invading pathogen can pass this first barrier, it is met by two systems 
described below. 
The immune system is classically divided into two categories: the innate immune 
system and the adaptive immune system. However, there is overlap between these 
categories and the innate and adaptive immune systems also work together 
(Ochsenbein and Zinkernagel 2000). The innate immune response is responsible for 
the first attack against and elimination of invaders entering the body. Its response is 
similar to every re-invasion by the same kind of invader, no matter how many times 
there has been a previous encounter. It is fast and not very specific, whereas the 
adaptive immune system, whose task is to recognize and destroy invaders which 
have escaped or survived by the innate system, takes longer to get activated. It is 
characterized by specificity and memory. The adaptive immune system is able to 
adapt to re-invasion; it can strengthen and accelerate its defence against towards re-
invasion by the same type of invader (Janeway 2008). 
1.1 Components of the immune system 
The immune system contains a multitude of different cells and molecules with 
specific functions and characteristics. The main cell types of the immune system can 
be seen in Figure 1. 
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Figure 1. The human immune cells.  Leukocytes differentiate from pluripotent 
hematopoietic stem cells and divide to lymphoid and myeloid lineages. T and 
B cells, NK cells and pDCs differentiate from lymphoid lineage progenitors. 
Monocytes, macrophages, granulocytes and mDCs develop from myeloid 
lineage progenitors. Modified from Immunobiology (Janeway 2008). 
The innate immune system in made up of cells such as neutrophils, basophils, 
eosinophils, monocytes, macrophages and natural killer (NK) cells. Additionally, the 
complement system is important for the innate immune response.  
The adaptive immune system comprises lymphocytes; T cells and B cells. These 
categories are further divided into more specific cell subsets. T cells express 
different markers according to which they are divided into helper T cells (Th), which 
are positive for the CD4 marker, into cytotoxic T cells (Tc) which express CD8 and 
into regulatory T cells. These subsets can be divided even further; for example the 
Th cells contain Th1, Th2 and Th17 cell populations, of which Th1 produce 
different set of cytokines than Th2 cells, and while Th1 activate macrophages, Th2 
cells generally activate B cells and Th17 are characterized by production of IL-17. B 
lymphocytes are divided into naïve B cells, memory B cells and plasma cells, which 
are activated B cells that produce antibodies. B cells got their name from the bursa 
of Fabricius, a lymphoid organ of chickens. However, it can also stand for “bone 
marrow-derived”, as bone marrow is where B cells mature. Different cell types act 
as antigen presenting cells: B cells, macrophages and dendritic cells (DC). 
pluripotent hematopoietic
stem cell
lymphoid 
progenitor cell
myeloid 
progenitor cell
macrophageDC
NK cell
B cell
T cell neutrophil
basophil
eosinophil
monocyte
erythrocyte
platelets
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In addition to cells, the immune system contains important secreted components 
such as complement, antibodies, chemokines and cytokines. Cytokines are small 
proteins of approximately 25 kDa in size. They are produced by several cell types, 
usually upon activation of the target cells, and upon binding to specific receptors, 
induce a multitude of responses in the cells (Janeway 2008). Chemokines, 
previously included in the interleukins (ILs), are cytokines belonging to a family of 
chemoattractant cytokines. They can be produced by many cell types as well, and 
recruit effector cells from the blood to sites of infection by inducing chemotaxis in 
cells to which they bind via chemokine receptors. Additionally, they can be involved 
in lymphocyte development and migration (Moser et al. 2004; Janeway 2008). 
1.2 Antibodies and antigens 
The term "antibody" was born in 1901. Previously, an "antibody" referred to an anti-
“body” fitting a “body”, which were not known yet. The first comprehensive theory 
of antibody production was published in 1896 by Paul Ehrlich. The theory suggested 
that antibody producing cells have surface molecules (or side chains) which can bind 
to antigens. Binding to a specific side chain causes the cell then to produce more of 
the same side chain and to release these side chains into the serum as antibodies. 
Two of these postulates by Ehrlich 1) that antibodies are identical to the antigen 
receptors, and 2) that antigen binding triggers the synthesis of antibody with the 
same specificity as the receptor, are now known to be fundamentally correct. Ehrlich 
won the Nobel prize for Medicine or Physiology in 1908 for his side chain theory 
together with Elie Metchnikoff, who discovered phagocytosis 
(http://focosi.immunesig.org/history). 
Antibodies are soluble B cell receptors. They are also called immunoglobulins (Igs). 
Antibodies are made up of two heavy chains and two light chains, which are held 
together by disulphide bonds (Edelman 1973). Both the heavy and light chains 
contain hypervariable regions in their amino terminal and constant regions in their 
carboxy terminal. The antigen recognition site is made up of the hypervariable 
regions from one light chain and one heavy chain. Therefore there are two antigen 
recognition sites per antibody. All the antibodies produced by a B cell carry the 
same specificity due to allelic and isotypic exclusion. Two types of light chains 
exist: λ and κ. There are five types of heavy chains with different constant (C) 
domains. These constant domains define the five major antibody isotypes. The C 
domain can be either: μ, γ, α, ε, or δ and they produce the Ig types IgM, IgG, IgA, 
IgE and IgD, respectively. Furthermore, IgGs can be IgG1, IgG2, IgG3 and IgG4 in 
humans and IgAs can be either IgA1 or IgA2. 
 19 
1.3 The thymus  
The immune system contains several tissues or organs which are composed of 
lymphoid cells surrounded by nonlymphoid cells. Lymphoid organs and tissues fall 
into two categories: primary (central) and secondary (peripheral) organs. Primary 
lymphoid organs are the sites where lymphocytes are generated and these are bone 
marrow and the thymus. Secondary lymphoid organs make up the tissues where 
immune cells are maintained and where the actual immune responses occur. These 
are the spleen, lymph nodes and mucosa-associated lymphoid tissues (MALT) 
(Janeway 2008). 
 
LYMPH 
NODES
LYMPH 
NODES
PEYER’S PATCHES
SPLEEN
THYMUS
BONE MARROW
LYMPH 
NODES
APPENDIX
TONSILS AND ADENOIDS
+ LYMPHATIC VESSELS
THE IMMUNE SYSTEM
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Figure 2. Central lymphoid organs are the thymus and bone marrow. The others are 
peripheral lymphoid organs. Lymphocytes originate from stem cells in the 
bone marrow and differentiate in the thymus, whereas B cells differentiate 
in the bone marrow. Lymphatic vessels (not shown here) drain extracellular 
fluid from peripheral tissues, through lymph nodes into the thoracic duct 
which empties into the subclavial vein. Lymphatic vessels contain fluid 
called lymph in which antigens and circulating lymphocytes are drained 
back into the blood. Lymphoid tissue is also associated with other mucosa 
(not show here). 
The thymus is a central organ of the immune system and it is the site for the 
establishment of central tolerance. Upon contact with foreign pathogens, the 
immune system must be capable of mounting a rapid immune response, yet be able 
to avoid excessive and unwanted responses, as well as reactions against self. This is 
attained by tolerance (Van Parijs and Abbas 1998). T lymphocytes originate from 
the bone marrow and migrate to the thymus to mature (hence, they are called T 
cells). In most mammals, the thymus is located in the thoracic cavity between the 
heart and the sternum. It is prominent during fetal development, but usually 
diminishes in size and function in adults (Janeway 2008; Rodewald 2008).  
The thymus is made up of several lobules, which are each divided into an outer 
cortex and an inner medulla (Boyd et al. 1993). Different stages of T cells reside in 
specific areas of the thymus, although during the process of maturation, they move 
from one compartment to the other. The different areas of the thymus form distinct 
microenvironments and are characterized by the presence of specialized thymic 
stromal cells. The main structure is formed by different types of thymic epithelial 
cells (TECs), which are surrounded by other stromal cell types, such as macrophages 
and DCs. Signals from stromal cells are required for T cell development (van Ewijk 
et al. 1994; Pearse 2006; Takahama 2006). 
Developing T cells undergo several steps during maturation, such as positive and 
negative selection described in more detail in chapter 2.1 on Central tolerance. 
Immature T cells, or thymocytes, can be found in the cortex, together with some 
epithelial cells and macrophages with which the T cells communicate. Positive 
selection occurs in the cortex. Mature thymocytes can be found in the medulla 
together with abundance of epithelial cells, and some macrophages and DCs. 
Negative selection is thought to take place in the medulla of the thymus. Thymus-
specific structures called the Hassal’s corpuscles are also located in the medulla. 
They are formed by concentric layers of epithelial cells (Boyd et al. 1993) and their 
importance in central tolerance was demonstrated recently (Watanabe et al. 2004). 
Before, it was known that Hassal’s corpuscles were involved in the maturation of 
developing thymocytes and removal of apoptotic thymocytes. It is now known that 
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in humans, a chemokine called thymic stromal lymphopoietin (TSLP) is expressed 
by Hassal’s corpuscles. TSLP activates DCs, which then help in the generation of 
regulatory T cells (Tregs) in the thymus (Watanabe et al. 2004). However, an 
identical mechanism does not exist in mice. Both DCs and Tregs are important 
players in tolerance and will be discussed in more detail in later chapters. 
The structure of the thymus plays an important role in the development of T cells, 
which relocate into, within, and in and out of different thymic compartments. The 
development of T cells is discussed in more detail below and consists of several 
steps: entry of lymphocyte progenitors into the thymus, proliferation as double 
negative (CD4-CD8-) cells, the generation and positive selection of double positive 
(CD4+CD8+) thymocytes in the cortex, their differentiation into single positive cells 
(CD4+ and CD8+) in the medulla, negative selection in the medulla and finally, 
export of mature T cells from the thymus (Kyewski et al. 2002; Petrie 2003; Gray et 
al. 2005; Takahama 2006). In order to make sure this development occurs in the 
correct order, the developing thymocytes and the thymic stromal cells must 
communicate with each other. This lympho-stromal interaction is a bilateral 
coordination or cross-talk between the architectural stromal cells and migrating 
lymphocytes (van Ewijk et al. 1994; Takahama 2006). The developing thymocytes 
actually create their own path with these interactions and change their thymic 
environment in order to ensure further development. In this process, chemokines 
play a crucial role. They are secreted from the thymic stromal cells and recognized 
by receptors on thymocytes. Deficiencies in such chemokines or their receptors can 
cause developmental arrest of T cells (Ueno et al. 2004). Thymic stromal cells also 
need communication with developing T cells in order to maintain their normal 
organization and maturation (Shores et al. 1991).  
Figure 3. The cellular composition of the thymus. The major cell types, cell-cell 
interactions and migratory route of developing thymocytes are shown. 
Lymphocyte progenitors enter the thymus through the vasculature of the 
cortico-medullary junction. Double negative (DN) T cells migrate towards 
the capsule. Conversion to double-positive (DP) T cells occurs in the outer 
cortex. Positively selected DP cells differentiate into single positive (SP) 
cells, which move to the medulla. There, autoreactive cells are eliminated by 
negative selection. Mature thymocytes return to the circulation.  Modified 
from Takahama (Takahama 2006) and Kyewski and Klein (Kyewski and 
Klein 2006). 
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Amazingly, only a few years ago, a second thymus was reported to be found in mice 
(Terszowski et al. 2006). These cervical lymphoid organs had a structure resembling 
that of thymic structure with a medulla and cortex, T cells of different 
developmental stages, expression of genes involved in T cell development (such as 
Rag1 and Rag2), DCs and endothelial cells as well as expression of Aire and Foxn1. 
Some differences were the number of T cells and proportion of mature T cells in 
cervical versus classical thymi. Export of functional T lymphocytes bearing different 
TCRs and transfer of immune competence by grafts consisting of the cervical 
thymus showed that the cervical thymus not only anatomically resembles a thymus 
but is also functional (Terszowski et al. 2006). 
Cervical thymuses had, however, been known to exist in other mammals such as in 
marsupials. They can have either a thoracic thymus, a cervical thymus or both. Even 
in humans cervical thymi have been reported, but it is not known how frequent they 
really are (Rodewald 2008). 
1.4 T cells 
The lymphocyte has become one of the most studied of all mammalian cells 
(Gowans 1996). T lymphocytes can be divided into two types: αβ T cells and γδ T 
cells, according to their TCR. It is the αβ T cells that are divided into CD4+ and 
CD8+ cells, and subsets such as Th1 and Th2 cells. The lymphocytes that first enter 
the thymus give rise to both αβ T cells and γδ T cells, out of which the αβ T cells 
CO
RT
EX
M
ED
U
LL
A
BLOOD VESSEL
TR
A
BE
CU
LE
THYMOCYTE
(DN)
THYMOCYTE
(SP)
B CELL
cTEC
DC
THYMOCYTE
(DP)
mTEC
SUBCAPSULAR
EPITHELIAL CELL
CAPSULE
MACROPHAGE
 23 
make up the major T cell population and the γδ T cells the less well-understood, 
minor population (Reiner 2007). 
Lymphocytes are able to recognize a massive amount of targets due to their antigen 
receptors which are made up of several gene segments assembled by somatic 
recombination. Several variable (V) gene segments, joining (J) segments and for 
some chains, diversity (D) segments exist and the recombination events joins any 
ones of these V, D and J segments together to form the variable part of the TCR. 
Thus different T cells bear unidentical TCRs since they are composed of different 
Vs, Ds and Js (eg. cell 1: V1D2J3 and cell 2: V5D7J1). Additionally, nucleotides 
can be added or removed from joining sites, or junctions between these segments, 
creating even more diversity (Carding and Egan 2002; Janeway 2008). 
1 . 4 . 1  α β  T  c e l l s  
αβ T lymphocytes are the major T cell population. They are the cells usually referred 
to when talking about T cells. αβ T cells reside mainly in lymphoid tissue, whereas 
γδ T lymphocytes reside mainly in epithelial tissues (Moser and Eberl 2007). About 
half of all T cells reside in connection with the gastro-intestinal tract. 
The development of T cells was described previously, as were different types, or 
subsets of T cells briefly. Three signals are required for activation of naïve T cells: 
1) antigen specific signals from the peptide-MHC complex with the TCR of the T 
cell, 2) activating co-stimulatory signals given to the T cells by the same APC (B7, 
or CD80 and CD86, recognized by CD28 on T cells), and 3) the cytokine milieu, 
important in directing the differentiation of the T cells. Activation of T cells leads to 
changes in their surface marker expression, cytokine production and function. CD8+ 
cytotoxic T cells (Tc) cause apoptosis in their targets, while CD4+ T cells are 
divided further into Th1 and Th2 cells, which secrete different sets of cytokines and 
stimulate antibody production by B cells, Th17 cells help recruit neutrophils and 
Tregs suppress T cell activity (Tseng and Dustin 2002; Reiner 2007; Appay et al. 
2008). A whole book, or several books, could be written about αβ T lymphocytes, 
the different subtypes and their functions, but in this work, we focused on γδ T 
lymphocytes described below. 
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Table 1. γδ vs. αβ T cells 
 γδ T cells αβ T cells 
antigen receptor CD3 complex + γδ TCR CD3 complex + αβ TCR 
number of possible 
receptors* 
ca. 1020 ca. 1015 
antigen recognition protein + non-protein peptide + MHC 
MHC restriction rare yes 
phenotype most CD4-CD8-  CD4+ or CD8+ 
frequency in blood 1-5% 65-75% 
distribution blood, epithelial and lymphoid tissues blood and lymphoid tissues 
effector capacity CTLs, cytokine production (Th1>Th2) CTLs (CD8+), cytokine production 
(Th1/Th2) 
function immunoregulation and immune 
surveillance 
immune protection and pathogen 
eradication 
* theoretical  Adapted from Carding and Egan, 2002 
1 . 4 . 2  γ δ  T  c e l l s  
γδ T lymphocytes differ from αβ T lymphocytes in their co-receptor expression 
pattern (such as CD4 and CD8), the types of antigens that they recognize, their 
distribution in the periphery and also, their function. 
γδ T cells make up only 1-5% of the circulating lymphocytes, but they are more 
frequent in epithelial tissues, such as the skin, intestine and reproductive tract. In 
these tissues, they can make up to 50% of the T cells (Carding and Egan 2002). 
Although they are such a small population, γδ T cells have large effects; even a little 
population of 104 cells could prevent airway inflammation and hyperresponsiveness 
(Hahn et al. 2003; Born et al. 2007). However, the numbers of γδ T cells vary with 
age and differ between the sexes (Moser and Eberl 2007). 
γδ T cells develop without MHC restriction, unlike αβ T cells, and they are able to 
recognize both soluble protein and non-protein endogenous antigens (Carding and 
Egan 2002). Exactly what determines which cells become αβ T cells and which γδ T 
cells is not yet known. The signal strength hypothesis suggests that strong TCR 
signals promote γδ T development, while weaker signals promote αβ T 
differentiation (Hayday and Pennington 2007). During early T cell development in 
the thymus, waves of differentiation of different γδ subsets, expressing distinct Vγ 
and Vδ gene segments takes place (see Picture) (Carding and Egan 2002; Xiong and 
Raulet 2007). However, the exact pathway of development of γδ T cells remains 
unclear. They seem to emerge directly from double negative T cells, and seem to 
require neither a double positive stage, nor a pre-TCR (Eberl and Littman 2004). 
There is no consensus for whether positive and negative selection is necessary for 
development of γδ T cells (Xiong and Raulet 2007), although it is beginning to look 
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like positive selection of γδ subsets does take place in some fashion. It has even 
been suggested that for the intraepithelial subset, selection would be mediated by a 
single autosomal gene in the thymic stroma (Lewis et al. 2006). γδ T cells may also 
be able to leave the thymus as committed precursors and mature in the periphery 
(Lambolez et al. 2006). An important fact to keep in mind is also that γδ cells 
produced at fetal and adult stages differ a great deal in repertoire, diversity and 
function (Xiong and Raulet 2007). 
 
Figure 4. Two lineages of T cells are produced in the thymus. Double negative  
precursors give rise to γδ T cells which lack CD4 and CD8 even when they 
are mature. The development of  γδ T cells is not well defined.  αβ T cells go 
through the double positive stage, enlarge and divide. Then they become 
double positive , before selection to develop into either CD4+ or CD8+ single 
positive cells and increased TCR expression. Mature T cells are exported 
from the thymus.  Modified from Immunobiology (Janeway 2008). 
There are several different groups of γδ T cells which have different functions, 
depending on their tissue location, antigen receptors and what part of immune 
response they act in (Haas et al. 1993; Carding and Egan 2002). For example, skin 
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γδ T cells, also called dendritic epidermal T cells (DETCs) are one such specific 
population, and populations of the tongue, lung and reproductive tract epithelium 
express “canonical” (= identical) TCRs  with the same V-D-J chains and junctions. 
However, these cells are found only in the mouse (Havran and Allison 1990; Itohara 
et al. 1990). Humans, and certain other mammalian species, have a population of γδ 
T cells called intraepithelial lymphocytes (IELs) which reside in the epithelium and 
epidermis (as well as genital tract and tongue) (Hayday and Tigelaar 2003). It seems 
that γδ T cells belong to the group of “unconventional T cells”, together with NKT 
cells and mucosa-associated invariant cells (MAIT) (Hayday and Tigelaar 2003). 
 
Figure 5. Mouse γδ T cell generation occurs in waves. γδ T cells with TCRs encoded 
by specific Vγ gene segments are exported from the thymus at defined 
periods of development. First, the Cγ1 locus is expressed with its closest V 
gene Vγ5. After a few days, cells bearing Vγ5 decline, and the next most 
proximal gene Vγ6 is expressed, and so on. Both rearranged γ chains are 
expressed with the same δ chain. These subpopulations then migrate to and 
populate different epithelial tissues in adult mice. The Vγ7+ T cells may be 
independent of the thymus. After birth, the αβ T cell lineage becomes 
dominant. Modified from Carding and Egan (Carding and Egan 2002). 
γδ T cells reside mainly in epithelial tissue layers such as the skin, intestinal 
epithelium, lung and tongue. In these locations, they function in innate immune 
defence (Raulet 1989; Allison and Havran 1991; Haas et al. 1993; Hayday 2000). The 
TCR of γδ T cells differs in these anatomical locations and most diversity is found in 
the populations residing in secondary lymphoid organs (Allison and Havran 1991). 
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Although the developing γδ T cells have a larger genetic capacity for TCR diversity 
than any other lymphocytes, they do not, for some unknown reason, make use of this 
potential. Especially γδ T cells in epithelia show limited receptor diversity (Allison 
and Havran 1991). Instead, γδ T cells are often oligoclonal populations and many 
populations have no joining segment diversity (Asarnow et al. 1988; Itohara et al. 
1990). Also the mechanisms that shape their repertoire remain unrevealed (Carding 
and Egan 2002). 
γδ T cells recognize antigens in a different way than do αβ T cells, since γδ T cells 
do not need to bind MHC. The manner of recognition seems to resemble that of 
antibodies. Which antigens γδ T cells bind are not very well characterized, since 
direct binding has not been shown for many antigens. The few known antigens seem 
to include both constitutively expressed targets of host cells and microbes as well as 
inducibly expressed antigens. Especially infected, diseased or stressed cells can be 
recognized by γδ T cells (Allison and Havran 1991; Hayday 2000; Hayday et al. 
2001). Two examples of groups of target antigens are heat shock proteins like HSP 
60 (60 kD (O'Brien et al. 1992; Constant et al. 1994) and pyrophosphates and 
alkylamines (Constant et al. 1994; Tanaka et al. 1995; Bukowski et al. 1999). 
Intracellular events after the antigen binding resemble those of αβ cells (Lafont et al. 
2001; Cipriani et al. 2002). Furthermore, γδ T cells recognize and respond to 
ubiquitous microbial products, “danger signals”, just as do cells of the innate 
immune system (Belles et al. 1999; Moser and Eberl 2007). Some studies even 
suggest that γδ T cells may be able to act as their own APCs (Wen et al. 1998; 
Belles et al. 1999). In any case, γδ T cells do seem to act as quite professional APCs 
since they produce markers common to APCs such as CD80/CD86 and CD40. 
Moreover upon stimulation, γδ T cells express MHC class II, more CD80/86 and 
CD40 as well as adhesion molecules in similar amounts as seen on DCs. γδ T cells 
were able to influence naïve T cells, which require APC contact, and additionally, 
they were able to efficiently process antigens (Brandes et al. 2005). However, how 
antigen uptake by γδ T lymphocytes takes place and why they act as APCs is 
currently not understood. 
γδ T cells seem to act as a link between innate and adaptive immunity similarly as 
DCs (Carding and Egan 2002). γδ T cells regulate the activation of for example NK 
cells (Ladel et al. 1996) and may affect the nature of the αβ T cell response to either 
a Th1 or Th2 type response, by means of their cytokine production (Ferrick et al. 
1995), usually biasing a Th1 type response (Yin et al. 2002). γδ T cells are able to 
induce effector-cell killing and/or cytolysis (Hayday and Tigelaar 2003) and may be 
able to induce tissue repair by secretion of growth factors (Jameson et al. 2002). γδ 
T cells have “considerable plasticity of function” and their function is in many ways 
dependent on the different types of activation (Carding and Egan 2002). Different γδ 
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populations may also function differently, even opposingly, for example some 
promoting and others, preventing inflammation (Hayday and Tigelaar 2003). γδ T 
cells influence B cells, possibly by cell-cell contact and can influence antibody 
production, Ig class switching and autoantibody formation in mice (Wen et al. 1994; 
Pao et al. 1996; Peng et al. 1996; Wen et al. 1996; Maloy et al. 1998). Additionally, 
γδ T cells have been reported to be in a continuous contact with DCs and other 
leukocytes (Wands et al. 2005) and induce DC maturation (Ismaili et al. 2002) via 
Fas-FasL interactions (Collins et al. 2005) (DCs are uniquely resistant to Fas-
mediated cell death, and can thus be activated via Fas) (Born et al. 2007). γδ T cells 
also induced expression of CD86 and MHC class I on DCs (Dieli et al. 2004; Conti 
et al. 2005). Reciprocally, γδ T cells are also influenced by DCs; DCs induce γδ T 
cell proliferation and cytokine production (Kunzmann et al. 2004). Cytokine 
production by γδ T cells may then affect other cells types, as mentioned above. 
Although all these functions have been suggested for γδ T cells, it is not yet clear 
what exactly γδ T cells do, and which γδ T cell subset carries out which function/s.  
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Figure 6. Mechanisms suggested for immunoregulation by γδ T cells.  The functions 
are based on effector molecules known to be expressed by γδ intraepithelial 
lymphocytes (IELs), as well as gene-expression profiles of epithelium-
associated γδ T cells and known γδ T cell targets. Modified from Hayday 
and Tigelaar (Hayday and Tigelaar 2003). 
A study on the chemokine, cytokine, and receptor expression on a subset of γδ T 
cells showed that most γδ T cells lack CCR7 and therefore do not home to secondary 
lymphoid tissues, unlike αβ T cells. Instead, γδ T cells express markers of 
inflammatory migration, homing them to sites of inflammation. However, upon 
TCR stimulation, γδ T cells switched from inflammation homing to secondary 
lymph node homing to sites of launching of adaptive immunity. They may be among 
the first cells which influence early adaptive immunity (Moser and Eberl 2007). 
Due to similarities of inflammatory responses to pathogens and autoimmune 
diseases, the role of γδ T cells has been studied in relation to autoimmune diseases. 
In EAE, a subset of γδ T cells may play a pathogenic role (Olive 1997), although 
most studies show an immunoregulatory or anti-inflammatory role for γδ T cells 
(Carding and Egan 2002). In NOD mice, a population of γδ T cells can suppress 
development of T1D (Harrison et al. 1996). Lpr mice on the other hand, lack γδ T 
cells and have a more severe phenotype (Peng et al. 1996). One more example is 
that γδ T cells are accumulated in synovium of rheumatoid arthritis patients 
(Holoshitz 1999). 
Recently, it has been demonstrated that γδ T cells which develop in the thymus and 
which interact with antigens during this development are not affected in the same way 
as αβ T cells are during their thymic development. Neither the number of γδ T cells 
nor their antigen specificity was affected by TCR-ligand interactions in the thymus. 
However, the γδ T cells that had interacted with antigen in the thymus developed into 
IFN-γ producing cells, while those that had not interacted with antigen, developed into 
IL-17 producing cells. In other words, thymic selection seemed to induce expression 
of distinct cytokine and chemokine receptors, which may further determine location of 
the cells. Thus, at least two functionally different populations of thymus-derived γδ T 
cells help control immune response (Jensen et al. 2008). 
2 TOLERANCE AND AUTOIMMUNITY 
The main function of the immune system is to fight off foreign invaders. However, 
another, equally important feature of the immune system is its capacity to 
distinguish between self and non-self. Self-tolerance is defined as the stable state in 
which the immune system does not react self-destructively against self-molecules, 
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cells or tissues (Pugliese 2004). Self-tolerance operates both centrally and in the 
periphery. The failure of self-tolerance leads to attack against self; against own 
molecules, cells and tissues causing destruction of self. Such deleterious actions are 
called autoimmune responses and can ultimately lead to autoimmune diseases 
(Pugliese 2004). 
2.1 Central tolerance 
Central tolerance is induced by negative selection of autoreactive cells, ie. of cells 
that can recognize structures of self in lymphopoietic organs. 
T lymphocytes originate from the bone marrow and then migrate to the thymus to 
mature. The aims of T cell development are the following: 1) to commit the cells to 
become T lymphocytes, 2) to rearrange the T cell receptor genes in order to generate 
a functional TCR, 3) to determine the αβ T cell line and the γδ T cells, 4) determine 
T cell subpopulations by expression of CD4 or CD8, 5) to select positively for TCR 
so that TCRs which bind to self-antigen and present MHC molecules with low 
affinity and avidity are chosen and, 6) to select TCR negatively in order to delete 
autoreactive T cell clones (Janeway 2008). 
During early maturation, T lymphocytes begin to assemble their T cell receptor 
variable (V), diversity (D) and joining (J) gene segments by somatic recombination. 
This results in a T cell population in which each T cell has a unique T cell receptor 
(Goldrath and Bevan 1999). T cell receptors are able to recognize processed 
antigenic peptides only when they are bound to MHC molecules on antigen 
presenting cells, such as DCs. This process is called antigen presentation. DCs 
determine when T cells become activated, and thus DCs act as a link between innate 
and adaptive immunity. Once activated, T cells begin to mature and take the shape 
of either Ths, Tcs or Tregs. 
Upon entry into the thymus, thymocytes are double negative (DN), lacking the 
expression of CD4 and CD8 (Lind et al. 2001). Once the thymocytes have 
successfully rearranged the β locus of their TCR, they begin to express both CD4 
and CD8 and become double positive (DP) cells, expressing both CD4 and CD8 
(Lind et al. 2001). Positive selection occurs in the cortex after rearrangement of the 
TCRα locus. Thymocytes are selected according to interactions between their TCR 
and self-peptide – MHC ligands on the surface of thymic stromal cells. T cells need 
to be able to recognize antigens presented by self MHCs. The randomly rearranged 
TCRs can be non-functional and thus cannot bind to the MHC-peptide complexes 
presented to them. Thymocytes expressing such non-functional TCRs are eliminated 
by death by neglect. Only those cells that react weakly are allowed to move on to the 
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medulla, where self-antigen presentation of TSAs takes place (Starr et al. 2003). 
Therefore, thymocytes with low to medium affinity for self-peptide-MHC 
complexes are positively selected. T cells interacting with MHC class II differentiate 
into CD4+ T cells, while those interacting with MHC class I differentiate into CD8+ 
single positive (SP) T cells (Starr et al. 2003).  
T cells which have undergone positive selection continue their education with a 
second step called negative selection. The order of these two processes is not 
necessarily chronological. Also the location of negative selection is unresolved and 
has been reported to take place in the cortex and medulla, but currently it appears that 
the medulla is favored (Kyewski and Klein 2006). During negative selection, T cells 
with high affinity to MHC-self-peptide complex undergo programmed cell death 
(Palmer 2003). Thymocytes which recognize the self-peptide-MHC complexes very 
strongly are destroyed, as they are potentially dangerous. Negative selection takes 
place in order to ensure that self-reactive T cells, which would otherwise attack self 
components, are eliminated (Ardavin 1997; Farr and Rudensky 1998). 
The purpose of negative and positive selection is to educate the T cell population 
into one that is able to bind to MHC molecules only when the MHC is associated 
with processed foreign antigenic peptides and thus, to avoid reactions against self-
peptides (Farr and Rudensky 1998). Thymic selection finally results in T cells that 
are both self-MHC restricted and self-tolerant and therefore, able to react against 
foreign antigens. Altogether, 97-99% of early, immature T cells are eliminated 
during these rigorous selection processes (Takahama 2006). This negative selection, 
by clonal deletion, is also called the development of central tolerance. 
2 . 1 . 1  m T E C s  
Thymic medullary epithelial cells (mTECs) have been characterized as the cell type 
which express a broad range of tissue-specific genes (Derbinski et al. 2001). 
Initially, the ectopic expression of peripheral self-antigens in the thymus was not 
recognized as an important process (Linsk et al. 1989). However, the functional role 
for this “promiscuous”, thymic expression of tissue-specific antigens (TSA) has 
been acknowledged in the recent years and is now understood to be very important 
in the induction of T cell tolerance (Derbinski et al. 2001; Kyewski and Klein 2006). 
The self-antigens expressed by mTECs represent almost all of the parenchymal 
organs and tissues of the body and include both developmentally and temporally 
regulated genes (Sospedra et al. 1998; Derbinski et al. 2001; Bruno et al. 2002; 
Gotter et al. 2004). Some of the antigens are known to be target autoantigens in 
autoimmune diseases, such as insulin, glutamic acid decarboxylases (GAD65 and 
67) and IA-2 in T1D, thyroid peroxidases and thyroglobulin in autoimmune thyroid 
disease as well as myelin basic protein in multiple sclerosis (MS) (Gotter et al. 
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2004). The genes promiscuously expressed by mTECs often co-localize in 
chromosomal clusters and they might constitute up to 10% of the genome, according 
to some studies (Gotter and Kyewski 2004). However, mTECs are not the only APC 
in the thymus. Which APCs present what and how their roles compliment each other 
are not yet understood. mTECs do present TSAs to T cells, but also thymic DCs 
obtain self-antigens from mTECs and present them to T cells (Zhang et al. 2003; 
Gallegos and Bevan 2004; Kyewski and Klein 2006). Furthermore, it is possible that 
peripheral DCs take up self-antigen and migrate to the thymus to supplement the 
range of TSAs presented to the developing T cells (Bonasio et al. 2006). Ectopic 
expression by mTECs is sufficient, but not necessary for the induction of tolerance 
(Derbinski et al. 2001).  
Furthermore, mTECs may play a role in the selection of Tregs in the thymus and thus 
be involved in induction of peripheral tolerance as well as central tolerance (Klein and 
Kyewski 2000). Additionally, mTECs can directly eliminate T cells that express TCRs 
for certain self-antigens (Zhang et al. 2003; Gallegos and Bevan 2004). 
Different TEC subsets have different functions. Cortical TECs (cTECs) help attract 
lymphoid precursors to the thymus from the blood and control the differentiation of 
T cells up to a point where they express the complete αβ T cell receptor complex. 
These T cells subsequently enter the positive selection phase, where T cells whose 
receptor recognizes complexes of MHC and self-peptide displayed on cTECs with 
enough affinity, are positively selected. Then the T cells move on to the medulla to 
meet mTECs and undergo negative selection (Hollander 2007). 
2.2 Peripheral tolerance 
Despite the development of central tolerance in the thymus, there is always some 
leakage of autoreactive cells to the periphery (Walker and Abbas 2002). Therefore, 
there are various other mechanisms that maintain and strengthen immune tolerance 
in the periphery. These means are collectively called peripheral tolerance. Peripheral 
tolerance can be induced by T cell anergy, by Tregs and cell death. In T cell anergy, 
the T cell becomes inactivated in response to an encounter with antigen. Although 
the T cell stays alive for some time, it is hyporesponsive (Schwartz 2003). 
Stimulation of T cells can also be downregulated by soluble factors by immune 
deviation. In immune deviation, a certain Th cell subset is preferentially activated 
instead of another in response to antigen (Rocken and Shevach 1996; Gao et al. 
1998). For example, activation of Th1 cells instead of Th2 cells, which then produce 
a different set of cytokines resulting in a different outcome than if Th2 cells had 
been activated. A more common mechanism is elimination of autoreactive T cells by 
intrinsic mechanisms. One such method is activation induced cell death (AICD). 
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AICD is induced by cell-surface death receptors on T cells, which are triggered 
initially through the TCR (Nagata 1997; Thornberry and Lazebnik 1998) and results 
in the elimination of T cells of unwanted specificities in order to maintain peripheral 
tolerance (Budd 2001). Another mechanism is called activated T cell autonomous 
cell death (ACAD) and results from the loss of survival signals for activated T cells. 
It attenuates already established T cell responses. Both AICD and ACAD act 
through apoptosis, a precisely controlled cell death mechanism (Van Parijs and 
Abbas 1998; Lenardo et al. 1999; Hildeman et al. 2003). 
In addition to the T cell intrinsic mechanisms of peripheral tolerance described 
above, also T cell extrinsic mechanisms exist. While intrinsic mechanisms act 
directly on responding T cells, the extrinsic regulatory mechanisms affect cells other 
than T cells; such as DCs or Tregs (Walker and Abbas 2002). 
2 . 2 . 1  D e n d r i t i c  c e l l s  i n  p e r i p h e r a l  t o l e r a n c e  
Dendritic cells (DC) are the most potent of the antigen presenting cells (APC). They 
have the capacity to capture and process an antigen and present it to naïve T cells. 
DCs were first characterized in the 1972 (Steinman and Banchereau 2007). 
The DCs are quite a heterogenous group of cells (Spits et al. 2000), which originate 
in the bone marrow from CD34+ progenitor stem cells. These progenitors migrate 
via the blood stream into peripheral tissues where they can differentiate into either 
myeloid (CD14+, CD11-, CD1+) or lymphoid precursor (CD14-, CD11c-, CD123+) 
cells. Which subtype of precursor type the cells differentiate into depends on the 
essential growth factors that the cells encounter. Growth factors are produced by 
various cell types, such as endothelial cells, mast cells, keratinocytes and fibroblasts 
and include GM-CSF, IL-4, IL-15, TNF-α, TGF-β and IL-3 among others 
(Mohamadzadeh and Luftig 2004; Reis e Sousa 2006). These precursors then 
differentiate further into myeloid precursors and to myeloid DCs (mDCs), whereas 
lymphoid precursors differentiate into lymphoid (plasmacytoid) DCs (pDCs). 
Myeloid DCs constitute the dominant subtype in the periphery and they are 
considered to be responsible for efficient uptake of antigens and presentation to T 
cells, whereas lymphoid DCs produce significant amounts of type I interferons 
(Cella et al. 1999; Banchereau et al. 2000; Penna et al. 2002; Colonna et al. 2004). 
There are also many other differences between mDCs and pDCs, such as their 
migratory features. While mDCs are responsive to several chemokines, and thus are 
rapidly recruited to a site of infection, pDCs localize predominantly in secondary 
lymphoid tissues and are responsive only to CXCL12 (Penna et al. 2002).  
Immature DCs reside in peripheral tissues where they ingest, accumulate and 
process antigens; sampling their antigenic environment. Immature DCs 
predominantly express molecules that enable them to recognize and phagocytose 
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antigens such as the macrophage mannose receptor and pattern recognizing 
receptors (PRR) (Adams et al. 2005) such as the Toll-like receptors (TLR) (Barton 
and Medzhitov 2003; Kokkinopoulos et al. 2005). TLRs are a group of 
transmembrane proteins that recognize pathogen associated molecular patterns 
(PAMPs) on invading bacteria and viruses. Immature DCs are unable to stimulate T 
cells (Barton and Medzhitov 2003). 
The recognition and ingestion of antigen stimulates DCs to mature. The maturation 
process leads to the abolishment of endocytic/phagocytic receptors, upregulation of 
chemokine receptors and the induction of adhesion molecules. This enables DCs to 
migrate out of nonlymphoid tissue into secondary lymphoid tissues such as the 
lymph nodes (Banchereau et al. 2000; Sozzani et al. 2000) and to present antigens to 
naïve T cells in the T cell areas of the lymph node. Mature DCs undergo phenotypic 
changes of the cell surface, including the up-regulation of HLA class II molecules 
and several co-stimulatory molecules such as CD40, CD80, CD83 and CD86 
(O'Sullivan and Thomas 2003; Adams et al. 2005). The up-regulation of HLA 
expression enhances antigen presentation to the T cell receptor (TCR) and its co-
stimulatory molecules, and induces full activation of T cells through the T cells’ 
CD28 receptor (Guermonprez et al. 2002). In other words, DCs display processed 
antigenic peptides on MHC class II molecules to CD4+ T cells (Dubois et al. 1997) 
along with co-stimulatory signals. In addition, T cell – DC interaction is mediated 
by several accessory receptors and their ligands, for example CD40 and CD40L, as 
well as adhesion molecules (Cella et al. 1996). Along with DC maturation, the 
morphology of the DCs also changes. Adhesive structures are lost, the cytoskeleton 
is reorganized and cell motility increases (Hart 1997; Lipscomb and Masten 2002). 
Finally, the maturation of DCs induces the cytokine and chemokine production by 
DCs (Banchereau et al. 2000; Adams et al. 2005). Activated mDCs release for 
example IL-12, which modulates and stimulates the production of IFN-γ from T 
cells, whereas pDCs produce high levels of type I interferons (Mackey et al. 1998). 
The multitude of markers expressed on different subsets of immature DCs, mature 
DCs and the cytokines and chemokines produced by DCs are reviewed extensively 
for example by Banchereau et al. (Banchereau et al. 2000). 
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Figure 7. Three types of signals are required for activation of naïve T cells by APCs, 
such as DCs. Signal 1 is communicated through the foreign peptide: self 
MHC complex bound by the TCR and co-receptor (CD4). This signals that 
antigen has been encountered. Signal 2 is necessary for activation, 
proliferation and survival. It is mediated via a co-stimulatory signal, for 
example CD28 on T cells and CD80 on APCs. Signal 3 is composed 
commonly of cytokines and determines the direction of T cell differentiation. 
Modified from Immunobiology (Janeway 2008). 
The mature DCs are effective APCs and are able to induce the activation of naïve T 
cells and NK cells (Godfrey et al. 2000). Naïve T cells circulate in the blood, 
travelling/trafficking continuously to the lymphoid organs and back to the blood, 
making contact with thousands of APC every day. A high number of contacts is 
essential, as only one in 104-106 naïve T cells is likely to be specific for a particular 
antigen, and as the T cells depend on signals for survival (Freitas and Rocha 2000). 
In order for a T cell to become activated and develop into effector cell, naïve T cell 
requires two signals from APCs in a process called T cell priming (Albert et al. 
2001; Shortman and Heath 2001). 
T CELL
CD4 
CD28 
MHC class II
+ antigen
TCR
CD80
(B7.7, B7.2)
LFA‐1
ICAM‐1 
or ‐2
APC
1
3
2
cytokines
TGF‐β
IL‐6
IL‐12
DC‐SIGN
ICAM‐3
 36 
In addition to being important cells in initiating an immune response against 
pathogens, DCs also play a role in the induction of tolerance. Not only do DCs 
function in the periphery, they also reside in the thymus where they present self-
antigens via MHC molecules in the thymic medulla. The importance of DCs in the 
thymus has been shown in studies where MHC class II molecules were only 
expressed in the thymic cortical epithelium, not by DCs in the thymic medulla. Such 
cases resulted in a high susceptibility for autoimmune disease, evidence that also 
DCs play a critical role in the education of T cells (Reis e Sousa 2006).  
Finally and very importantly, DCs can determine when T cells become activated and 
what type of response they make. DCs can tolerize autoreactive T cells in the 
periphery by inducing deletion, anergy, or by expanding Tregs (Steinman and 
Nussenzweig 2002). Accumulating evidence also shows that DCs promote the 
differentiation of Tregs (Hubert et al. 2007). Exactly how communication between 
these cells occurs is not known, except that it is complex.  
DCs are important cells which function in regulating the magnitude and quality of 
the immune response. How DCs coordinate central and peripheral tolerance is 
currently an active field of research. What is clear, is that defects in DC functions, 
which maintain tolerance, can lead to autoimmune and/or inflammatory diseases 
(Steinman and Nussenzweig 2002; Manuel et al. 2007). 
2 . 2 . 2  T r e g s  a n d  p e r i p h e r a l  t o l e r a n c e  
Suppressor T cells and cell mediated suppression were described as early as in the 
1960s, but both the cells and their function remained controversial for years 
(Nishizuka and Sakakura 1969; Penhale 1973; Sakaguchi et al. 1982). Finally, little 
by little, these cells, equipped with a new name: “regulatory T cells” (Tregs) were 
accepted by researchers. When it was shown that they are able to suppress the 
activation and proliferation of autoreactive lymphocytes (Sakaguchi 2004), their 
popularity rose and Tregs became a hot topic in immunology. Now several different 
subsets of Tregs have been described (Sakaguchi 2004). 
In the past years, accumulating evidence has been obtained showing that a subset of 
the medium- to high-affinity, self-recognizing, developing T cells are positively 
selected and such cells differentiate into Tregs (Sakaguchi 2004). This distinct 
population of T lymphocytes usually expresses the IL-2 receptor α chain (CD25) 
(Sakaguchi et al. 1995) and the transcription factor FoxP3 (Fontenot et al. 2003; Hori 
et al. 2003; Sakaguchi 2004), in other words they are usually CD4+CD25+FOXP3+ T 
cells, although new Treg markers are being found as well. New markers are needed, 
since it is becoming increasingly clear that FoxP3 is not a pure Treg marker, but may 
be expressed on non-regulatory cells as well. Tregs play a distinct role in the 
suppression of autoreactive T cells in the periphery (Sakaguchi 2004).  
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Why Tregs are so important was shown by Sakaguchi et al. (Sakaguchi et al. 1995). 
Their research showed that removal of the CD4+CD25+ T cell subpopulation from 
normal animals resulted in spontaneous autoimmune disease and importantly, that 
restoration of this T cell population prevented autoimmunity (Sakaguchi et al. 1995). 
Foxp3+ cells originate in the thymus, but the mechanisms of their differentiation are 
still unknown. One suggested hypothesis is that they develop in the medulla of the 
thymus and have high affinity to self-antigens, yet they are able to escape negative 
selection due to Foxp3 expression (Watanabe et al. 2005; Liston and Rudensky 
2007). Additionally, other costimulatory factors and cytokines are important for 
Treg development. One model of the steps of Tregs development is first recognition 
of self-peptide with appropriate affinity, followed by exposure to cofactors leading 
to up-regulation of Foxp3 expression. Later, the reinforcement of Foxp3 expression 
serves as protection from negative selection (Liston and Rudensky 2007). 
Actually, there are several subsets of Tregs (Bach 2003; Bluestone and Abbas 2003; 
Liu and Leung 2006), though a consensus for these has not been reached. So-called 
natural Tregs such as the CD4+CD25+ T cells develop during T cells development in 
the thymus (La Cava et al. 2006). Adaptive Tregs can be induced into Tregs from Th 
cells or from natural Tregs in the periphery by antigenic stimulation and cytokines 
(TGF-β) (Bluestone and Abbas 2003; Chen et al. 2003; Shevach et al. 2008). 
Adaptive Tregs are subpopulations such as IL-10 producing Tr1 cells and TGF-β 
producing Th3 cells (Wing et al. 2006). How each subpopulation exerts its 
suppressive or regulatory role is not yet clear, but one hypothesis is that naturally 
occurring Tregs would prevent immune responses to self-antigens and adaptive 
Tregs would regulate adaptive immune responses (Bluestone and Abbas 2003). 
2.3 Autoimmunity – breakdown of tolerance 
In autoimmune diseases, target organs are attacked by autoantibodies and/or by T 
cells (Santamaria 2001). The targets of T cells can be a single or several antigens 
which are restricted to a single, or multiple organs (Marrack et al. 2001; Santamaria 
2001). As the autoimmune disease progresses epitopes of target molecules multiply 
in a process called determinant spreading (Sercarz 2000). How autoimmune 
destruction occurs is quite complex and varies, but it involves a range of different 
immune cell types and killing pathways. For example T1D seems to result from an 
attack of autoreactive CD4+ and/or CD8+ T cells on the insulin producing β-cells of 
the pancreas, while in myasthenia gravis (MS) and systemic lupus erythematosus 
(SLE) autoreactive Th2 cells induce B cells to produce autoantibodies, which cause 
the autoimmunity (Santamaria 2001). 
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Autoimmune diseases are caused when tolerance breaks down. This means that a 
responsiveness to self-antigens arises and sustained adaptive immune reactions 
result in pathology. In other words, a body’s tissues are attacked by its own immune 
system When a T cell meets an APC, like a DC, it decides whether to initiate 
autoimmunity, immunity or tolerance. This decision is mediated by co-stimulatory 
factors which help to decide which type of reaction will follow. In the absence of co-
stimulation, tolerance is induced. If APC express self-antigens and maturation 
signals, autoreactive T cells become activated (Lesage and Goodnow 2001; Ohashi 
2002). 
Autoreactive lymphocytes that have escaped the thymus are present in everyone, but 
autoimmunity arises only in some cases, due to a sustained attack against target 
antigens. See Chapters 2.2 and 2.2 for more about central and peripheral tolerance. 
3 AUTOIMMUNE DISEASES 
The failure of self-tolerance can lead to autoimmune responses, cellular or tissue 
destruction and ultimately manifest as an autoimmune disease (Pugliese 2004). 
Paul Erlich called the phenomenon of self-tolerance “horror autotoxicus”, whereby 
the body somehow abhorred the production of harmful “autotoxins” against self that 
could otherwise cause tissue damage or dysfunction. However, it took a while – 
several decades – until the existence of autoimmune reactions were recognized 
(Maslloréns 2000). 
The prevalence of autoimmune diseases is estimated to be about 5% of the general 
population (Marrack et al. 2001). Usually, autoimmune diseases are chronic, life-
long and require immune-modulatory as well as pharmacological/ replacement 
therapies for treatment. In 2000 there were at least 40 known or suspected 
autoimmune diseases (Mackay 2000). Autoimmune diseases are usually more 
common in women than in men (Lleo et al. 2008). 
In brief, autoimmunity results from abnormal recognition of self-antigens by T cells 
and B cells. This usually leads to autoantibody production. The classical definition 
of autoimmune disease included four criteria and were later divided into three 
groups (Witebsky et al. 1957; Rose and Bona 1993; Marmont 1994): 1) direct 
evidence that the disease can be transmitted from human to human or from human to 
animal (by antibodies, T or B lymphocytes) 2) indirect proof by isolation of 
autoantibodies or autoreactive T lymphocytes, or reproducing the disease in an 
animal model and 3) circumstantial evidence via clinical signs such as lymphocyte 
infiltrates in target tissue or association with other autoimmune diseases in the same 
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person, or family. These criteria have been revised later, but in principle, are still 
valid (Rose and Bona 1993).  
Normally, the immune system does not react to self-antigens. However, when 
immunological tolerance breaks down, autoimmune disease arises. Immune and 
autoimmune responses both involve the same mechanism, which are: 1) an antigen 
or autoantigen 2) a response by immune cells (such as T cells, B cells and APCs) 3) 
“messenger molecules” such as cytokine, chemokines and receptors for them and 4) 
costimulatory molecules on the cells involved (Mackay 2000). 
Autoimmune diseases can be divided into two main categories: systemic and organ 
specific diseases. Organ-specific autoimmune diseases can be either organ specific 
destructive or organ-specific non-destructive (Davidson and Diamond 2001). 
Organ-specific autoimmune diseases are characterized by the immune response 
being directed against a specific organ or organs, and even a certain part or cell type 
of an organ. For example, in T1D beta cells of pancreatic islands are affected 
(Marrack et al. 2001). Other examples are Grave’s disease and Hashimoto’s 
thyroiditis, both of which affect the thyroid gland. Although any or every organ can 
be the target of autoimmune disease, the endocrine glands are more susceptible to 
autoimmunity than other organs. It is not known why this is the case. The thyroid, 
the pancreas and adrenal cortex are examples of these autoimmune prone organs and 
when considered together as a group, they are responsible for half of the organ-
specific autoimmune cases in Europe and in the USA (Anderson 2002).  
Non-destructive autoimmune diseases involve autoantibodies which meddle with the 
function of an organ, but do not induce destruction (Gazda et al. 1995). Such 
diseases are Graves’ disease and myasthenia gravis. 
Systemic autoimmune diseases are characterized by the immune response directed 
against ubiquitous self-antigens causing destruction of a wide range of tissues. 
Examples of systemic autoimmune diseases are systemic lupus erythematosus (SLE) 
and primary Sjögren’s syndrome in which tissues such as the kidney, skin and brain 
are affected (Coppo et al. 2003). 
When a person, or other organism, is sick or under stress, lymphopenia, meaning the 
loss of a large number of T lymphocytes, may occur. This is followed by quick T 
cell proliferation in order to reconstitute the immune system. This phenomenon is 
known as homeostatic proliferation (Rocha et al. 1983). However, not all T cell 
populations necessarily expand in similar amounts and this may cause a distortion of 
cell populations favouring expansion of self-reactive T cell populations (Ernst et al. 
1999; La Gruta et al. 2000). This in turn could be a possible explanation for 
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autoreactivity seen in autoimmune diseases. States of lymphocyte deprivation may 
therefore lead to autoimmunity (King et al. 2004). 
One theory explaining the induction mechanism of autoimmune diseases is the 
“danger hypothesis”, which states that tissue injury itself cannot cause an 
autoimmune reaction, but also a “danger” signal is required to be presented by APCs 
in order to initiate an immune response (Matzinger 1994; Matzinger 2002). 
Therefore, it would be more important for an organism to recognize what is 
dangerous and what is not, instead of what is self and non-self (Matzinger 2002). 
3.1 Genetics of autoimmune diseases 
Genetic susceptibility to, or protection from polygenic autoimmune diseases (i.e. 
autoimmune diseases with multiple causative genes) are conferred, with a few 
exceptions, by polymorphisms in multiple genes acting in concert. This has been 
shown by differences in concordance rates between monozygotic and dizygotic 
twins (Wandstrat and Wakeland 2001). Monozygotic twins are genetically identical, 
except for their BCR and TCR genes, which are subject to somatic mutation and 
inactivated genes on the X chromosomes in female twins (Strachan 2003). Dizygotic 
twins share about half of their genes with their twins, just like siblings. By 
comparing disease rates in monozygotic and dizygotic twin pairs, assuming they 
share the same environment, one can find out the proportion of a disease that is due 
to genetic factors. The proportion of a random sample of pairs that are concordant 
for a trait of interest is called concordance rate. The concordance rate, i.e. how much 
of the disease is due to genetic factors, varies between different autoimmune 
disorders. For example, concordance rates for monozygotic twins are 12-15% for 
rheumatoid arthritis (RA), 24-57% for SLE and 30-50% for T1D. In contrast, 
concordance rates in dizygotic twins are 3-4% for RA, 2-5% for SLE and 0-13% for 
T1D (Wandstrat and Wakeland 2001). Familial clustering of different autoimmune 
diseases and co-association of several autoimmune diseases is often observed (Vyse 
and Todd 1996). 
Susceptibility genes can be either such that direct the response to particular 
autoantigens or those influencing tolerance, apoptosis, or inflammatory responses. 
Many common autoimmune diseases such as rheumatoid arthritis, multiple sclerosis 
and type 1 diabetes also show strong association to specific MHC alleles 
(Theofipoulos 1995). A multitude of other genes such as cytokines, 
immunoglobulins, adhesion molecules and genes encoding T cell receptors have 
been shown to be involved in autoimmune diseases (Theofipoulos 1995). Some 
genes are common such as CTLA-4, the polymorphisms of which can be linked to 
susceptibility to Graves disease (Yanagawa et al. 1995), type 1 diabetes (Marron et 
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al. 1997), Addison’s disease (Kemp et al. 1998) and multiple sclerosis (Ligers et al. 
1999). Sex differences also exist (Lleo et al. 2008) and most autoimmune disease are 
more common in women. 
MHC alleles and haplotypes, particularly of MHC class II genes, are associated with 
many autoimmune diseases (Nepom and Kwok 1998). The most known example is 
T1D for which there are both risk alleles and protective alleles (Redondo and 
Eisenbarth 2002). The mechanism/s by which MHC alleles influence disease 
susceptibility are unclear, but they are likely to be related to antigen presentation in 
the thymus and/or the periphery. 
3.2 Non-genetic factors 
In addition to genetic factors, also non-genetic factors contribute to the development 
of autoimmune diseases. One piece of evidence for this is that the concordance rates 
for monozygotic twins are far from 100% in polygenic autoimmune diseases (as 
mentioned above). Furthermore, the penetrance in spontaneous animal models of 
autoimmune disease, such as inbred rodent strains, is not complete and can be 
affected by changes in their environment (Shepel and Gould 1999; Lam-Tse et al. 
2002). Stochastic events may also be of importance for the development of 
autoimmunity. For example inbred rodent strains kept under identical conditions can 
still display a variable phenotype. Some explanations for these stochastic factors 
could be differences in the randomly generated antigen receptor repertoires, 
variability of intracellular signaling proficiency and spatial and temporal elements 
(causing the “right” lymphocyte to be in the right place at the right time or not) 
(Germain 2001). 
3.3 Autoantibodies in autoimmune diseases 
Autoantigens are self-structures with which autoantibodies or autoreactive T cells 
react and which are associated with autoimmune diseases. Antibodies that react in 
the absence of immunization with the target are called natural antibodies and can 
also be found in autoimmune diseases (Lacroix-Desmazes et al. 1998; Quintana and 
Cohen 2004). The effector mechanisms in autoimmune diseases are mediated both 
through autoantibodies, as well as through T cells. These mechanisms can be 
classified into types II-IV with analogy to hypersensitivity reactions (Coombs 1968).  
The mechanism of autoantibodies resembles the common response of an organism 
to antigens. Autoantibodies, like antibodies, show class-switch from IgM to IgG and 
other classes, the antibody genes mutate over time, they show strong specificity to 
their target and they undergo affinity maturation. This means that the autoantibodies 
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present late in a disease are more strongly reactive with their targets than early 
antibodies (Miller et al. 1990; Shlomchik et al. 1990). The number of targets of 
autoantibodies is surprisingly small; only 1-2% of the human proteins (Plotz 2003). 
Additionally, there is no common principle or feature that links this group of 
autoantibody molecules together. Also, why specific epitopes, or autoepitopes, the 
antigenic determinants of autoantibodies, are recognized is another key question of 
autoimmunity (Mackay et al. 1986, Mackay et al. 2004). Despite new knowledge on 
the properties, structural features and of certain groups of autoantibodies, the 
reasons and mechanisms for autoantibody synthesis remain a mystery (Plotz 2003). 
The pathogenesis and etiology of autoimmune diseases are not understood and 
therefore, researchers have turned to autoantibodies in order to elucidate 
autoimmune mechanisms and to find out clues as to why autoimmune disease arise 
(Plotz 2003).  
3.4 Monogenic autoimmune diseases 
Generally, autoimmune diseases are caused by complex interactions of several 
different genes and environmental factors. Only a few monogenic autoimmune 
diseases have been described (Ulmanen et al. 2005). These include APECED 
(discussed in detail later), ALPS, IPEX and IL-2Rα deficiency. In these rare 
diseases, the malfunction of one gene is the cause of autoimmune tissue destruction. 
The analyses of the molecular pathology of these diseases are more straightforward 
than of diseases with polygenic backgrounds. Not only are monogenic diseases 
severe and important per se, what’s more, studying monogenic diseases is a good 
way to learn more about complex diseases as well (Ropers 2007). 
The disease called immunodysregulation, polyendocrinopathy, and enteropathy, X-
linked (IPEX) (OMIM 304790) is caused by mutations in FOXP3 (Bennett et al. 
2001; Brunkow et al. 2001; Wildin et al. 2001). As the name indicates, IPEX is 
inherited in an X-linked fashion and in addition, it is a recessive disease (Wildin et 
al. 2002). IPEX is also called XLAAD for X-linked autoimmunity-allergic 
dysregulation syndrome. The disease is very severe and leads to early death. The 
phenotype is highly variable with T1D, severe enteropathy, hypothyroidism and 
autoimmune skin disease among other symptoms.  Additionally, for example severe 
allergic inflammation, secretory diarrhea, hemolytic anemia and thrombocytopenia 
have been described (Powell et al. 1982).  
The phenotype of the disease suggested a defect in Tregs and study of IPEX 
indicated that Foxp3 was required for thymic development of Tregs (Fontenot et al. 
2003; Hori et al. 2003; Khattri et al. 2003). Peripheral naïve T cells may also be 
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induced to express Foxp3 and gain Treg function in the periphery (Kretschmer et al. 
2005). Foxp3 (from forkhead box P3) is a forkhead transcriptional factor essential 
for Treg differentiation and function. Although the exact functional mechanisms of 
Foxp3 have not been specified yet, it has been shown to interact with nuclear factor 
of activated T cells (NFAT) and to bind directly to other target genes (Zheng and 
Rudensky 2007). However, FoxP3 may not be the master regulator of Tregs, but 
other transcriptional events may also be involved (Hill et al. 2007). Treg deficiency 
has been also associated with diseases other than IPEX. Such examples include 
rheumatoid arthritis, MS and T1D (Ehrenstein et al. 2004; Viglietta et al. 2004; 
Lindley et al. 2005). Although lack of Foxp3 expression alone is not sufficient to 
explain Treg function (Vignali 2008), studies of IPEX and its mouse model have 
unravelled important knowledge on Treg function and maintenance of tolerance. 
Mutations in either the Fas (TNFRSF6) or FasL genes cause the autoimmune 
lymphoproliferative syndrome (ALPS-1) (Behrmann et al. 1994; Fisher et al. 1995; 
Wu et al. 1996) and mutations in caspase 10 gene cause ALPS-2 (Wang et al. 1999). 
Fas, Fas-L and caspase 10 all belong to the same Fas-mediated pathway for 
apoptosis (Wu et al. 1996; Wang et al. 1999; Chun et al. 2002; Sprick et al. 2002; 
Walsh et al. 2003) which is important for T cell homeostasis. A mutation in caspase 
8 has recently been detected in two children of one family with ALPS (Chun et al. 
2002). ALPS type III has also been described (Van Der Werff Ten Bosch et al. 
2001). Type I can be divided into types Ia and Ib according to slightly different 
disease components (Van Der Werff Ten Bosch et al. 2001); (Rieux-Laucat et al. 
2003). ALPS (OMIM 601859) is inherited in an autosomal, dominant fashion 
(Straus et al. 1999) and is characterized by lymphocytosis, i.e. accumulation of 
double negative T cells (CD3+ TCRαβ CD4-CD8-), nonmalignant lymphadenopathy, 
splenomegaly and hypergammaglobulinemia. Autoimmune manifestations include 
autoimmune hemolytic anemia, idiopathic thrombocytopenic purpura and 
autoimmune neutropenia (Straus et al. 1999). ALPS-3 is milder than the other types 
of ALPS (Van Der Werff Ten Bosch et al. 2001) and mutations in other than Fas-
linked pathways have been suggested as causes for this disease subtype (Rieux-
Laucat et al. 2003). Fas is an important factor in the regulation of T cell 
homeostasis, self-tolerance and stopping immune responses. Thus, defective Fas 
leads to deficient apoptosis, the accumulation of lymphocytes in lymphoid organs 
and an excess of autoreactive naïve T cells as they are not eliminated as they should 
be (Kischkel et al. 1995). In one SLE patient, a mutation in FasL causing defective 
apoptosis was found. However, FasL mutations were not found to be a common 
cause of SLE (Wu et al. 1996). Studying ALPS has taught us more about how the 
death receptor cascade functions in immunological processes (Worth et al. 2006). 
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IL-2Rα deficiency (OMIM 606367) causes an impairment of peripheral tolerance. 
Also IL-2Rα deficiency is rare and causes a multitude of immunological deficiencies 
and autoimmune symptoms (Sharfe et al. 1997; Ulmanen et al. 2005). IL-2Rα is also 
called CD25 and is important for Tregs (Sakaguchi 2005), proliferation of T cells as 
well as being an activation marker for T cells. In the absence of a functional CD25, 
Tregs were not able to maintain peripheral tolerance in the IL-2Rα deficient patients 
(Sharfe et al. 1997; Roifman 2000; Caudy et al. 2007). Studies of IL-2Rα deficiency 
have shown that CD25 is important for expression of IL-10 by CD4+ T cells (Caudy 
et al. 2007) and have confirmed that CD25+ Tregs are needed for peripheral 
tolerance through keeping autoreactive cells in the periphery in control (Sharfe et al. 
1997; Roifman 2000).  
3.5 Autoimmune polyendocrine syndromes 
Autoimmune polyendocrine syndromes/polyglandular syndromes (APS) make up a 
group of rare, but unique autoimmune diseases (Schmidt 1926; Eisenbarth and 
Gottlieb 2004). The autoimmune polyendocrine syndromes are APS-1, -2, -3 and -4 
(Neufeld et al. 1980; Neufeld et al. 1981; Brun 1982; Obermayer-Straub and Manns 
1998; Betterle et al. 2002; Betterle and Zanchetta 2003). APSs tend to be associated 
with each other and with other organ-specific autoimmune disorders (Neufeld et al. 
1980; Riley 1992). 
Table 2. APS classification 
APS SUBTYPE DEFINING DISEASE COMPONENTS CONDITIONS 
APS-1 chronic candidiasis, chronic 
hypoparathyroidism, Addison's disease  
at least two present 
   
APS-2 Addison's disease + autoimmune thyroid 
diseases and/or T1D  
Addison's disease always 
present 
   
APS-3 autoimmune thyroid disease associated 
with other autoimmune diseases 
excluding Addison's disease 
and/or hypoparathyroidism 
   
APS-4 combinations not included in the groups 
1-3 
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APS-1 and APS-2 share features of their clinical phenotype, but differ in their 
prevalence, time of onset and inheritance (Eisenbarth and Gottlieb 2004). APS 1 will 
be discussed in more detail in the following sections. 
APS-2 is also called Schmidt’s disease, according to the discoverer of two patients 
with non-tuberculous Addison’s disease and chronic thyroid disease by M.B. 
Schmidt in 1926 (Schmidt 1926). APS-2 is a polygenic disease with a combination 
of Addison’s disease with autoimmune thyroid disease and/or T1D as the disease 
components. The patients do not have hypoparathyroidism or candidiasis, the onset 
is at an adult age and the etiology is multifactorial (Carpenter et al. 1964; 
Obermayer-Straub and Manns 1998; Eisenbarth 1999). APS 2 patients also have 
circulating autoantibodies (Song et al. 1996). APS-2 is more common than APS-1 
(Guisan et al. 1969). APS-2, as well as isolated Addison’s disease, show strong 
association with the MHC locus (HLA-DR3 and DR4 alleles) and both diseases are 
more common in females, as opposed to APS-1 (Eisenbarth and Lebovitz 1978; 
Partanen et al. 1994; Huang et al. 1996). 
APS-3 is a heterogenous disease with autoimmune thyroid disease and at least one 
other autoimmune disorder, excluding Addison’s disease. The mode of inheritance and 
background are unknown (Neufeld et al. 1980; Neufeld et al. 1981; Obermayer-Straub 
and Manns 1998). APS was classified earlier into three subtypes (Neufeld et al. 1980), 
but the classification has recently been modified into four subtypes (Betterle and 
Zanchetta 2003). The classification of APS-1 and APS-2 remain as they were before, 
but APS-3 is now classified into four subtypes APS-3A, APS-3B, APS-3C and APS-
3D according to the different organ-specific and nonorgan-specific autoimmune 
diseases associated with autoimmune thyroiditis (excluding Addison’s disease and 
hypoparathyroidism). APS-4 is a group of all the clinical associations not included in 
the other APS subtypes (Betterle and Zanchetta 2003). The mechanisms for the 
molecular pathology behind these diseases remain unknown. 
4 APECED 
APECED (autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy; 
OMIM 240300), also called autoimmune polyglandular syndrome type 1 (APS1), is 
a rare, monogenic autoimmune disease caused by mutations in the Autoimmune 
Regulator (AIRE) gene (Consortium 1997; Nagamine et al. 1997). APECED 
belongs to APS disease group (Eisenbarth and Gottlieb 2004) and is an organ 
specific AID affecting several endocrine and ectodermal tissues and organs 
(Perheentupa 2002).   
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A patient with APECED-like symptoms was described for the first time in the 
literature in 1929 (Thorpe 1929). Back then, APECED was called APS1 or 
Whitaker’s syndrome and after that, several different names were applied to this 
disease (Leonard 1946; Whitaker 1956; Neufeld et al. 1981; Ahonen 1985). 
Nowadays, only the names APECED or APS1 are used. 
4.1 Genetics of APECED 
APECED is an autosomal, recessively inherited disease (Ahonen 1985; Vogel et al. 
2002). Initially, the APECED locus was mapped to chromosome 21q22.3 in Finnish 
patients (Aaltonen et al. 1994). In a study consisting of a multinational group of 
APECED patients, the same chromosomal locus was found responsible for the disease 
in both the Finnish patients as well as in patients of other nationalities (Bjorses et al. 
1996). However, the haplotype segregation predicted different mutations in patients of 
different origin (Bjorses et al. 1996). The causative gene of APECED was found in 
1997. The same gene was found both in Finnish patients as well as in patients of other 
nationalities (Consortium 1997; Nagamine et al. 1997). It was a novel gene named 
AIRE for Autoimmune Regulator. Confirmation for defects in AIRE causing 
APECED came from studies which identified AIRE mutations in APECED patients 
(Consortium 1997; Nagamine et al. 1997) (Aaltonen and Bjorses 1999). 
APECED is quite a rare disease. However, it is enriched in certain isolated 
populations such as in the Finns (lifetime prevalence 1: 25,000) (Perheentupa 1972; 
Norio et al. 1973), Iranian Jews (1:9,000)(Zlotogora 1992) and Sardinians 
(1:14,500) (Rosatelli et al. 1998). APECED is also relatively common in Norway 
(Myhre et al. 2001) (1:90,000) (Kisand et al. 2008) and in Northern Italy (Betterle et 
al. 1998). Additionally, numerous cases have been reported in Great Britain (Pearce 
et al. 1998), North America (Scott et al. 1998), Eastern and Central European 
countries (Cihakova et al. 2001) and Japan (Kogawa et al. 2002). Among the Finnish 
and Iranian Jewish populations, the disease is presumably inherited from just one or 
two founder individuals (Bjorses et al. 1996). The phenotype differs between Finns 
and Iranians somewhat, as well as in other populations, partly due to the differing 
patient mutations in AIRE. However, different mutations do not have a great impact 
on disease phenotype, hence other factors, such as possible additional genes and 
environmental factors also affect the phenotype (Bjorses et al. 1996). 
Altogether, there are about 90 patients who have been diagnosed with APECED in 
Finland. This is the largest population of patients and has been thoroughly analyzed 
and the course of their disease has been extensively followed-up (Perheentupa 2006). 
Due to its relative abundance in Finland, APECED belongs to the Finnish disease 
heritage (Nevanlinna 1972; Perheentupa 1972; Norio et al. 1973; Norio 2000). 
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4.2 Clinical phenotype 
What makes this monogenic disease so fascinating is the vast and variable 
phenotype due to mutations in just one gene. APECED is characterized by a triad of 
main manifestations of which at least two must be present for diagnosis: Addison’s 
disease (adrenocortical failure), hypoparathyroidism and chronic mucocutaneous 
candidiasis (CMC) (Perheentupa 2002). Additionally, as the name of the disease 
indicates, APECED patients develop a variable number of other symptoms affecting 
endocrine and ectodermal organs and tissues.  
Endocrinopathies include type 1 diabetes (T1D), gonadal atrophy (testicular and 
ovarian failure), autoimmune thyroid disease (hypothyroidism), and gastric parietal 
cell atrophy (Ahonen et al. 1990; Betterle et al. 1993; Perheentupa 2002). Testicular 
failure occurs more commonly in older patients, whereas ovarian failure affects over 
50% of female APECED patients aged over 20 (Perheentupa 2006). Autoimmune 
hepatitis is an additional, serious disease component that can lead to acute liver 
failure and even death if untreated (Perheentupa 2006). 
Ectodermal disease components are typically alopecia, vitiligo, nail dystrophies (eg. 
enamel hypoplasia 77% prevalence), rash with fever and keratoconjunctivitis (and 
other eye problems even leading to blindness in 11% of the Finnish patients with eye 
problems) (Wagman et al. 1987; Ahonen et al. 1990; Lukinmaa et al. 1996; Perniola 
et al. 1998). 
Mucocutaneous candidiasis can infect the oral, oesophageal and the vaginal mucosa 
as well as the nails. Candidiasis may even lead to squamous cell carcinoma of the 
mouth or of the oesophagus (Perheentupa 2006; Rautemaa et al. 2007). All Finnish 
APECED patients get candidiasis at some stage of their life and it is usually their 
first symptom. Other APECED patient populations also have high prevalences of 
CMC (Betterle et al. 1998; Collins et al. 2006; Stolarski et al. 2006; Wolff et al. 
2007). An exception is Iranian Jews who usually do not get CMC (Zlotogora 1992). 
A number of rare disease components and individual disease cases have also been 
described (Ahonen et al. 1990; Friedman et al. 1991; Betterle et al. 1998; Franzese 
et al. 1999; Makitie et al. 2006). The main clinical features of APECED are 
summarized in Table 3 (Ahonen et al. 1990; Myhre et al. 2001; Perheentupa 2002). 
Usually autoimmune diseases are more common in women than in men (Lockshin 
2006). However, APECED is an exception, because it affects both men and women 
equally (Perheentupa 2006). 
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Table 3. Disease components of APECED.  
DISEASE COMPONENT PREVALENCE % 
Triad  
Mucocutaneous candidiasis 100 
Hypoparathyroidism 79 
Addison's disease 72 
Other endocrine components  
Gonadal failure* 60 
Hypothyroidism 4 
Type 1 diabetes 12 
Malabsorption 18 
Autoimmune hepatitis 12 
Autoimmune gastritis 13 
Pernicious anemia 13 
Other ectodermal components  
Enamel hypoplasia 77 
Alopecia 72 
Vitiligo 13 
Nail dystrophy 52 
Keratopathy 35 
Adapted from Ahonen et al. 1990 and Perheentupa 2002 
* postpubertal individuals  
 
The course of the disease varies among patients. The onset of APECED occurs 
usually in childhood, by the age of five in Finnish patients (0,2-18 years) (Ahonen et 
al. 1985) and at the average age of 9 years in Norwegians (Wolff et al. 2007). 
Candidiasis appears at a very young age (peak incidence is over the first two years 
of life, although it may not appear until adulthood) (Perheentupa 2002), 
hypoparathyroidism at the age of 3-5 years, followed by adrenal failure at the age of 
11-15 years (Ahonen et al. 1990). Hypoparathyroidism is more common in female 
APECED patients with a prevalence of 98% vs. 71% in men and also appears earlier 
in women (Gylling et al. 2003). Several deaths due to APECED have been described 
in Norwegians (Wolff et al. 2007). 
Most adult patients have up to seven different disease components (some with 
combinations of over ten components!). Disease symptoms may manifest even more 
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as the patients age, since the prevalence of most components increases with age at 
least until the age of 60 yrs (Ahonen 1985; Ahonen et al. 1990; Perheentupa 2002; 
Perheentupa 2006).  
The clinical picture varies from one patient to another and even siblings within one 
family may have a very different phenotype. Also the occurence of the different 
disease components vary between populations (Ahonen et al. 1990; Betterle et al. 
1998; Perheentupa and Miettinen 1999; Myhre et al. 2001; Perheentupa 2002). The 
reasons for this complexity are not yet understood, but one suggestion is the 
involvement of genetic factors other than AIRE (Ahonen et al. 1990). 
4.3 Diagnosis and treatment 
In short, diagnosis is based on the clinical detection of the triad of disease 
components, sequencing of AIRE mutations (although this usually only covers the 
major mutations) and testing for APECED autoantibodies in the serum. After 
diagnosis, follow-up and therapy should be arranged in addition to regular 
monitoring of new symptoms and disease components. The major forms of 
treatment for APECED patients are antifungal drug therapy when required and 
adequate replacement therapy for endocrine organ failures, as well as specific 
treatment for other disease components as required. Additionally, it is important to 
inform patients and their families of how the disease may evolve (Perheentupa 2002; 
Perheentupa 2006).  
4.4 Genetic factors affecting the APECED phenotype  
In monogenic disease, the main cause for the disease is a mutation in a single 
causative gene, rendering it unfunctional. However, the nature of the mutation may 
affect the causative disease phenotype. Yet, even in monogenic diseases there are 
often other modifying factors that have a small or a bit larger impact on the precise 
disease phenotype. These factors can be other genes, for example HLA. 
4 . 4 . 1  C o r r e l a t i o n s  b e t w e e n  m u t a t i o n s  a n d  p h e n o t y p e  
To date, over 60 patient mutations have been reported in the AIRE gene (Consortium 
1997; Nagamine et al. 1997; Heino et al. 2001; Halonen et al. 2002; Meloni et al. 
2002; Buzi et al. 2003; Harris et al. 2003; Vogel et al. 2003; Peterson et al. 2004; 
Meloni et al. 2005; Podkrajsek et al. 2005; Dominguez et al. 2006; Stolarski et al. 
2006; Ulinski et al. 2006; Wolff et al. 2007). A mutation registry has been set up at 
bioinf.uta.fi/AIREbase. Mutations occur throughout the protein coding region of 
AIRE and include different mutation types: single nucleotide substitutions, small 
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insertions and deletions. Additionally, mutations affecting the splicing consensus 
sequences have been identified.  
In isolated populations, where APECED is enriched, an apparent founder effect 
results in one common mutation in the majority of the disease alleles. The major 
Finnish mutation is R257X (called FinnMajor), substituting a C to T and changing 
arginine to a premature STOP codon in exon 6. 77% of Finnish patients analyzed are 
homozygotes and 17% are compound heterozygotes for R257X (Perheentupa 2006). 
Furthermore, about 30% of non-Finnish patients also have the R257 mutation 
(Bjorses et al. 2000). Thus, the FinnMajor mutation is also the most common mutation 
in non-Finnish populations (Scott et al. 1998). In Sardinian APECED patients the 
mutation R139X dominates, comprising 90% of their mutant alleles (Rosatelli et al. 
1998). Amazingly, all the Iranian Jews with APECED are homozygous for Y85C. 
This mutation has not been reported in any other patients from other populations 
(Zlotogora 1992). Another mutation common in several different APECED patient 
populations is the deletion (967-979del13bp) in exon 8 (Nagamine et al. 1997; 
Pearce et al. 1998; Scott et al. 1998; Wang et al. 1998; Heino et al. 1999; Bjorses et 
al. 2000; Dominguez et al. 2006; Wolff et al. 2007). 
No strong correlations have been shown between the genotypes and phenotypes of 
APECED patients. Only an association between the lack of the FinnMajor mutation 
and a decrease in the frequency of candidiasis has been shown (Halonen et al. 2002). 
Additionally, CMC is rare in the Iranian Jews with APECED, all of whom carry the 
Y85C mutation (Zlotogora 1992). The variability of APECED and the differences in 
the range of disease components between patients suggest that factors other besides 
AIRE, genetic and/or environmental, affect the disease phenotype (Halonen et al. 
2002). An interesting note on the heritability of APECED is that although APECED 
appears to be inherited in an autosomal, recessive fashion, one Italian family with 
APECED carrying mutation G228W has shown a dominant negative mode of 
inheritance (Cetani et al. 2001). A mouse model in which the same mutation was 
knocked into mice caused autoimmunity in the mice and also showed a dominant 
negative effect (Su et al. 2008).  
Most mutations in the coding region of AIRE are nonsense mutations which lead to a 
premature STOP codon. Missense mutations are also common and reside in functional 
protein domains of AIRE. These mutations have been utilized to analyze the functions 
of the different AIRE domains (Bjorses et al. 2000; Pitkanen et al. 2000; Pitkanen et 
al. 2001; Halonen et al. 2004; Uchida et al. 2004; Pitkanen et al. 2005). 
4 . 4 . 2  A P E C E D  a n d  H L A  
Unlike in many common autoimmune diseases, APECED, or increased risk for 
APECED, has not been shown to be associated with polymorphisms in the human 
 51 
leukocyte antigen (HLA) gene locus. However, individual HLA class II alleles have 
been shown to affect the phenotype of APECED. The strongest associations were 
for alopecia and Addison’s disease and T1D. For T1D the association was found for 
a protective allele (Halonen et al. 2002). The same alleles have also been found to be 
associated with these disease components in non-APECED patients (Maclaren and 
Riley 1986; Weetman et al. 1991; Halonen et al. 2004). 
4.5 Autoantibodies in APECED  
Many of the clinical manifestations of APECED patients are associated with the 
presence of circulating autoantibodies directed against specific autoantigens 
expressed in the affected tissue. They may be a cause of target tissue destruction and 
these autoantibodies also often precede specific manifestation. Therefore, they are 
valuable in diagnosis of APECED as well as in predicting the course of the disease 
to some degree (Ahonen et al. 1987; Betterle et al. 1998; Betterle et al. 2002).  
APECED patients produce high-titer IgG autoantibodies with high affinity for 
tissue-specific antigens. This has made the use of these autoantibodies valuable for 
identifying autoantigens important in also more common autoimmune diseases, 
since patients with similar individual disease components may harbor autoantibodies 
against the same autoantigen targets (Mirakian et al. 1998). 
Using a set of three autoantibodies: P450c21, P450scc and AADC, the sensitivity of 
diagnosis of APECED was 89% (Soderbergh et al. 1996). Presence of antibodies 
against 21-hydroxylase predict the development of adrenal insufficiency (Ahonen et 
al. 1987; Betterle et al. 2002). Some of the APECED autoantibodies are specific for 
APECED, whereas others are found in other autoimmune diseases as well. A 
specific autoantigen is, for example, anti-tryptophan hydroxylase (TPH), whereas 
eg. anti-GAD-65 autoantibodies are found in T1D and anti-21-hydroxylase 
antibodies are typical for Addison’s disease as well (Baekkeskov et al. 1990; 
Winqvist et al. 1992; Ekwall et al. 1998; Ekwall et al. 1999). 
Many of the APECED autoantibodies are directed against intracellular key enzymes 
in the affected organs such as the adrenal gland, gonads and placenta (Peterson et al. 
1998). The major autoantigens in APECED belong to the steroidogenic P450 
superfamily. They are the steroidogenic enzymes 17-α-hydroxylase (P450c17), 21-
hydroxylase (P450c21) and cholesterol side-chain cleavage enzyme (P450scc) 
(Krohn et al. 1992; Winqvist et al. 1992; Uibo et al. 1994; Winqvist et al. 1995), 
catalyzing the chemical reactions required for the production of steroid hormones 
like aldosterone, progesterone and cortisole (Chen et al. 1996). P450c21 and 
P450scc are associated with Addison’s disease in APECED (Soderbergh et al. 
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2000), as is also P450c17 (Uibo et al. 1994). P450c21 is expressed in the adrenal 
cortex, while P450c17 and P450scc are expressed in the gonads as well (Peterson et 
al. 1995). However, P450scc alone associates with hypogonadism (Soderbergh et al. 
2000). The presence of P450c17, P450scc and P450c21 precede adrenocortical and 
ovarian failure and therefore can be used as predictive markers for APECED 
(Ahonen et al. 1987).  
Another group of APECED autoantigens is pteridine dependent hydroxylases and 
includes autoantibodies against tryptophan, tyrosine and phenylalanine hydroxylase 
(TPH, TH and PAH, respectively) (Ekwall et al. 1998; Ekwall et al. 2000; Hedstrand 
et al. 2000), although the role of PAH as an autoantibody for APECED is disputed 
(Ekwall et al. 2000). They are involved in the catalysis of serotonin and dopamine 
together with aromatic L-amino acid decarboxylase (AADC), which is also an 
APECED autoantigen (Husebye et al. 1997; Ekwall et al. 2000). TPH correlates 
with gastrointestinal dysfunction (malabsorption) and targets serotonin-secreting 
enterochromaffin cells of the small intestine (Ekwall et al. 1998). 
Autoantibodies against cytochrome P450 enzymes 1A2 and 2A6 are present in 
APECED patients with chronic, autoimmune hepatitis (Clemente et al. 1997; 
Clemente et al. 1998), as well as AADC (Gebre-Medhin et al. 1997). 
GAD65 (Bjork et al. 1994; Velloso et al. 1994) and AADC (Husebye et al. 1997) are 
pancreatic autoantibodies, react against islets of Langerhans and generally predict 
T1D. Yet, in APECED their value in this prediction is not high (Tuomi et al. 1996). 
In the case of GAD65 this may be due to the autoantibodies targeting different 
epitopes in APECED than in T1D patients (Velloso et al. 1993; Bjork et al. 1994). 
Additionally in APECED patients with T1D, autoantibodies against tyrosine 
phosphatase, islet cell antigen-2 (IA-2), insulin and/or islet cell autoantibodies (ICA) 
are present (Ahonen et al. 1985; Tuomi et al. 1996; Gylling et al. 2000; Klemetti et 
al. 2000). However, only IA-2 was shown to have a predictive value for T1D in 
APECED (Soderbergh et al. 2000). 
Autoantibodies against hair follicles associate with alopecia totalis in APECED 
(Hedstrand et al. 1999). The transcription factors SOX9 and SOX10 are APECED 
autoantigens expressed in melanocytes and have been associated with vitiligo in 
APECED (Hedstrand et al. 2001).  
Various other tissue-specific autoantibodies: GAD67, insulin, thyroid peroxidase, 
thyroglobulin and calcium-sensing receptor (Li et al. 1996; Betterle et al. 1998; 
Heino et al. 2001; Peterson et al. 2004) have also been identified as targets for 
autoimmune response in APECED. Surprisingly, APECED patients may have 
organ-specific autoantibodies even if they show no signs of the diseases (Soderbergh 
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et al. 1996). Why these specific antigens are targets of APECED autoantibodies is 
not understood. 
5 MOUSE MODELS OF AUTOIMMUNITY 
Mice are used in several branches of biological research in order to study different 
aspects that cannot be studied in humans in order to gain insight to what happens on 
a whole organism level. In order to study disease mechanisms, such as those for 
autoimmunity, animal models are valuable tools in addition to cells and in vitro 
experiments. Although lower organisms such as bacteria, worms and flies can be 
used for some aspects, mammalian models are needed in order to understand disease 
mechanisms of higher level organisms. For example one cannot study tolerance in 
worms lacking an adaptive immune system and no thymus is present in species 
which are more primitive than vertebrates (Rodewald 2008). The mouse is a widely 
used mammalian model animal, due to its small size, short lifespan, short generation 
time and similarity in some respects, and to some extent, to humans (Haley 2003).  
Most human genes have mouse homologues. These homologous genes can be 
manipulated, for example stably or conditionally knocked-out, in order to produce 
mouse models of human disease. For example the Aire knock-out mouse is a model 
for the human APECED disease, in which the human AIRE gene is rendered 
unfunctional due to mutations. Genetic manipulation of the mouse has been made 
possible by developments in different transgenic technologies for targeted gene 
manipulation and the availability of embryonic stem cell lines (Glaser et al. 2005). 
Availability of inbred mouse strains, phenotypic databases and the mouse genome 
sequence are important tools for current biomedical research (Waterson et al. 2002; 
Guenet 2005). Analyses of immunological mouse models have helped understand 
more about our immune system. For example intracellular signalling pathways have 
been elucidated and regulatory mechanisms of autoimmunity have been illuminated 
(Mak et al. 2001). However, valuable as mouse models are, one must bear in mind 
when converting these data to humans that mice are not men (Leiter 2002; Haley 
2003; Mestas and Hughes 2004). 
5.1 Selected mouse models of autoimmunity 
There are probably hundreds, if not thousands of different mouse models of some 
form of autoimmunity or immune deficiency. This chapter will concentrate on some 
interesting and relevant autoimmune mouse models. These include models for MS, 
SLE and T1D, which are among the most common autoimmune diseases (Morel 
2004) as well as some monogenic mouse models relevant to this study.  
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Animal models, particularly mice in the last few decades, have become the best tool 
in which to study disease mechanisms and particularly those of autoimmune 
diseases (Morel 2004). Organ-specific autoimmune diseases contain autoantibodies 
against antigens confined to a particular organ, whereas systemic autoimmune 
diseases are characterized by antigens widely distributed throughout the body (Van 
Parijs and Abbas 1998). Many mouse models of autoimmunity are induced models, 
for example several models of gastritis (Sakaguchi et al. 1985; Field et al. 2005). 
Autoimmunity in mice may be induced by several methods such as by thymectomy, 
manipulation of thymus, or of their T cells, by immunization etc. Induced mouse 
models will not be discussed here. 
5 . 1 . 1  N O D  m i c e  
Type 1 diabetes (T1D), also called insulin-dependent diabetes mellitus or juvenile 
diabetes, is one group of glucose intolerance syndromes. The non-obese diabetic 
(NOD) mouse is probably one of the most well-known models of autoimmune 
disease. This mouse is used as a model of T1D although many papers have reported 
differences with human T1D (Velloso et al. 1994; Leiter 2002; Roep and Atkinson 
2004). The model was established by Makino et al. in 1980 (Makino et al. 1980). 
The mice develop insulitis already at 5 weeks of age. Onset occurs usually around 
12-14 weeks of age, slightly earlier in females than in males (Andre et al. 1996). The 
cumulative incidence of diabetes reaches 80% of females and 35% of males at 30 
weeks of age (Makino et al. 1980). In a dirtier environment, the mice are less sick 
(Singh and Rabinovitch 1993; Bach 1994; Bowman et al. 1994) due to unknown 
environmental factors. 
Several loci, MHC and others seem to control the susceptibility to T1D in NOD 
mice. Exact genes causing the dysregulation seen in NOD mice have not been 
identified so far and absence of protective genes has been hypothesized to affect the 
NOD phenotype (Anderson and Bluestone 2005). It is only known that NOD mice 
have several defects in central tolerance, in the process of thymic selection 
(Kishimoto and Sprent 2001). These include defects in apoptosis during thymic 
deletion (Lesage et al. 2002; Liston et al. 2004), morphological lesions (Delovitch 
and Singh 1997; Atlan-Gepner et al. 1999), and global defects in thymic negative 
selection (Kishimoto and Sprent 2001).  Yet the molecular mechanisms for these 
defects remain unclear, though a multitude of different hypotheses have been 
suggested by different groups. NOD mice usually also develop other autoimmune 
syndromes besides T1D. These include autoimmune inflammation of salivary glands 
or ducts (sialitis) (Hu et al. 1992), autoimmune thyroiditis (Many et al. 1996), 
autoimmune peripheral neuropathy (Salomon et al. 2001) and a SLE-like disease if 
exposed to killed mycobacterium (Silveira and Baxter 2001). T lymphocytes are key 
players in these diseases, but the other factors such as antigens recognized and role 
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of costimulation vary (Anderson and Bluestone 2005). Transfer of islet-specific 
CD4+ T cells accelerates the onset of T1D in NOD mice (Haskins and McDuffie 
1990). However, both CD4+ and CD8+ T cells are required for β cell destruction 
(Gerling et al. 1992). NOD mice show a multitude of immune defects and defects in 
several leukocyte subsets (Anderson and Bluestone 2005). There are however, 
differences between different NOD colonies (Pozzilli et al. 1993). In the NOD mice, 
autoantigens are targeted against at least insulin, GAD and IA-2 (Lieberman and 
DiLorenzo 2003). Proinsulin is the essential driver autoantigen in T1D (Harrison et 
al. 2008). In T1D there is a strong influence of the MHC and a multitude of other 
loci each having additional weak effects on the phenotype, as opposed to the case of 
APECED (discussed below in 5.2 Mouse models of APECED). However, similarly 
to APECED, there are defects in DC maturation in NOD mice (Prasad and Goodnow 
2002; Prasad and Goodnow 2002). 
Thanks to NOD mice, although the molecular pathology remains incompletely 
resolved, progress has been made and we have learnt more about organ-specific 
autoimmune diseases, T1D and some mechanisms behind a complex disease 
(Atkinson and Leiter 1999; Adorini et al. 2002; Anderson and Bluestone 2005). 
5 . 1 . 2  E A E  m i c e  
Multiple sclerosis (MS) is an inflammatory disease of the central nervous system in 
which chronic inflammation, demyelination, and axonal damage occur. Why MS 
occurs is proposed to be due to the breakdown of tolerance to CNS self-antigens in 
genetically susceptible individuals (Frohman et al. 2006; Zozulya and Wiendl 2008). 
Experimental autoimmune encephalomyelitis (EAE) is the rodent model of MS. 
First it was shown that EAE mice can be protected from disease by injection of 
CD4+ splenocytes or thymocytes (Furtado et al. 2001). By studying EAE mice 
further, important mechanisms in the immunopathology of MS and CNS have been 
revealed. Now it is known that EAE can be alleviated by transfer of Tregs and that 
certain Treg populations play a key role in MS by suppressing T cell mediated 
“autoaggression” against structures of the central nervous system (CNS). Also DCs 
may play an important role in MS, in modulating Treg responses (Zozulya and 
Wiendl 2008). 
In addition to the EAE mice, many other mouse models of MS have been used as 
well. An example of one that has been around for a long time as a model of 
demyelination induced by a virus. This is Theiler's murine encephalomyelitis virus 
(TMEV) infection of mice, which stimulates a MS-like disease in susceptible strains 
of mice. However, TMEV does not cause disease in humans and is thus 'merely a 
disease of mice' (Drescher and Sosnowska 2008). Other models are different types 
of transgenic and induced mice (Morel 2004; Bettelli 2007). 
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5 . 1 . 3  S c u r f y  m i c e  
Scurfy is an X-linked, recessively inherited mouse mutant model (Brunkow et al. 
2001). The phenotype of scurfy mice resembles human IPEX (Lyon et al. 1990). 
With the help of scurfy (sf) mice, the human Scurfin or FOXP3 was found after 
identifying mouse Foxp3. The human FOXP3 is homologous to mouse scurfin, or 
Foxp3 (Brunkow et al. 2001). The name scurfy comes from the meaning of the word 
scurfy: scaly or shredded dry skin. This phenotype or disease “scurfy” applies to the 
appearance of the scurfy mice (Brunkow et al. 2001). 
Absence of functional FOXP3 leads to IPEX in humans (discussed in section 3.4) 
and the corresponding defect leads to a similar disease in scurfy mice. Disease is due 
to Treg deficiency, due to the lack of FOXP3 which is a transcriptional enhancer 
(Marson et al. 2007; Zheng et al. 2007) necessary for normal function of Tregs 
(Yagi et al. 2004). In the absence of FOXP3, T lymphocytes still develop markers 
for Tregs, but the Tregs are not able to function as suppressors (Gavin et al. 2007). 
Scurfy mice have fulminant systemic autoimmunity, like IPEX patients, but they 
also exhibit lymphoproliferative infiltrations of the liver, spleen and lymph nodes, 
which does not usually manifest in IPEX patients (Torgerson and Ochs 2007). In 
mice, in addition to the infiltrations, the CD4+ T cells hyperproliferate, and an 
elevation in cytokine levels is notable (Brunkow et al. 2001).  
5 . 1 . 4  l p r  a n d  g l d  m i c e   
Deficiency of the lpr and gld genes causes very similar phenotypes. The lpr 
phenotype resembles human systemic lupus erythematosus (SLE). SLE is an 
autoimmune, inflammatory disease of connective tissue with variable features and it 
is able to affect nearly every organ. Additionally, high titers of systemic 
autoantibodies are produced in SLE patients (Liu and Mohan 2006). 
The mutated gene in ALPS type 1a was found with the help of the spontaneous 
mouse model for ALPS called the lpr/lpr or lpr mouse, in which lpr stands for 
lymphoproliferation (Watanabe et al. 1991). These mice were found to lack 
expression of Apo-1 (CD95) (Watanabe-Fukunaga et al. 1992). Apo-1 is also called 
Fas and mediates apoptosis (Trauth et al. 1989; Yonehara 1999). In other words, the 
lpr mouse carries a spontaneous mutation in Fas rendering it unfunctional 
(Watanabe-Fukunaga et al. 1992) (Kuhtreiber et al. 2003). 
The lpr mice have been bred into different backgrounds and these background 
strains affect the disease phenotype (Cohen and Eisenberg 1991), similarly as in 
other mouse models. Lpr mice develop numerous autoimmune traits and 
accumulation of double-negative (CD4-CD8-) T cells, just like in ALPS (Cohen and 
Eisenberg 1991). The lpr mice produce autoantibodies to target antigens 
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homologues for the human SLE autoantigens, such as against chromatin and DNA. 
However, mice produce additional autoantibodies against targets not found in 
human patients, such as IgG rheumatoid factors (Eisenberg et al. 1979). The 
autoantibodies common in mice and men are believed to reflect the essential 
immunoregulatory abnormalities of SLE, but how they generate the pathology is not 
yet understood (Cohen and Eisenberg 1991). In addition, it is important to keep in 
mind that mouse strains, or background genes may have an important impact on the 
phenotypes and autoimmune features of SLE mouse models (Bygrave et al. 2004). 
FasL-deficient mice are called gld/gld or gld mice, in which gld stands for generalized 
lymphoproliferative disease (Roths et al. 1984). Deficiency in gld is also autosomal, 
and recessively inherited. It leads to lymphoproliferation and autoimmunity 
resembling ALPS type 1b, which is caused by mutations of the human FasL. The 
phenotype of gld mice is nearly identical to that of lpr mice (Allen et al. 1990; Cohen 
and Eisenberg 1991), since the two mice have genes defective in the same Fas (CD95) 
– FasL (CD95L) pathway of apoptosis (Kuhtreiber et al. 2003). 
Studies using these two mouse models have given new insights into systemic 
immunity and control of lymphocyte proliferation (Cohen and Eisenberg 1991). 
Additionally, they have taught us that autoimmune disease can be mediated by 
defects in apoptosis genes (Nagata and Suda 1995; Kuhtreiber et al. 2003). 
Interestingly, lupus patients do not commonly seem to have mutations in FasL and 
show accelerated apoptosis – exactly the opposite to the situation in the mouse 
models (Kuhtreiber et al. 2003; Xue et al. 2006). 
5 . 1 . 5  O t h e r  s e l e c t e d  m o u s e  m o d e l s  
Mice with a defect in IL-2R (CD25) have a severe phenotype of autoimmunity, 
including splenomegaly, lymphadenopathy, colitis and hemolytic anemia, similar to 
the phenotype of scurfy mice (Willerford et al. 1995). Studies on mice lacking CD25 
have implied defects in Tregs, but exact mechanisms are not yet known.  Further 
studies are required to verify the mechanism of the corresponding pathology in the 
human disease (Torgerson and Ochs 2007). 
Alopecia areata (AA) develops spontaneously in several animal species (McElwee et 
al. 1998). For example C3H/HeJ mouse colony manifests clinical and 
immunological features that resemble those of human AA (Sundberg et al. 1994). 
The mice produce antibodies against hair follicle structures and react with keratins 
similarly as do human AA antibodies (Tobin et al. 1994). These mice are an 
appropriate model for human AA and support the hypothesis that AA results from 
an abnormal autoimmune response to hair follicles (Tobin et al. 1994).  
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New Zealand mice are a spontaneous animal model of human SLE (Andrew et al., 
1978, Borchers A Ansari AA et al. 2000 Semin Arthritis Rheum). Other, less well-
known autoimmune models are for example mouse models of autoimmune ovary 
disease (AOD) and experimental autoimmune uveitis (Caspi et al. 2008), as well as 
new models such as for ocular myasthenia gravis (oMG) (Yang et al. 2007) and 
autoimmune gastritis (Alderuccio et al. 2002).   
Animal models of other APS’s than APS 1 include other animals than just mice. 
There are the spontaneous models of obese strain White Leghorn chicken (OS 
chicken) for APS 2, the BioBreeding (BB) rat for APS 3 and the NOD mouse, 
described above, for APS 4 (Ikegami 2002). In addition, induced models can be 
found for APS2 and 3. For example, the administration of cyclosporin A and 
subsequent thymectomy lead to APS 2 in mice (Sakaguchi and Sakaguchi 1989). 
Another experimental model worth mentioning is the Smyth line chicken model. 
Spontaneous vitiligo and AA like symptoms are manifested in these birds. 
Furthermore, these chickens express autoantibodies against melanocytes (Smyth and 
McNeil 1999). 
5.2 Mouse models of APECED 
Aire-deficient mice have been valuable tools in learning more about Aire function 
and the pathogenesis of APECED (Anderson et al. 2002; Ramsey et al. 2002; 
Kuroda et al. 2005). 
The first two mouse models of APECED were published in 2002 and were both Aire 
knock-outs made in 129/Sv ES cells and backcrossed into the C57/BL6 background 
(Anderson et al. 2002; Ramsey et al. 2002). Both of the mouse models showed 
general signs of autoimmunity while lacking clinical symptoms resembling those of 
APECED patients. However, in the first Ramsey paper, the knock-out mice had not 
yet been backcrossed into congenity in the B6 strain and infertility, as well as some 
other symptoms were greater before the line was congenic in B6 mice (own 
observations and Goodnow, personal communication). 
Autoimmune manifestations of these mice, which were kept in sterile conditions and 
which developed normally, include lymphocyte infiltrates of the target organs, 
circulating autoantibodies and infertility (Anderson et al. 2002; Ramsey et al. 2002). 
The Ramsey mouse was constructed by the Peltonen group using targeted disruption 
of exon 6 of murine Aire in order to mimic the FinnMajor mutation (Ramsey et al. 
2002). The size, weight and maturation of the Aire-deficient mice were normal 
compared to wild type (wt) mice, i.e. Aire-positive controls. However, Aire-
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deficient mice did not reproduce in normal numbers and 85% of the males and 
females were found to be infertile. This feature resembles the clinical phenotype of 
human APECED, as APECED patients develop ovarian failure in 39% to 72% of 
cases (at 15 years and 36 years respectively). Hypogonadism occurs also in male 
APECED patients, but their testicular failure occurs at a later age and lower 
prevalence than the ovarian failure in women with APECED (Perheentupa 2002; 
Perheentupa 2006). 
Histological analyses of the Ramsey mouse showed atrophy of the thymus and adrenal 
glands as well as lymphocyte infiltrations in the liver, in accordance with autoimmune 
hepatitis in APECED patients (prevalence 12%). Organ atrophy varied between mice, 
for example one atrophied ovary was found. This variance resembles the variable 
phenotype between patients. In the Aire-deficient mice, circulating autoantibodies 
were found against liver, spermatogonia/spermatids, exocrine pancreas, adrenal cortex 
and in one case, β cells of islets of Langerhans. This also resembles the panel of 
autoantibodies found in APECED patients (Halonen et al. 2002). 
Analyses of the Aire deficient mice revealed that lymphocyte populations were 
normal, with the sole differences in hyperproliferation. Hyperproliferation of Aire 
deficient T cells occurred in response to immunisation and in three out of the 24 
splenic TCR vβ chain families of the Aire knock-out mice as compared to Aire-
positive mice. These defects were suggested to imply at least a partial role for Aire 
in regulation of peripheral tolerance, since the overrepresentation of certain TCRs 
may induce imbalance in T cell homeostasis. The authors hypothesized that 
environmental stimuli could also be a cause of the autoimmune reactions seen in the 
Aire knock-out mice, since in the mouse model, as with APECED patients, disease 
manifests after birth and thus after contact with the outside world (Ramsey et al. 
2002). However, a fresh report showed that no environmental stimulation is needed 
for autoimmunity in Aire deficient mice (Gray et al. 2007).  
The mouse model constructed by Anderson et al. (Anderson et al. 2002) was 
produced by conditional targeted disruption of exon 2, including parts of the 
surrounding intronic sequences. 
This induced defect may not cause marked differences from the Ramsey mouse in its 
outcome, since no truncated form of Aire could be detected in the Ramsey model, nor 
was it reported in the Anderson mouse (Anderson et al. 2002; Ramsey et al. 2002). 
Histological analyses showed, again, lymphocytic infiltrations in the salivary glands, 
ovarian follicles, retina of the eye. Autoantibodies were observed against oocytes of 
the ovary, parietal cells of the stomach and the outer layer of the retina of the eye. 
Thus a broad, yet specific defect of tolerance was observed. No faults with retina or 
salivary gland have been shown in APECED patients (Lambe et al. 2007). Further, 
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the phenotype of the two mouse models also differs slightly with their findings of 
target organs. This may of course be due to the difference in gene disruption.  
Further analyses of the mice showed that the number of mTECs was twice as much as 
that in the wt mice and the number of activated memory T cells was also twice as high in 
the Aire deficient mice compared to the wt mice. The results of gene expression studies 
suggested that Aire functions in non-hematopoietic cells. Follow-up experiments 
showed that Aire functions in the radio-resistant stromal cells of the thymus. 
Furthermore, it was shown by cell transplantation experiments that Aire-deficient 
lymphocytes were sufficient to cause autoimmunity in alymphoid Rag0/0 recipients. 
Finally, using microarrays, Aire was shown to function as a transcriptional regulator 
of 200-1200 genes and thus control the expression of ectopic antigens in the thymus 
by mTECs. However, not all of the previously established ectopically expressed 
genes (Derbinski et al. 2001) were found to be down-regulated in Aire deficient 
mice. Thus, Aire appears to regulate only a fraction of these genes.  
After these two mouse models had been characterized, a few more Aire deficient 
mice strains were published. First, another Aire knock-out was constructed using 
gene targeting of exons 5 to 12 into TT2 embryonic stem cells and then ICR 8 cell 
embryos which were mated into the C57/BL6 and BALB/c backgrounds. Also these 
C57/BL6 Aire-/- mice showed a reduction in reproductive capacity and presence of 
lymphocytic infiltrates in lacrimal glands, parotid glands, submandibular glands, and 
in addition, a reduction in tear secretion. No other pathologic changes were found. A 
new finding was autoreactivity against α-fodrin, although the expression of α-fodrin 
in the thymus was unrepressed. In the BALB/c background, additional features were 
lymphoid cell infiltrations of the gastric mucosa and autoantibodies against gastric 
mucosa. The genetic background was concluded to clearly influence the target-organ 
specificity of the autoimmune attack caused by Aire deficiency (Kuroda et al. 2005). 
The mouse constructed by Anderson et al. in 2002 was backcrossed into different 
mouse strains (Jiang et al. 2005). The comparison showed that different 
backgrounds did affect the phenotype of the mice, just as individual APECED 
patients show variation in their disease phenotype. The pattern of organs targeted by 
the autoantibodies varied between backgrounds and the severity of the targeting 
differed from mild in the C57BL/6 to strong in the NOD strain. The other strains 
analyzed were Balb/c and SJL/J. Autoantibodies were found in line with the pattern 
of autoimmune manifestations (Jiang et al. 2005). NOD mice are known to have 
defects in their central induction of tolerance by clonal deletion (Kishimoto and 
Sprent 2001), so a more severe phenotype in this background was expected. A 
significant finding was that the NOD background did not broaden the range of 
protein targets in the Aire deficient NOD mice, although the intensity was stronger 
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in the Aire-/- NODs (Jiang et al. 2005). Explanations for the varying phenotypes in 
the different mouse backgrounds and why such a limited array of antigens are 
targeted if Aire controls thymic ectopic expression of hundreds of genes (Anderson 
et al. 2002; Johnnidis et al. 2005) remain to be resolved.  
Later, another Aire knock-out mouse was published by a Japanese group (Niki et al. 
2006). This time the mouse constructed was back-crossed into the NOD mouse 
strain (Kuroda et al. 2005). Not surprisingly, considering the complicated NOD 
background, their Aire-/-NOD-/- mice exhibited both expected and unexpected 
autoimmune characteristics. Homozygous offspring did not quite follow the Hardy-
Weinberg equilibrium, as less Aire-/- homozygotes were born than expected. The 
Aire deficient NOD mice showed a decrease in body-weight, with one third also 
eliciting growth retardation and gaunt appearance. A reduction of pancreatic size 
was observed together with lymphocytic infiltrates. Infiltrates were also present in 
the pancreatic lymph nodes, submandibulary and axillary lymph nodes, which were 
moreover enlarged in size. The degree of infiltrations was more severe in the Aire 
deficient NODs than in the pure NOD strain and infiltrations were present in more 
numerous organs, such as the liver, lung, thyroid gland and prostate and seminal 
vesicle of the male mice. Furthermore, the intra-pancreatic autoantibody specificity 
had switched from targeting β cells to acinar cells in the Aire deficient NODs and 
the degree of pancreatic lesions was augmented, as was the acceleration of the onset 
of the lesions. Small numbers of mice showed a reduction in thymocyte number and 
the CD44high and ICOS-expressing cell populations of splenic CD4+ cells, activated 
T cells, were increased in Aire deficient NOD mice. Unlike NOD mice, Aire-/- NOD 
mice did not develop diabetes, implying a role for Aire in resistance to diabetes, 
probably due to the alteration of the pancreatic target molecule in Aire-/- NODs. 
Finally, serum IgM and all subclasses of IgG except IgG3 were elevated in Aire-/- 
NOD mice, associating with the augmented production of autoantibodies against 
various organs. The mice rarely survived more than 5 months probably due to the 
severe autoimmune phenotype (Niki et al. 2006). Although it is difficult to 
differentiate the role of Aire in the complicated NOD background, the alteration of 
pancreatic target from β cells to acinar cells is an interesting finding (offering an 
explanation for absence of diabetes in the Aire-/- NODs noted already by (Jiang et al. 
2005)) and deserves further focus. 
A fifth Aire deficient mouse was published in 2008 (Hubert et al. 2008). This was 
the third knock-out mouse in the C57BL/6 background this time disrupting exon 8. 
This mouse was used for expression analyses of Aire using a new monoclonal 
antibody and no new/unexpected phenotypes or findings were published in this 
mouse strain (Hubert et al. 2008). 
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Su et al. (Su et al. 2008) constructed a knock-in mouse by introducing a dominant-
negative Aire mutation (G228W) into C57BL/6 and NOD mice. These mice showed 
global TSA suppression, and these decreased expression levels caused 
autoimmunity, showing that normal expression levels of TSAs are important in 
development of central tolerance. These mice also exhibited a novel autoimmune 
phenotype consisting of autoimmune thyroiditis and spontaneous peripheral 
neuropathy (Su et al. 2008).  
Only one double knock-out mouse model including the Aire knock-out has been 
reported. In these mice, both Aire and Foxp3 were deficient. FoxP3 deficient scurfy 
mice in the B6 background were crossed with Aire deficient mice in either the B6 or 
NOD background (Chen et al. 2005). The double knock-outs died, or had to be 
terminated before 28 days of age. Before about 10 days after birth, their phenotype 
seemed approximately normal. After that, infiltrations appeared in their lungs by day 
14. The liver was also invaded by infiltrations and mild pancreatitis was noted. More 
severe pathology was noted, not surprisingly, in the NOD background compared to 
the B6 background. Aire seemed to accelerate pathology caused by FoxP3, since the 
same targets as in scurfy mice were affected in the double knock-outs, only more 
severely. It was surprising that while the lung and liver suffered severe damage, 
many tissues remained very healthy. Autoantibodies did not seem to be the cause of 
the “fulminent autoimmune disease”. Furthermore, defective genes in NOD and Aire 
seem to function via different pathways in central tolerance, which may be due to 
their expression in the thymocytes and stromal cells, respectively (Chen et al. 2005). 
To summarize, in mice, Aire deficiency results in almost complete failure to delete 
self-specific lymphocytes in the thymus (Liston et al. 2003) and the mice have 
served as a valuable tool in studying the function of Aire in vivo. Aire deficiency 
resulted in quite a mild autoimmune phenotype in the various C57BL/6 strains 
(Anderson et al. 2002; Ramsey et al. 2002; Kuroda et al. 2005). A few more features 
were seen in the Balb/c background (Kuroda et al. 2005) and a more severe model of 
autoimmunity was reported in the NOD background than expected (Jiang et al. 
2005; Niki et al. 2006). The Aire deficient phenotype is inducible by transferring 
either Aire-/- lymphocytes to immunodeficient mice, or Aire-/- thymic stromal cells to 
normal mice (Anderson et al. 2002; Anderson et al. 2005; Kuroda et al. 2005). 
These mouse models provide interesting and valuable models for studies of 
immunological tolerance and its breakdown, but whether they are good models of 
APECED is dubious; the similarity between the clinical effect of Aire deficiency in 
mouse and men is debatable (Kekalainen et al. 2007). 
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MOUSE STRAIN GENE CONSTRUCT REFERENCE 
C57BL/6 exon 4/5 Ramsey et al. 2002 
C57BL/6 exon 1 Anderson et al. 2002 
C57BL/6, Balb/c exon 5 Kuroda et al. 2005 
C57BL/6, Balb/c, SJL & NOD back-cross Jiang et al. 2005 (Anderson mouse) 
NOD back-cross Niki et al. 2006 (Kuroda mouse) 
C57BL/6 exon 8 Hubert et al. 2008 
6 Autoimmune Regulator (AIRE/Aire) 
Autoimmune Regulator (AIRE) was found to be the causative gene for APECED in 
1997. It was cloned independently by two collaborations to chromosome 21, to locus 
21q22.3 using positional cloning (Consortium 1997; Nagamine et al. 1997). Two years 
after finding AIRE, its mouse homologue, Aire, was cloned and characterized by several 
groups in 1999 (Blechschmidt et al. 1999; Mittaz et al. 1999; Wang et al. 1999). Murine 
Aire is located on chromosome 10 and is highly homologous in structure and sequence 
with the human AIRE. The Aire protein is 71% homologous with the human AIRE 
protein (Blechschmidt et al. 1999; Mittaz et al. 1999; Wang et al. 1999). 
6.1 AIRE/Aire, the gene and the protein 
The AIRE gene contains 14 exons spanning 12 kb of genomic DNA. The exons have 
boundaries that follow the GT-AG rule (Mount 1982). The last exon of AIRE seems 
to overlap with the promoter area of the gene PFKL (which stands for 
phosphofructokinase). PFKL is transcribed from the same strand of DNA as AIRE 
(Levanon et al. 1995). The AIRE cDNA was originally isolated from an adult human 
thymus cDNA library and contains an open reading frame (ORF) with a high GC 
content (69%). The AIRE promoter contains a TATA box, a GC box and the 5’ end 
of the gene also harbours a CpG island (Consortium 1997; Nagamine et al. 1997; 
Aaltonen and Bjorses 1999; Meriluoto et al. 2001). 
AIRE encodes for a protein of 545 amino acids and has a predicted molecular mass 
of 58 kDa (Consortium 1997; Nagamine et al. 1997). The AIRE protein contains 
several functional domains which are suggestive of a role as a transcriptional 
regulator. The N-terminus contains a conserved nuclear localization signal (NLS) 
and a homogenously staining region (HSR) domain. In the middle lies a Sp100, 
AIRE, NucP41/75 and DEAF-1/supressin (SAND) domain, four nuclear receptor-
binding LXXLL motifs (in which L = leucine and X is any amino acid) are 
Table 4. Aire deficient mouse models 
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interspersed along AIRE and the C-terminus harbours two plant-homeodomain 
(PHD) -type zinc fingers (Consortium 1997; Nagamine et al. 1997). 
 
Figure 8. The AIRE gene. A schematic representation showing the functional 
domains (above) and exons (below) of the AIRE gene. Modified from 
Peterson and Peltonen (Peterson and Peltonen 2005). 
Since AIRE is quite difficult to express as a whole in vitro, and stable cell lines have 
also been rather unsuccessful in the past, the functional domains have been studied 
using in vitro assays in order to shed light on the function of AIRE. The NLS directs 
AIRE to the nucleus and a nuclear export signal (NES) may direct it out again 
(Pitkanen et al. 2001). The SAND domain is involved in DNA binding of AIRE 
(Kumar et al. 2001; Purohit et al. 2005). The HSR domain is responsible for the 
homomultimerization of AIRE (Halonen et al. 2004) and AIRE can appear as 
homomers (Pitkanen et al. 2000; Kumar et al. 2001). The HSR domain has also been 
reported to be involved in the attachment of AIRE with cytoplasmic filaments 
(Pitkanen et al. 2001; Ramsey et al. 2002) and in the targeting of AIRE to nuclear 
bodies and to molecular complexes (Halonen et al. 2004). The PHD zinc fingers are 
important for AIRE, since the major patient mutations occur in them (Heino et al. 
2000). The PHDs mediate the transactivation ability of AIRE, especially the second 
PHD (Bjorses et al. 2000; Pitkanen et al. 2001; Uchida et al. 2004; Meloni et al. 
2008). The first zinc finger may also harbour E3 ubiquitin ligase activity (Uchida et 
al. 2004), but this has not been conclusively proven and instead, it may also mediate 
protein-protein interaction (Bottomley et al. 2005). There is also a leucine zipper 
(LZ) motif in the first PHD zinc finger (Consortium 1997; Nagamine et al. 1997; 
Mittaz et al. 1999) and this possibly helps AIRE form dimers (Kumar et al. 2001). A 
proline rich area in AIRE (Consortium 1997; Nagamine et al. 1997; Mittaz et al. 
1999) may mediate protein-protein interactions (Kay et al. 2000). The last LXXLL 
in the COOH terminal end of AIRE is important for transactivation as well (Meloni 
?
?
?
?
?
??? ??? ??? ??? ??? ???????
????
?
?
????
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?????? ???
? ? ? ? ? ? ? ? ? ?? ?? ?? ?? ??
????
 65 
et al. 2008). Other roles for domains in AIRE, and for areas between them, have also 
been suggested, but need yet to be confirmed. AIRE has many domains similar to 
Speckeld protein 100 kDa (Sp100) proteins, which are involved in transcriptional 
activation and repression (Seeler et al. 1998; Yordy et al. 2005). 
A recent study also revealed that the homogenously staining region (HSR) domain 
of AIRE may actually resemble a caspase recruitment domain (CARD). The CARD 
structure has six alpha helices whereas the HSR model of AIRE has four, but 
otherwise they are rather similar in their 3D structure. Furthermore, CARD has the 
same function as it is also involved in the transactivation activity of AIRE, leading 
to AIRE and CBP accumulation in the nucleus. This results in alterations in the 
mTEC transcriptome, since co-expression of CBP and AIRE seems to increase the 
transactivation potential of AIRE, possibly leading to induction of TSA expression 
(Ferguson et al. 2008). 
The same AIRE domains are also found in the mouse homologue of AIRE 
(Blechschmidt et al. 1999; Mittaz et al. 1999; Wang et al. 1999). 
6.2 Associations of AIRE with other autoimmune diseases 
To resolve whether AIRE is involved in the susceptibility of complex autoimmune 
diseases, several association studies of the AIRE gene with the different disease 
components included in APECED, like T1D and hypoparathyroidism, have been 
recently reported. Linkage disequilibrium was found between HLA class II region 
and autoimmune hepatitis (AIH) in pediatric patients (Djilali-Saiah et al. 2004) and 
one intronic polymorphism in AIRE (G11107A) correlated with systemic sclerosis 
(Ssc) and with Ssc associated with thyroiditis (Ferrera et al. 2007). Recently, AIRE 
has been shown to be strongly associated with vitiligo in a case-control study. This 
raises the possibility of defective skin antigen selection in the thymus being involved 
in the resulting melanocyte destruction in vitiligo (Tazi-Ahnini et al. 2008).  
A group who studied whether AIRE is involved in the pathogenesis of alopecia 
areata (AA), also showed that there was a strong association of one potentially 
functional AIRE polymorphism, the 961G allele, with the most severe form of AA 
and with early-onset AA. Furthermore, they suggest that this allele may decrease the 
DNA-binding activity of AIRE, offering an explanation of the high frequency of AA 
in APECED (Tazi-Ahnini et al. 2002). Surprisingly, another group could not 
replicate this result in their AA patients (Pforr et al. 2006). The first group continued 
their studies and analyzed six SNPs in AIRE. In this new analysis, the allele 
previously reported was no longer significantly associated. However, two other 
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haplotypes were associated with AA. The authors suggest this may represent one 
genetic risk factor for AA (Wengraf et al. 2008). 
A study analyzing AIRE SNPs suggested that AIRE does not associate with T1D 
(Turunen et al. 2006), and another study indicated that there was no association of 
the mutations in exons 6 and 8 of the AIRE gene with inflammatory bowel disease 
(Torok et al. 2004). AIRE gene polymorphisms in exons 6, 8 and 10 did not 
contribute to the development of isolated autoimmune hepatitis (AIH) either, nor did 
AIRE SNPs associate with patients with sporadic idiopathic hypoparathyroidism 
(Goswami et al. 2005).  
In this context it is interesting that mmutational analysis of the AIRE gene first 
showed that patients with sporadic autoimmune Addison’s disease (AAD) may 
actually have APECED although they had not been diagnosed. One such patient (out 
of 40) was found, with mutations in AIRE but with AAD as his only disease 
component of APECED (Boe et al. 2002). Nonetheless, no association of the 
common United Kingdom mutation (964del13bp) in the AIRE gene with AAD or 
APSII was found (Vaidya et al. 2000). Following this, negative results were 
published by another group analyzing whether AIRE gene polymorphisms (9 SNPs) 
or copy number variations were associated with AAD and with APS II (Boe Wolff 
et al. 2008). 
6.3 Expression of AIRE/Aire 
AIRE is localized in cells mainly in the nucleus appearing mainly as nuclear bodies 
(NBs) (Bjorses et al. 1999; Heino et al. 1999; Rinderle et al. 1999). The nuclear bodies 
resemble promyelocytic leukemia (PML) nuclear bodies which are known to be 
associated with different transcriptionally active proteins (Bjorses et al. 1999; Heino et 
al. 1999; Rinderle et al. 1999). When AIRE cDNA is transfected into cultured cells, 
the recombinant AIRE is expressed in the nucleus either in NBs, or evenly distributed, 
lacking NBs (Akiyoshi et al. 2004; Ilmarinen et al. 2005; Tao et al. 2006). In addition, 
AIRE colocalized with intermediate filaments or microtubules and with vimentin in 
the cytoplasm, as well as was present in aggregates of different sizes (Bjorses et al. 
1999; Heino et al. 1999; Rinderle et al. 1999). Also human thymus tissue sections 
contain expression of AIRE in the cytoplasm (Cavadini et al. 2005). 
The earliest expression of Aire mRNA was seen after E14 (Zuklys et al. 2000). 
However, according to another study, Aire was detected at E14.5 (Adamson et al. 
2004) and in a third, at E16 (White et al. 2008) probably reflecting the sensitivity of 
the detection methods used. Aire mRNA is expressed in different forms, suggestive 
of splice variants, in the thymus and secondary lymphoid organs. In addition to the 
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full Aire gene, eleven splice variants of murine Aire have been described (Ruan et 
al. 1999). So far, the functional relevance of the different RNA variants is open. 
The highest expression level of AIRE/Aire is found in the thymus, in the medulla 
and corticomedullary junction, in cells called thymic medullary epithelial cells 
(mTECs) (Consortium 1997; Nagamine et al. 1997; Bjorses et al. 1999; Rossi et al. 
2007; Martins et al. 2008). AIRE has also been reported to be expressed in another 
type of antigen presenting cell (APC) in the thymus, namely in cells of the 
monocyte-dendritic cell lineage (Heino et al. 1999). Lower levels of AIRE/Aire 
expression have been reported in other immunological tissues; the spleen, lymph 
nodes and fetal liver (Consortium 1997; Nagamine et al. 1997; Bjorses et al. 1999) 
and cells of the immune system; differentiated DCs and peripheral blood monocytes 
(Heino et al. 1999) (Kogawa et al. 2002; Sillanpaa et al. 2004). Additionally, very 
low quantities were detected in thyroid gland and heart, but none in the pancreas, 
liver or spleen in one study (Ruan et al. 1999). Furthermore, no expression of Aire in 
any other cell types tested except mTECs was reported by yet another study (even in 
DCs vs. previous reports (Kogawa et al. 2002; Sillanpaa et al. 2004)) (Klamp et al. 
2006). So, whether or not Aire is expressed in tissues other than thymus was 
disputed (Mathis and Benoist 2007). Furthermore, AIRE seems not to be expressed 
in target organs such as the adrenal cortex, adult liver and pancreas (Bjorses et al. 
1999; Heino et al. 1999). 
The cell type in which Aire is expressed in thymus is clear. Expression of Aire in the 
lymph nodes has been shown quite convincingly (see Tables 4 and 5), but the cell type 
is not clear, as expression has been reported in lymphocytes, neutrophilic 
granulocytes, DCs, medullary and paracortical cells (Bjorses et al. 1999; Heino et al. 
1999). In any case, expression of Aire in secondary lymphoid organs suggests a role in 
peripheral tolerance. No expression in any other cell types tested (even in DCs vs. 
previous reports (Kogawa et al. 2002; Sillanpaa et al. 2004)) (Klamp et al. 2006), 
before a fresh report indicating expression of AIRE in B cells and possibly in 
DC/macrophages and granulocytes (Suzuki et al. 2008). An interesting theory to why 
Aire may be expressed in very low levels in tissues such as testis, spleen and lymph 
nodes, at mRNA level, is that Aire is expressed in CD11c+ DCs, and these cells 
migrate into all the aforementioned tissues (Heino et al. 2000), but in limited amounts. 
Making use of a new AIRE antibody and flow cytometry, it was newly shown that 
Aire+ cells were restricted to the thymus, to the thymic medulla and was extremely 
low in DCs (Hubert et al. 2008). 
Tables 4 and 5 below show expression of Aire and AIRE in humans and mice, 
respectively.
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Mouse Aire is expressed in similar locations as the human AIRE. As mice are more 
readily available for analysis, expression studies have been broader in mouse tissues 
and have revealed Aire expression in several more tissues than in humans, albeit at 
low levels. Expression has been observed at RNA level in the brain, liver, kidney, 
pancreas, intestine, gonads, thyroid gland and adrenal glands (Blechschmidt et al. 
1999; Heino et al. 2000; Halonen et al. 2001) and at protein levels in thymus, spleen 
and lymph nodes (Adamson et al. 2004). 
The differences in methods, antibodies and probes probably explain the differences 
in expression found between different studies. For example using Northern blot, 
Aire expression was undetectable, but using RT-PCR Aire could be detected in the 
thymus, ovaries, lungs, testes, kidney and adrenal glands of the mouse (Ruan et al. 
1999). Now the consensus concerning Aire expression seems to be shifting towards 
expression in restricted lymphoid organs (Klamp et al. 2006). 
A fascinating fresh report only just released (Saltis et al. 2008), shows that Aire is 
expressed in all gnathostome classes except in cartilaginous fish. The sequence of 
Aire was compared in mouse, human, opossum, chicken, Xenopus frog, zebrafish 
and puffer fish. All species had the first PHD domain but the other domains were 
absent or divergent in these species. Other conserved domains were the NLS and 
HSR. The second PHD domain showed more sequence similarity to Ring finger 
domains than to PHD domains. Still, the conserved regions convey the nuclear 
localization, transport and dimerization of Aire. This evolutionary comparison 
shows that certain parts of Aire, like the SAND domain, has evolved very quickly 
and may be more random in its binding. Aire-dependent T cell tolerance probably 
dates back to the emergence of bony fish (Saltis et al. 2008). 
6.4 Interactions of AIRE/Aire 
As it is most likely that AIRE is located in larger molecular complexes in cells, it is 
most important to study what other molecules may reside in these complexes and/or 
interact with AIRE. Not many interaction partners of AIRE have been found yet, 
considering the amount of research done on AIRE. The common transcriptional 
coactivator CREB-binding protein (CBP) was shown to interact in vitro with AIRE 
(Pitkanen et al. 2000) and to activate the transcription of self-antigens as a regulator 
of transcription together with CBP (Pitkanen et al. 2005). How AIRE and CBP 
collaborate on the molecular level remains to be resolved, although a fresh report 
suggests AIRE is needed for CBP to localize from the cytosol to the nucleus and 
CBP may induce AIRE’s transactivation potential (Ferguson et al. 2008).  
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AIRE has been shown to interact with several members of the nuclear transport 
receptor importin α family. These interactions proposed that AIRE is imported into 
the nucleus using the classical importin α/β pathway (Ilmarinen et al. 2005). Why 
exactly AIRE is transported in and out of the nucleus is not yet known.  
Interactions have been shown with PIAS proteins as well (Ilmarinen et al. 2008). 
AIRE and PIAS proteins were found in common complexes, but AIRE was not 
found to be SUMOylated by PIAS. PIAS1 probably affects the SUMOylation of 
molecules other than AIRE in the complex in which they reside and by interactions 
with SUMO moieties in proteins included in the complex (Ilmarinen et al. 2008). 
Additionally, AIRE interacts with multiple components of the transcription complex 
including a novel interaction with the protein GBDR1 (glialblastoma cell 
differentiation factor-related protein) and functions in a novel manner, differing 
from classic transcription factors (Tao et al. 2006). The ubiquitin-associated (UBA) 
domain in GBDR1 often associates with components of the ubiquitin pathway (Tao 
et al. 2006), in line with the first PHD finger in AIRE having E3 ligase activity 
(Uchida et al. 2004). As this finding has not been confirmed, the role of 
ubiquitination in AIRE function is currently not known (Bottomley et al. 2005). 
The newest interaction partner found for AIRE is a heterotrimeric complex of DNA-
dependent protein kinases (DNA-PK), which once again, affects the transactivation 
capacity by phosphorylating AIRE. This modification may affect other features of the 
functional regulation of the AIRE protein as well (Liiv et al. 2008). Chromatin 
modifications may also be affected by AIRE as it was just shown that AIRE may 
directly bind to histones and sense epigenetic chromatin modifications (Org et al. 2008). 
6.5 Functions of AIRE/Aire 
The fact that AIRE is expressed in mTECs was the first hint of its role in central 
tolerance (Blechschmidt et al. 1999; Heino et al. 1999), since mTECs express a vast 
range of tissue-specific antigens (TSAs) (Derbinski et al. 2001). Additionally, in 
vitro studies had shown that AIRE has transcriptional activation potential (Bjorses et 
al. 2000; Pitkanen et al. 2001). 
6 . 5 . 1  A i r e  i n  c e n t r a l  t o l e r a n c e   
The current hypothesis for the function of Aire is that AIRE regulates the ectopic 
transcription of certain genes encoding peripheral TSAs in mTECs in the thymus 
(Klein and Kyewski 2000; Anderson et al. 2002). Absence of AIRE causes a defect 
in the thymic expression of ectopic antigens and subsequently loss of tolerance to 
these antigens resulting in the widespread autoimmunity in APECED patients. Proof 
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for this hypothesis comes from studies mainly in Aire deficient mice, described 
below.  
The function of Aire in negative selection was proven by two groups (Anderson et 
al. 2002; Liston et al. 2003; Liston et al. 2004) using TCR transgenic mouse models. 
They provided direct evidence that Aire deficiency causes a disruption in the process 
of T cell deletion in the thymus. Liston et al. also showed the first proof of central 
tolerance affecting TSAs as well as ubiquitous antigens (Liston et al. 2003). 
First it was considered that AIRE may be involved in transcription complexes, not 
directly contacting DNA but modulating the promoters of the TSA genes (Derbinski 
et al. 2005). A recent study showed that Aire binds directly to DNA and to the 
promoters of some of its target genes in vivo, directly regulating their expression in 
the thymus. Thus, Aire seems to regulate the expression of autoantigens (Ruan et al. 
2007). The set of genes directly regulated by Aire is not defined, but Ruan et al. 
reported some target genes downstream of Aire. These included some autoantigens, 
post-translational modifiers, transcription factors and growth factors, of which three 
are involved in immunologically relevant pathways. Studying these further may help 
explain the mechanism of Aire function (Ruan et al. 2007). Furthermore, AIRE may 
constitute a part of a transcriptional complex together with IRF8 (Giraud et al. 2007) 
and possibly other proteins. Global chromatin modification may be used by Aire to 
silence TSA expression (Ferguson et al. 2008). Excitingly, it was recently found that 
AIRE may be necessary for regulation of transcription at elongation phase (Oven et 
al. 2007; Org et al. 2008). More research is required for the elucidation of the 
molecular mechanisms of Aire. 
Microarray and expression studies using mTECs isolated from Aire knock-out mice 
have shown that the expression of a sizeable subset of hundreds to thousands of tissue-
specific antigen genes in the mTECs is lost in the absence of Aire (Anderson et al. 
2002; Derbinski et al. 2005). Some of these genes seem to encode proteins which are 
known targets of APECED autoantibodies, such as insulin (Gylling et al. 2000).  
Many transcription factors have dual activating and silencing capabilities (Gabellini 
et al. 2003). Therefore array studies showing both up-and down-regulated genes in 
absence of Aire may not be so surprising. Up-regulation of some TSAs occurs in 
absence of Aire (Derbinski et al. 2005). The genes dependent on Aire are found in 
clusters, where single clusters can contain both Aire up- and down-regulated genes. 
No single explanation for this has been established, but epigenetic regulation 
mechanisms (such as methylation) have been suggested (Gotter and Kyewski 2004).  
Analysis of the chromosomal clustering of Aire-controlled genes showed, further, 
that Aire controls antigen presentation of TSAs and other genes. Further, AIRE is 
not likely to function merely by chromatin remodeling (Johnnidis et al. 2005) since 
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Aire-controlled and Aire-independent genes were often interspersed. Using slightly 
different analyses, Gotter and Kyewski came to the similar conclusions (Gotter and 
Kyewski 2004). 
Hughes and Friedman (Hughes and Friedman 2006) extended the Aire gene 
expression analysis reported by Anderson et al. (Anderson et al. 2002) by analyzing 
the up-and down-regulated, Aire-dependent genes. The aim was to see whether 
Aire-activated genes are disproportionately tissue-specific. Particularly they studied 
the genes down-regulated by Aire. They found differences among the genes both 
activated and repressed by Aire, as well as those unaffected by Aire, confirming 
Anderson’s results. Expression levels of Aire activated genes were lower than those 
of other genes. Phylogenic studies showed that evolution of Aire may have occurred 
long ago, although the proteins activated by Aire may have changed with evolution 
(Hughes and Friedman 2006). 
A loss of tolerance to two Aire-dependent antigens, a stomach antigen (mucin 6) and 
an eye antigen (interphotoreceptor retinoid-binding protein, IRBP) has been reported 
in Aire deficient mice. Absence of the expression of these antigens in the thymus 
caused autoimmunity against the eye and the stomach, showing a direct link 
between TSA expression controlled by Aire and an autoimmune phenotype in Aire 
knock-out mice. Identification of these specific antigenic targets show that the lack 
of expression of these targets in the thymus causes the generation of harmful 
antibodies against them and that this autoimmunity is dependent on Aire (DeVoss et 
al. 2006; Gavanescu et al. 2007).  
Another finding supporting the hypothesis of AIRE regulating TSA expression in 
the thymus came first from a study showing that proinsulin expression in the thymic 
epithelium was correlated with the gene dosage of functional Aire alleles (Liston et 
al. 2004). Later, direct correlation between AIRE and insulin expression in the 
thymus was shown by another group (Sabater et al. 2005). This would imply that 
AIRE regulates insulin expression (Sabater et al. 2005). Levels of AIRE may, 
according to the authors, also influence T1D (Sabater et al. JAutoim 2005). 
Autoimmune susceptibility may in fact arise from small differences in expression 
levels of genes involved in the pathway from TCR to cell death, called quantitative 
variation of negative selection (Liston and Rudensky 2007). Variable expression 
levels of AIRE and TSAs in the thymus of different individuals were shown by 
Taubert et al. by examining human mTECs. This was evidence for the regulation of 
TSAs by AIRE (Taubert et al. 2007).  
Opposingly, Aire-deficient mice develop autoimmunity against some antigens that 
are expressed in thymus despite the absence of Aire. These genes are not Aire-
dependent. One of such antigens is α-fodrin and an other is pancreas specific protein 
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disulphide isomerase (PDIp) (Kuroda et al. 2005; Niki et al. 2006). A possible 
explanation for this could be that Aire is involved in the processing and presentation 
of these antigens. Further the suggested function of Aire as an ubiquitin E3 ligase 
may play a role in this function (Uchida et al. 2004). Further clues to the 
other/alternative roles of Aire come from expression array analyses which have 
shown for example down-regulation of a gene involved in MHC class II peptide 
loading. These studies also hint at Aire deficient mTECs having poorer antigen 
presentation efficiency than Aire-positive mTECs (Anderson et al. 2005). Why the 
autoimmune phenotype of APECED patients and Aire deficient mice are limited to a 
certain set of tissues is not known. 
Not long ago, it was confirmed that Aire functions in tolerance by the negative 
selection of T effector cells, not positive selection of Tregs (Anderson et al. 2005). 
The authors showed that Aire is involved in negative selection, as had been shown 
by previous reports. Moreover, they demonstrated that Aire may be involved in 
negative selection processes other than just expression of TSAs, perhaps in the 
interaction between cells presenting TSAs and thymocytes. In any case, the function 
of Aire is critical for inhibiting AID (Anderson et al. 2005). 
Finally, while Aire had been shown to have an allele dose-dependent effect on TSA 
expression in the thymuses of mice (Liston et al. 2004), no effect on TSA expression 
in the lymph nodes was observed in this new study. In the thymus, Aire and TSAs 
were both localized in the medulla. Aire could directly induce the expression of 
TSAs and a correlation between expression of Aire and TRAs was suggested (Kont 
et al. 2008).  
 
Thus, accumulating evidence shows AIRE is important in central tolerance. The 
exact mechanism for how AIRE functions in TSA expression and which TSAs it 
targets and why, still need to be confirmed. The recent active research in the field 
has already provided many hypotheses and pieces of knowledge that will need to be 
put together and tested in the near future. 
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Figure 9. The role of Aire in central tolerance. Aire drives expression of self-antigens 
presented to developing T cells. Self-specific T cells are eliminated, while 
microbe-specific T cells survive and leave the thymus to fight infection. In 
the absence of Aire, some self-antigens are not expressed, self-reactive T 
cells are not eliminated and autoreactive t cells are allowed to escape the 
thymus, into the periphery, where they attack organs and cause autoimmune 
disease. Modified from Heath and Scott (Heath and Scott 2002). 
6 . 5 . 2  A i r e ,  m T E C s  a n d  t h y m i c  s t r u c t u r e  
Aire deficiency may cause changes in the organization and composition of the 
medullary epithelium (Gillard et al. 2007). This could explain some functions of Aire. 
However, previous work has not shown serious defects in thymic stromal structure in 
Aire knock-out mice (Anderson et al. 2002; Kuroda et al. 2005). In any case, Aire 
plays a role in thymic epithelial cell differentiation and in “terminal differentiation” 
i.e. mTECs maturation enabling them to express TSAs (Derbinski et al. 2005). 
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Earlier, it has been shown that Aire is expressed in cells and anatomical sites 
important for negative selection and that this expression is modulated by T cells 
undergoing negative selection. Additionally, the role of Aire as a transcriptional 
regulator and correlation of Aire expression with the structural organization of the 
thymus, suggest that Aire may play a role in determining the architectural 
organization of the microenvironment of the thymus and thus, affects T cell 
selection and self tolerance in this way. It is known that the disruption of the thymic 
architecture causes defects in the expression pattern and function of the thymus (van 
Ewijk et al. 1994). Indeed, absence of Aire did lead to some unorganization of the 
thymic stroma in one mouse model. Aire was also differently expressed during 
positive and negative selection in the thymus. Aire was localized to sites of negative 
selection and modified by cells in these locations (Zuklys et al. 2000).  
Aire has previously been suggested to be regulated by lymphotoxin beta receptor 
(LtβR) signaling, by the lymphotoxin-pathway (Chin et al. 2003; Chin et al. 2006; 
Zhu et al. 2006). Surprisingly, two groups have recently published papers showing 
the contrary: that the lymphtoxin pathway or LtβR do not affect the mTECs or 
regulation of TSA expression by Aire (Venanzi et al. 2007; Martins et al. 2008) (at 
least not directly). Using whole genome transcriptome analysis, it was shown that 
absence of LtβR does not have an effect on Aire expression, or on Aire-controlled 
tissue specific antigen (TSA) expression. The elimination of LtβR did not perturb 
Tregs or the allocation of DCs in the thymus. Contrarily, LtβR signaling did affect 
the 3D structure of mTECs, but in an Aire-independent manner. The 3D structure of 
the thymic medulla was disturbed in LtβR deficient mice leading to an abnormal 
distribution of mTECs and T lymphocytes, causing autoimmunity. Therefore, the 
correct structure of the thymic medulla guarantees negative selection by providing 
an environment facilitating T cell-epithelial cell interaction (Martins et al. 2008).  
These findings are in line with Boehm et al. (Boehm et al. 2003) who showed that 
LtβR-/- mTECs express normal levels of AIRE. Also Rossi et al. (Rossi et al. 2007) 
proposed that another pathway concerning the  TNF superfamily receptor, through 
activator of NFκB (RANK) may explain the phenomena previously suggested to be 
due to LtβR, concerning promotion of AIRE+/+ mTEC development (Venanzi et al. 
2007). RANK signals from intrathymic lymphoid inducer cells induce the 
development of Aire+ mTEcs (Rossi et al. 2007). This theory was newly confirmed. 
White et al. suggest that initial differentiation of Aire+ mTECs requires RANK with 
inducer cells and then mTEC turnover/survival via CD40 interactions with 
lymphocytes expressing CD40L in the thymus (White et al. 2008). 
Absence of Aire and/or of mTECs causes blockage of T cells between the SP3 and 
SP4 stages of T lymphocyte development (Li et al. 2007). Although these SP3 T cells 
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were not yet fully mature, nevertheless, some were exported to the periphery and may 
have contributed to the autoimmunity in Aire deficient mice (Li et al. 2007). 
 
Although the stroma in Aire deficient mice was intact (Anderson et al. 2002; Kuroda 
et al. 2005), alterations in the thymic medullary epithelium were noted. These 
alterations caused changes in thymic environment suggesting Aire has a role in 
mTEC differentiation and/or survival. This would imply a broader role for Aire than 
just in regulation of TSA expression, maybe as a “randomizer” of gene expression 
(Gillard et al. 2007). New studies concerning mTECs have shown that Aire+ mTECs 
arise from a unique mTEC cell lineage and express tight-junction components 
claudin 3 and claudin 4 (Cld3,4) (Hamazaki et al. 2007). The mTECs that express 
Aire only make up a small proportion of all mTECs (Derbinski et al. 2001) and this 
subset expresses a lot of MHC class II and costimulatory molecules as well as Aire 
(Hamazaki et al. 2007). Studies on AIRE have therefore also taught us about the 
development of the mTEC lineage (Hollander 2007). However, whether the terminal 
differentiation model holds and how exactly Aire functions in mTECs and mTEC – 
lymphocyte interactions remains to be seen. 
6 . 5 . 3  A i r e  i n  t h e  p e r i p h e r y  
While it is clear that AIRE plays an important role in central tolerance, it has been 
suggested that it has additional functions outside of the thymus. Aire is expressed in 
the periphery and could act there in the control of peripheral tolerance. This means 
controlling self-reactive T cells which have escaped thymic negative selection. 
Three mechanisms of function for Aire and cell types involved in development of 
tolerance have been the focus of studies so far: 1) DCs, 2) thymic development of 
Tregs and 3) functions in the stromal cells of lymph nodes. 
Several publications have reported expression of Aire in the periphery, in secondary 
lymphoid organs and DCs (Halonen et al. 2001; Adamson et al. 2004; Sillanpaa et al. 
2004; Ramsey et al. 2006). First, AIRE/Aire was shown to be involved in DC 
differentiation (Sillanpaa et al. 2004).  Later, it was shown that Aire-deficient DCs 
activate naïve T cells more efficiently than Aire-positive DCs and that Aire may thus 
control T cell activation by DCs in the periphery (Ramsey et al. 2006). However, loss 
of Aire in DCs alone was insufficient to break tolerance (Anderson et al. 2002). 
It has been shown that TSA expression in the thymus can drive positive selection of 
Tregs (Jordan et al. 2001; Walker et al. 2003). Thus, Aire-positive mTECs may be 
involved in the development of Tregs in the thymus (Aschenbrenner et al. 2007). 
However, numbers and functions of Tregs were normal in Aire deficient mice 
(Anderson et al. 2002; Kuroda et al. 2005). Double knock-outs of Aire and FoxP3 
had a more severe phenotype than the individual knock-outs, although they 
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resembled more of a scurfy type than a mixture of Aire deficiency and scurfy (Chen 
et al. 2005). Nevertheless, it was shown that when Aire-positive mTECs were 
targeted to present an antigen, this resulted in production of Tregs specific for the 
antigen. This occurred independently of antigen transfer to DCs, indicating that 
mTECs themselves were able to present the antigen, and that mTECs are important 
for Treg development (Aschenbrenner et al. 2007). Thus, the absence of Aire may 
lead to defects in Tregs acting in the periphery. This study, together with a few other 
recent reports, shows that Aire is involved in both clonal deletion and differentiation 
of Tregs. Tregs were also found to be impaired in function in APECED patients, 
although these defects were not found in Aire deficient mice (Kekalainen et al. 
2007). These findings begin to link Aire, FoxP3 and Treg selection (Nomura and 
Sakaguchi 2007). Still, it has not been directly shown that Aire promotes thymic 
development of Tregs. Since Tregs develop in the cortex whereas Aire is expressed 
in the medulla of the thymus, the role of Aire in development of Tregs requires 
further investigation. 
Aire was recently shown to be expressed in the stromal cells of lymph nodes. Aire 
controls the development of tolerance to retinal and pancreatic antigens. However, 
peripheral tolerance plays an important role in the “decision to commence” 
autoimmunity. Induction of anergy by antigen presentation in for example lymph 
nodes in the periphery is required in addition to central tolerance in order to avoid 
autoimmune attack (Lambe et al. 2007). Stromal cells of lymph nodes are also 
involved in TSA presentation to CD8+ T cells in a similar way to thymic TSA 
presentation, leading to clonal expansion and subsequent elimination of the T cells. 
This mechanism possibly reinforces peripheral tolerance induced by cross 
presentation by DCs (Lee et al. 2007; Zehn and Bevan 2007). Although this would 
be a tempting role for Aire in the periphery, the role of Aire in stromal lymph node 
cells remains at present unclear, as for example insulin, an Aire-dependent TSA, is 
not expressed in these cells (Lee et al. 2007).  
Just before sending in this thesis, an intriguing study by Gardner et al. (Gardner et 
al. 2008) identified cells in peripheral lymphoid tissues, in the T and B cell area 
interfaces, expressing Aire and mediating deletion of autoreactive T cells. These 
data suggest peripheral lymphoid tissues act as a “safety net”, stopping autoreactive 
T cells, specific for other antigens than those expressed in thymus, from escaping 
elimination in the periphery. Further, this group showed that the number of Aire-
controlled genes in the periphery is only about 1/10 of those controlled in the 
thymus and that these gene pools do not overlap much, although both include many 
TSAs (Gardner et al. 2008; Kyewski 2008). This study adds to the list of questions 
to be answered about Aire and the role of Aire, especially in the periphery. 
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6 . 5 . 4 .  O t h e r  f u n c t i o n s  o f  A I R E / A i r e  
A i r e  a n d  a p o p t o s i s  
Apoptosis plays an important role in autoimmunity such as in T cell development, T 
cell repertoire, immune responses etc (Kuhtreiber et al. 2003). Aire has been shown 
to interact with DNA-PK. DNA-PK activates apoptosis, therefore indicating a 
possible role for AIRE in apoptosis. Furthermore, AIRE contains a CARD domain 
which may interact with apoptotic molecules, thus indicating a possible role for Aire 
in apoptosis (Kuhtreiber et al. 2003). 
Centrally, it has been hypothesized that Aire may induce apoptosis in mTECs. Aire-
positive mTECs have a high turn-over rate (10% per day!). Additionally, Aire 
promotes changes that ensure efficient presentation of TSAs, termed “terminal 
differentiation” since Aire-induced apoptosis is not immediate, but leads to changes in 
mTECs culminating in their death. Whether these effects of Aire are direct or indirect 
is not known. Aire could therefore facilitate cross-presentation of self-antigens 
produced to DCs before the mTECs are programmed to die (Gray et al. 2007). 
Expression of AIRE in the testis may be required for the scheduled apoptosis of 
germ cells (Schaller et al. 2008). This conclusion came from a finding where Aire 
deficient mice had reduced levels of scheduled apoptosis, but reciprocally, higher 
levels of sporadic apoptosis. This lead to the hypothesis that scheduled apoptosis 
provides a “counterselection mechanism” keeping the germline stable. So, cells with 
mutated genes would apoptose spontaneously and prematurely if they acquire 
mutations (Schaller et al. 2008). 
A i r e  i n  t h y m o m a  a n d  l y m p h o m a  
Marginal zone B cell lymphoma has been reported in Aire deficient mice over 1 year 
to 2 years of age, as well as liver infiltrates consisting of B cells. These symptoms 
are suggestive of antigen exposure and lymphocyte overactivation. A peripheral role 
for Aire in control of APC development and marginal zone B cell activation is thus 
implied by this study. Aire may therefore have a peripheral regulatory role by 
controlling the development of APCs and marginal zone B cell activation, or 
modulation of their phenotype (Hassler et al. 2008).  
 
A mysterious lack of Aire expression has been noted in thymomas, possibly due to 
gene silencing or maturational arrest of epithelial cells (Offerhaus et al. 2007). 
Another study of Aire in relation to cancer has been reported where AIRE 
expression was noted to be decreased in thymomas, compared to healthy thymuses 
(Suzuki et al. 2008). This is in agreement with findings by Ströbel et al. (Strobel et 
al. 2007), although Ströbel. et al. noted a total absence of AIRE. 
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Finally, an important note is that there are some differences in the role of AIRE/Aire 
in mice and men. For example FoxP3 Tregs are defective in APECED patients 
(Kekalainen et al. 2007), but such defects have not been observed Aire-deficient mice 
(Anderson et al. 2005; Kuroda et al. 2005; Niki et al. 2006; Kekalainen et al. 2007). 
To summarize, Aire plays an essential role in central tolerance. It regulates 
development of tolerance to several autoantigens and functions also in the negative 
selection of autoreactive T cells, by regulation of TSAs in the thymus (reviewed by 
Peterson et al. 2004). Aire may also play a role in the periphery, perhaps in 
peripheral tolerance, but whether this is the case and how Aire functions outside of 
the thymus is not yet established (Cheng et al. 2007). 
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1 AIMS OF THE STUDY 
APECED is a monogenic autoimmune disease and, therefore, in addition to being an 
intriguing disease of which the mechanisms are not yet understood, also a unique 
”simple model” enabling the study of the onset of autoimmune diseases in general. 
The specific aims of this study were: 
1. To use the Aire-deficient mouse model of APECED as a tool in order to 
study the APECED autoantibodies 
2. To study the possible role of AIRE in peripheral tolerance 
3. To find out whether Aire affects the development of γδ T cells 
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2 MATERIALS AND METHODS 
Published materials and methods 
The materials and methods used in this study are described in the original 
publications (I-III) in more detail. 
 
Material or method Original 
publication 
Aire-deficient mice I, III 
APECED patients II, III 
preparation of tissues and blood I, II, III 
DNA extraction I 
PCR/RT-PCR I 
SDS-PAGE and Western blotting I 
Cloning of autoantigens and constructs I 
In vitro transcription and translation (ITT) I 
Radioimmunoprecipitation (RIPA) I 
Assays for nuclear antibodies I 
RIA for detection of insulin I 
Genotyping of mice I, III 
Lymphocyte proliferation assay (thymidine 
incorporation) 
I, III 
extraction/homogenization of cells I, III 
Cell culture II 
Culture of Candida albicans II 
MoDC stimulations and infections II 
Cytokine assays II 
Affymetrix arrays II 
Genome-wide expression analyses II 
Pathway analyses II 
RNA extraction II, III 
cDNA synthesis II, III 
Taqman (Q-RT-PCR) II, III 
Flow cytometry (FACS) II, III 
TCR repertoire analysis III 
Statistical analyses I, II, III 
Ethical considerations I, II, III 
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Ethical considerations 
This study has been evaluated and approved by the Laboratory Animal Committees 
of the National Public Health Institute and of the University of Helsinki, Finland, as 
well as the State Provincial Offices of Southern Finland. The study has been 
conducted according to good practise in laboratory animal handling and the 
regulations for handling genetically modified organisms have been followed. 
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3 RESULTS 
1 No typical APECED autoantibodies in Aire deficient mice (I) 
A characteristic attribute of APECED is a spectrum of well-characterized, 
circulating, tissue-specific autoantibodies. The presence of autoantibodies targeted 
to endocrine organs has been reported in Aire deficient mouse models using indirect 
immunofluorescence analyses of tissue sections by three independent mouse models, 
all of the B6 background (Anderson et al. 2002; Ramsey et al. 2002; Jiang et al. 
2005). This suggests that autoimmune processes against these tissues might be 
present in Aire deficient mice despite the absence of clinical disease. The 
discrepancies between the symptoms of Aire deficient mice and patients with 
APECED led us to investigate whether the Aire deficient mice produce 
autoantibodies similar to human APECED.  This issue is important not only for 
evaluating the relevance of Aire deficient mice as a model of APECED, but for 
autoimmunity in general and for comparison of the mechanisms of autoimmunity 
between mice and man. 
In the first study we tested the presence of autoantibodies against eleven human 
APECED antigen homologues in Aire deficient mice, listed in bold in Table 7.  
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Table 7. Autoantigens and autoantibodies in APECED. 
AUTOANTIGEN PREVALENCE CLINICAL DISORDER TARGET ORGAN REFERENCE 
P450c21 66 % Addison's disease adrenal cortex Krohn et al. 1992, Uibo et al. 1994, 
Chen et al. 1996, Söderbergh 2000 
P450c17a 44 %    
P450scc 52 %    
P450scc   failure of gonads gonads Söderbergh 2000, Uibo et al. 1994 
Thyroid peroxidase 
(TPO) 
36 % hypothyroidism thyroid gland Perheentupa et al. 1998 
Thyroglobulin (TG) 36 %   Perheentupa et al. 1998 
GAD65, GAD67 37 %** T1D pancreas Gylling et al. 2000 
IA-2     
insulin*     
Tyrosine hydroxylase 
(TH) 
40 % alopecia scalp Hedstrand et al. 2000 
Cyp1A2  autoimmune hepatitis liver Clemente et al. 1997, 1998, Gebre-
Medhin et al.1997, Husebye et al. 
1997, Söderbergh 2000 
Cyp2A6     
AADC 51 %    
Tryptophan 
hydroxylase (TPH) 
45 % intestinal dysfunction/ 
malabsorption 
gastrointestinal 
tract 
Tuomi et al. 1996, Ekwall et al. 1998, 
Söderbergh 2000 
GAD65, GAD67   pancreas  
SOX9  vitiligo skin Husebye et al. 1997, Hedstrand et al. 
2001 
SOX10     
AADC     
ICA  T1D pancreas Ahonen et al. 1985 
IFN-α, IFN-ω, (IFN-β, 
IFN-λ1¤) 
100 %   Meager et al. 2006 
NALP 49 % hypoparathyroidism parathyroid 
gland 
Alimohammadi et al. 2008 
TDRD6 49 %   Bensing et al. 2007 
enolase  58 %   O'Dwyer et al. 2007 
bold - analyzed in our study   Modified from: Meriluoto et al. 
2001, Heino et al. 2001,  grey, cursive - new  autoantibodies 
described after our antibody screen 
 
  Peterson et al. 2004, and Peterson 
and Peltonen 2005 *controversial data 
    ** GAD65 
    ¤ = also called IL-29     
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1.1 Cloning of APECED antigens and their murine homologues  
In order to determine whether APECED autoantibodies found in Aire deficient mice 
correspond to their human equivalents, we screened the sera of individual Aire deficient 
mice for antibodies against autoantigens previously identified in APECED patients.  
First, the cDNAs of murine homologues for eleven human APECED autoantigens 
(see Table 1.) were amplified by RT-PCR. Then, they were cloned into an 
appropriate expression vector. Correctness of the clones was verified using DNA 
sequencing, followed by production of the antigens by in vitro transcription-
translation (ITT). Analysis of the radiolabelled ITT products in SDS-PAGE 
confirmed their expected molecular masses. Finally, these radiolabelled human or 
mouse polypeptides were used as antigens in immunoprecipitation assays.  
1.2 Screening for APECED autoantibodies in Aire deficient mice 
Initially, sera from individual Aire deficient mice were tested for antibodies against 
the human autoantigens 21OH, 17OH, P450scc, TPH, AADC, GAD65, IA-2, and 
Cyp1a2 and Cyp2a5. Unexpectedly, neither Aire-/- nor Aire+/+ mice displayed 
antibodies against any of the human APECED antigens tested. In order to rule out 
the possibility that the murine autoantibodies do not react with the human 
homologues, we went on to repeat the assay using the mouse homologues of human 
APECED autoantigens, cloned as explained above. The mouse genes were: 21OH, 
17OH, P450scc, TPH, AADC, IA-2, PAH, Sox9, Cyp1a2, Cyp2a5 GAD1 and 
GAD2 (and later, insulin). 
Sera from 20 individual wt and 20 Aire deficient mice were tested for reactivity 
against the in vitro synthesized, 35S-labeled mouse antigens using, again, 
immunoprecipitation assays. No autoantibodies were found in these mouse sera. As 
positive controls and in order to confirm our assay worked, we showed that in vitro 
produced human P450scc and GAD65 antigens could be immunoprecipitated with 
sera from APECED patients. Furthermore, we verified that in vitro synthesized 
mouse AADC was precipitated with an AADC positive serum from an APECED 
patient (Figure 10).  
Negative results must be thoroughly verified. We therefore went on to analyze sera 
from Aire+/+ or Aire-/- mice by immunoblotting using the eleven in vitro translated 
mouse antigens. None of the sera which we had obtained from the Aire knock-out 
mice (3-7 Aire+/+ and 3-7 Aire-/- sera were tested per antigen, as well as human 
serum controls) reacted against any of the in vitro synthesized antigens tested.  
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Figure 10. Autobodies against the APECED antigens tested were not detected in Aire 
deficient mice, or were not present in levels higher than in wt mice. 
However, some reactivity against different unidentified polypeptides of the rabbit 
reticulocyte lysate, in both wt and the Aire deficient mouse sera were revealed. Yet 
no distinct knock-out specific immunoreactive bands could be detected. The 
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immunostaining pattern with the serum from the same mouse remained the same in 
spite of the antigen used. Interestingly, the staining patterns seemed to be serum 
specific, showing individual reactivity patterns for the mice. 
It has been reported (Anderson et al. 2002; Liston et al. 2004) that Aire controls the 
expression of insulin in the thymus in mice. Proinsulin is the driver antigen in T1D 
in NOD mice and likely to be the primary antigen in human common T1D 
(Nakayama et al. 2005; Harrison et al. 2008; Kobayashi et al. 2008). Insulin is also a 
well-known autoantigen in T1D in both humans and mice, as well as in APECED 
patients (Maruyama et al. 1988; Gylling et al. 2000). A previous study concerning 
60 Finnish patients with APECED had shown that 12 of them developed type 1 
diabetes and insulin autoantibodies were detected in 36% of the prediabetic 
APECED samples (Gylling et al. 2000). Furthermore, insulin antibodies were not 
found in the sera of non-diabetic patients. Taking these findings into consideration, 
we wanted to determine the presence of insulin autoantibodies in Aire deficient 
mice. Since ITT did not provide the post-translational modifications to the 
synthesized insulin polypeptide, an immunoprecipitation assay using 125I human 
insulin was used instead for this antigen. We could not detect a significant difference 
in insulin reactivity between the 21 Aire-/- and the 21 Aire+/+ mouse sera tested. 
1.3 Systemic autoantibodies  
Systemic autoimmune diseases such as SLE and Sjögren’s syndrome (SS) are 
characterized by anti-nuclear autoantibodies (ANAs) in both mice and men. SS is 
also a disease component of APECED. A few groups have reported that APECED 
patients have low-titer systemic autoantibodies as well as circulating ANAs 
(Perniola et al. 2000; Obermayer-Straub et al. 2001). Therefore, we wanted to test 
Aire deficient mouse sera for presence of ANAs. Commercial Hep 2 cell slides were 
used to test sera from 18 Aire-/- and 18 Aire+/+ mice individually. 
Nearly equal amounts of ANA-positive titers (≥100) were detected in both knock-
out and wt sera (in eight and six mice, respectively), whereas higher numbers of 
mouse sera: 12 Aire-/- and 14 Aire+/+, tested negative. Positive reactions of high titers 
(≥ 500) were detected in six Aire knock-out sera and in two wt sera, but this 
difference was not statistically significant (p = 0.241). 
Five sera from Aire-/- and wt mice each which had tested ANA positive were tested 
further by line blotting for extractable nuclear antigens. Three of the five sera and 
1/5 wt serum gave a faint reaction with histones and 1/5 of the Aire-/- sera reacted in 
addition with RNP-A, RNP 70kd, CenpB and Scl70-proteins. None of these 
autoantibodies are typical for SS.  
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1.4 Proliferation of lymphocytes in response to autoantigens 
Lastly, we wanted to determine whether the Aire deficient mice elicited T cell 
responses against the autoantigens studied. Spleen cells isolated from 7 Aire-/- and 5 
Aire+/+ mice were harvested and then cultured for six days in the presence of 
reticulocyte lysates with or without addition of in vitro produced autoantigen, or in 
the presence of medium only (control). A stimulation index of two, compared with 
the control wells, was used as threshold. Proliferative responses against altogether 
seven antigens in Aire-/- mice and against six antigens in Aire+/+ mice were detected 
with no apparent pattern. Two mice, one Aire-/- and one Aire+/+, demonstrated T cell 
responses also against the plain reticulocyte lysate. Knock-out mice did not elicit 
higher levels of proliferative responses versus wt mice. Thus, none of the 
autoantigens studied produced proliferative responses more often in lymphocytes 
from the Aire-/- mice than in lymphocytes from the Aire+/+ mice.  
2 APECED patient DCs are defective (II) 
AIRE plays an important role in central tolerance. However, AIRE is also expressed 
in the peripheral monocyte/dendritic cell lineage (Heino et al. 1999; Kogawa et al. 
2002; Sillanpaa et al. 2004; Zheng et al. 2004)) and the expression has been shown 
to be increased during the differentiation process of human monocyte to dendritic 
cells (Sillanpaa et al. 2004). Moreover, it has been proposed that AIRE is required 
for normal development and function of dendritic cells (Sillanpaa et al. 2004; 
Ramsey et al. 2006). The tolerogenic activity of AIRE not only takes place centrally, 
in the thymus, but AIRE is also involved in the regulation of peripheral tolerance, at 
the level of T cell – peripheral DC interaction (Ramsey et al. 2006). Still, the 
functions of AIRE in DCs are presently not known. 
In order to further investigate the role of AIRE in host immune functions and DC 
biology, we compared the properties and transcript profiles in in vitro monocyte-
differentiated dendritic cells (moDCs) obtained from APECED patients carrying the 
most common human AIRE mutation (R257X) and in healthy controls. 
The high prevalence of chronic mucocutaneous Candida albicans infections (CMC) 
in APECED patients is a prospective sign of a defect in peripheral tolerance and/or 
innate immunity. Currently, the molecular basis of the increased susceptibility for 
CMC in APECED patients remains elusive. 
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2.1 AIRE is expressed in human DCs and its expression remains 
unchanged in response to microbial stimulation  
We compared the expression of AIRE in moDCs generated from six APECED 
patients and six controls as well as in the plasmacytoid DC (BDCA 4+) and myeloid 
DC (CD1c+, BDCA 1) subsets which we isolated directly from the blood of three 
healthy control individuals. The expression levels of AIRE mRNA were assessed 
using Q-RT-PCR. They were relatively low and nearly equal in all three DC 
populations studied. We also studied whether the expression level of AIRE mRNA 
would change during stimulation of moDCs with different microbes or their 
components. No significant changes in response to Sendai virus infection or 
stimulation with Candida albicans were observed. 
2.2 Monocytes from APECED patients differentiate into immature 
moDCs and express typical DC specific genes 
First, we studied whether monocytes isolated from peripheral blood of APECED 
patients are able to differentiate normally in vitro and do they show typical features 
of moDCs. Microscopical examination showed that moDCs from APECED patients 
and controls looked very similar during the 6 day differentiation culture in vitro with 
GM-CSF and IL-4 stimulation. Infection of cells with Sendai virus or stimulation 
with Candida albicans produced cellular processes typical for differentiated moDCs 
in both patient and control moDCs.  
Further analysis of differentiation of AIRE-deficient moDCs using established DC 
markers and flow cytometry showed that the mean fluorescent intensity of HLA-II-
DR of APECED moDCs was slightly lower than the corresponding levels of the 
controls. However, upon stimulation with E. coli-derived lipopolysaccharide (LPS) 
or infection with Sendai virus, HLA- II-DR was expressed at higher levels in patient 
moDCs than in control moDCs. Similarly, CD86 was expressed at a similar basal 
level, whereas expression levels were somewhat higher in stimulated patient DCs 
compared to control moDCs. However, there was a lot of individual variation in the 
expression of these markers and none of the differences were statistically significant. 
The transcript levels of moDC-specific genes characteristic of differentiated 
immature DCs (Lehtonen et al. 2007) (CD1α, DC-SIGN, IL-21 receptor, IRF4, 
FcεR1a, SOCS1, WNT5a, and TLR2) were measured using Q-RT-PCR and 
calculated from two to six patients (depending on the marker) and from six controls. 
Slightly higher expression of DC-SIGN (not significant) and IL-21R (p = 0.04) and 
a lower expression of FcεR1A (p = 0.014) were found in APECED moDCs as 
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compared to control moDCS. The other marker genes showed no significant 
differences between patients and controls.  
2.3 Impaired expression of inflammatory cytokine genes in AIRE 
deficient moDCs in response to microbial stimulation 
In order to detect functional defects in patient DCs we analyzed microbe-induced 
cytokine gene expression in APECED moDCs using, again Taqman Q-RT-PCR. 
Prior to stimulation, the expression of most cytokine and chemokine mRNAs 
appeared similar in APECED and control DCs, suggesting normal monocyte-DC 
differentiation with the exception of CXCL8 transcript levels which were lower in 
patients versus controls (Article II, Figure 3;  p ≤ 0.01).  
For stimulation, we used live Candida albicans and Sendai virus, which have been 
widely used as microbial stimuli in DC research. Control moDCs showed clear 
induction of most cytokines transcript levels tested in response to Sendai virus 
infection (p ≤ 0.01). Conversely, APECED moDC responses remained at levels that 
were at least a hundred fold lower. Nonetheless, these differences were not statistically 
significant (p > 0.05) in our study sample. C. albicans was quite a poor inducer of IL-
29 in both patients and controls. TNF-α and CXCL8 transcript levels were similar in 
APECED and control moDCs in response to C. albicans stimulation. CXCL10 was 
induced more weakly in APECED moDCs (p ≤  0.001). CXCL8 and TNFα were up-
regulated significantly in both APECED and control moDCs in response to C. 
albicans, whereas in control cells IL-12p35, IFN-β and CXCL10 mRNA expression 
was also stimulated significantly (p ≤ 0.01 or p ≤ 0.001) by C. albicans.   
2.4 Reduced cytokine production by APECED patient moDCs in response 
to microbial stimuli 
We further analyzed cytokine concentrations in cell culture supernatants of moDCs 
that were infected with Sendai virus or stimulated with C. albicans or LPS for 24h. 
This was done using a FACS-based, multiplex bead assay. The basal expression 
level of TNF-α, IL-1β, IL-6, CXCL8 and IL-12 in unstimulated cells was lower in 
APECED moDCs than controls (Figure 11). The production of TNF-α, IL-1β, IL-6, 
CXCL8, IL-10 and IL-12 was clearly higher in controls in response to stimulation 
with C. albicans. The differences were statistically significant for TNF-α, IL-1β, IL-
6 and CXCL8. Likewise, there was a clear difference in the ability of APECED 
moDCs and control moDCs to produce cytokines in response to Sendai virus 
infection or LPS stimulation (Figure 11). Of the stimuli used, Sendai virus infection 
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induced the highest levels of TNF-α, IL-1β and IL-12, while LPS was the best 
inducer of IL-6 and IL-10.  
 
Figure 11. Cytokine production was reduced by patient moDCs (grey) compared to 
moDCs from healthy controls.  MoDCs differentiated from APECED 
patients or control individuals had been stimulated with LPS (100 ng/ml), C. 
albicans (MOI 1), or infected with Sendai virus (MOI 5). Supernatants were 
collected at 24 h after microbial stimulation and cytokine levels were 
determined by flow cytometry. Statistical significances between the groups 
were calculated using Students t-test (*p<0.05). 
 93 
 
 
2.5 Expression profiles of AIRE deficient DCs show aberrations in 
immunologically important pathways 
Differences in the genome-wide transcript patterns in APECED and control moDCs, 
were observed using Affymetrix expression array U133 Plus 2.0 chip analyses. Total 
cellular RNAs were isolated from three APECED patient-derived and three healthy 
donor-derived moDCs individually. Additionally, moDCs from the same three 
patients and healthy controls were stimulated with C.albicans for 24h and analyzed 
using individual Affymetrix chips. After data processing and quality control, data 
was analyzed using GeneSpring software. Lists of individual genes over two-fold 
up- or down-regulated (p<0.05) in APECED moDCs prior to and after stimulation 
were obtained. Out of these genes, those belonging to the most consistently and 
differentially expressed Gene Ontology (GO) categories are emphasized in the 
Volcano plots. A few genes, like CXCL8, IL-10, and TNF-α, were down-regulated 
at both protein and at mRNA levels as well as/or in Affymetrix array analyses in our 
study. 
After studying individual genes, we proceeded to study changes that cannot be 
detected at analysis on the single gene level in order to gain more insight into the 
groups of genes, or pathways modestly down-regulated in the patients. For this 
purpose, we applied an in-house developed tool for pathway analysis. We observed 
changes in the functional groups of genes or their regulatory pathways using the 
Gene Ontology (GO) category classification in patient moDCs. Quite a few 
immunologically important pathways were down-regulated in APECED moDCs. 
Down-regulated pathways included cell-cell signalling, cytokine and chemokine 
activity, host defence and inflammatory response, lymphocyte activity, and cell 
motility in unstimulated APECED moDCs. After C. albicans stimulation of 
APECED moDCs, the pathways described above, as well as those involved in 
chemotaxis and G-protein regulated signalling pathway were clearly downregulated 
(Figure 12). Some pathways like cell-cell signalling, defence response and cytokine 
activity were down-regulated in both experimental settings. 
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Figure 12. Gene Ontology classes of the (a) molecular function and (b) biological 
process are shown schematically. The most significant gene sets 
differentially expressed in nonstimulated and C. albicans-stimulated 
APECED patient moDCs are enriched according to the pathway analysis. 
Colored circles show regulated pathways and gray circles represent 
nonregulated pathways (cut-off p≤0.0001). Several immunologically 
important molecular functions and biological processes were downregulated 
in both unstimulated and stimulated patient cells. Thus, important 
differences in patient moDCs were found compared to control moDCs. More 
pathways were down-regulated in nonstimulated patient moDCs than C. 
albicans stimulated moDCs (red vs. light blue circles). This indicates 
differences in patient moDCs already at the unstimulated state 
3 Gamma delta T cells in APECED (III) 
Absence of AIRE/Aire has been shown to disrupt αβ T cell selection and to have a 
profound effect on αβ T cell development, allowing autoreactive T cells to mature. 
However it is not known whether Aire is needed for normal γδ T cell development. 
How γδ T cells develop is not well understood, but it differs in many ways from that 
of αβ T cells. In this study, we have analyzed the γδ T cell compartment in Aire-/- 
mice and in APECED patients. 
3.1 γδ T cells are present at normal frequency in Aire deficient mice 
We began by testing if the absence of Aire in MECs in the thymus would affect the 
frequency of T cells committed to the γδ T cell lineage. We used the “Ramsey Aire 
knock-out mouse” (Ramsey et al. 2002), which mimics the FinnMajor mutation and 
syngeneic parental mice as controls. FACS analysis revealed that the mean amount 
of γδ TCR-positive T cells was not significantly different from that of wt mice. In 
the spleen, the number of γδ T cells was also similar between knock-outs and 
controls, as was the fraction of γδ T cells out of all CD3+ splenocytes. 
An important location of γδ T cells is the intestinal epithelium. Flow cytometry 
could not be used for quantitation in these solid tissues, so we homogenized pieces 
of intestine, followed by Q-RT-PCR in order to measure the relative abundancy of 
γδ T cells within the intestine. We selected the TCR Cδ gene for measurement, as it 
is deleted during TCR α locus rearrangement, whereas TCR γ mRNA can also be 
expressed by αβ T cells. No differences were noted between the amounts of TCR Cδ 
in the intestines of knock-out and wt mice (see Figure 13).  
We also analyzed the subset of γδ T cells in the skin. However, since their thymic 
development at embryonic days 12-13 precedes the expression of Aire, which is first 
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detected at embryonic day 14.5, it is not likely that they would be affected by Aire-
deficiency. Indeed, the amount of Cδ mRNA was similar in Aire-/- and Aire+/+ mice. 
 
Figure 13. The number of γδ T cells is similar in Aire-/- and Aire+/+ mice. (A) Thymus, 
(B) and (C) spleen, (D) ileum, and (E) skin. In A, B and C flow cytometry 
was used, while in D and E the amount of TCR Cδ mRNA was measured 
using Q-PCR, normalized against HPRT expression levels. Black circles 
symbolize Aire-/- mice and open circles WT mice. Mean values are indicated 
by horizontal lines. None of the differences are statistically significant. 
3.2 The TCR γ repertoire of γδ T cells is normal in Aire-/- mice 
For a more detailed view of γδ T cell development we next analyzed the TCR γ 
chain repertoire in Aire knock-out and wt mice. An earlier analysis of this mouse 
model had shown abnormalities in certain TCR Vβ genes, while others were normal. 
A set of primers specific to all expressed Vγ genes was designed, with one primer 
amplifying the conserved Vγ5.1 – 5.3 area. The 3' primers were designed to an area 
conserved in the 3 functional Cγ genes. This allowed amplification of the full γ 
repertoire. Then, the CDR3 length patterns were determined by electrophoresis.  
In the thymus, polyclonality was observed. The CDR3 pattern in all five Vγ 
amplifications produced a generally Gaussian distribution and the patterns were 
virtually identical in Aire-/- and Aire+/+ mice. Additionally, the same CDR3 lengths 
dominated in each Vγ gene. In the spleen, no significant differences were observed 
either and the repertoire was very similar to that of thymic γδ T cells. In the ileum, 
oligoclonality was observed. This finding was consistent with previous observations, 
and the repertoires were visibly different from those of the thymus or spleen. Yet, 
the range and the average rearrangement patterns were quite alike in knock-outs and 
controls. We also carried out a limited analysis of the Vδ5 repertoire, which is 
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associated with polyclonal γδ T cells in lymphoid organs and the ileum and obtained 
similar results. To summarize, our results indicated that despite the absence of Aire, 
γδ T cells develop in normal numbers and contain a normal TCR repertoire. 
3.3 γδ T cells of Aire-/- mice do not show signs of increased activation  
The disruption of thymic negative selection of αβ T cells in Aire deficient mice 
leads to hyperreactivity and augmented expression of activation markers. Since 
CD25 is an activation marker on γδ T cells, we measured the expression of CD25 on 
γδ T cells of the spleen. No significant differences were found between Aire 
deficient and wt mice, nor were there differences in the frequencies of large γδ blasts 
in the spleen. 
Next, we stimulated splenic γδ T cells with a mAb specific to γδ TCR, immobilized 
to the culture well bottom, in order to test the reactivity of the cells. The mAb did 
not induce significant proliferation on its own. After that, we added cytokines and 
growth factors found in the culture medium of Concanavalin A-stimulated spleen 
cells. This resulted in an obvious proliferative response in most knock-outs and wt 
mice. Surprisingly, the response of knock-outs was significantly higher that that of 
the wt mice, although individual variation was considerable. Therefore, the γδ T 
cells in Aire deficient mice were not found to be hyperreactive. 
3.4 Target tissue infiltrates are not composed of γδ T cells 
One important feature of the immunopathology of Aire deficient mice is infiltrating 
lymphocytes in target tissues. Consequently, the amount of TCR Cα mRNA was 
significantly higher in the salivary glands of Aire-/- mice compared to Aire+/+ mice. 
However, no difference in the amount of TCR Cδ mRNA was observed, confirming 
that there were no increases in numbers of γδ T cells. Next, we analyzed the γ chain 
repertoire of the cells located in the salivary glands. The patterns were more 
oligoclonal than in the spleen, and not all the Vγ genes were detected in every 
animal, but no differences could be observed between wt mice and Aire knock-outs. 
An oligoclonal repertoire may point to either an ongoing autoimmune response, or it 
could be due to the scarcity of T cells in the tissue. We wanted to distinguish 
between these possibilities and thus, we compared the local TCR γ repertoire in 
salivary glands to the systemic repertoire in spleen of the same mouse. Our 
hypothesis was that given the similar numbers of γδ T cells in the salivary glands of 
both Aire+/+ and Aire-/- mice, an active process in the Aire-/- mice would be 
characterized by a more intensive skewing of the local repertoire, due to clonal 
expansions.  
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In order to study this hypothesis and to obtain a quantitative view of the difference 
between a systemic and local repertoire, we adapted a previously described method 
(Gorochov et al. 1998). In this method, areas of individual in-frame peaks in the 
CDR3 length profiles are expressed as a percentage of the combined areas of all the 
in-frame peaks in the profile. Two profiles are then compared by extracting the 
relative peak areas of one profile from the other, and the total difference is expressed 
as a range of 0-100%. Therefore, a value of 100% means totally different profiles 
and 0% completely overlapping profiles.  
Quantitative comparison of the TCR γ repertoire in salivary glands and spleen 
confirmed oligoclonality. The average difference was roughly similar in both (39 ± 
25% and 34 ± 17%, respectively). Detailed analyses of each Vγ gene alone did not 
show significant differences between the Aire-/- and Aire+/+ mice either. When the 
same comparison was done between salivary glands and thymic repertoire, again a 
similar result was obtained. To summarize, our data are not consistent with 
significant pathological γδ T cell infiltrates in the salivary glands of the Aire-/- mice. 
3.5 APECED patients have normal frequencies of γδ T cells  
Finally, we measured the frequency of circulating γδ T cells in APECED patients. 
The mean frequency of γδ T cells within the CD3+ population was a bit higher in the 
APECED patients than in healthy controls. However, the difference was not 
statistically significant. Interestingly, a subset of six patients had values outside the 
range of healthy controls and all of these patients were women. Yet, when we 
analyzed the whole patient cohort divided by sex, we did not find that female 
APECED patients would have an increased frequency of γδ T cells. 
APECED is a very variable disease, with some components found in most patients 
and others affecting only a subset of them. Why this heterogeneity exists is not 
known. When we checked the clinical records of the subgroup of six female patients 
mentioned above, we saw no clear associations with any given disease component. 
Nor did we see correlation in the total number of different components. Therefore, 
although the findings on γδ T cells in this patient group are interesting, we have no 
evidence yet that they would represent anything else than random variation. 
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Figure 14. The frequency of peripheral blood γδ T cells in APECED patients is similar 
to that of controls. Black circles represent patients and open circles healthy 
controls. Mean values are indicated by horizontal lines. The differences are 
not statistically significant. 
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4 DISCUSSION 
1 Of mice and men: differences in autoantibodies and autoimmune 
diseases in the absence of AIRE/Aire 
We analyzed Aire deficient and wt mouse sera for autoantibodies against eleven of 
the known APECED autoantigen mouse homologues, but did not find any, or higher 
levels of autoantibodies in Aire knock-out mice than in controls. Since most of the 
APECED autoantibodies are quite common in patients, present at frequencies over 
20%, our analysis of 20 Aire deficient mouse sera should have been large enough to 
detect even low frequency autoantibodies, if they would have been present in the 
mice. Therefore we consider our negative results significant. Furthermore, we tested 
both human and mouse antigens. We also carried out several controls in order to 
make sure our tests were sensitive enough. However, there were a few antigens we 
did not test for (eg. SOX10, TPO, TG, IA-2, and H+K+-ATPase) and we cannot say 
whether mice have autoantibodies against them or not. Yet, our assays did include 
most of the known major targets in APECED and since those were absent in knock-
out mice, our results showed that generally, the mice we tested do not show the 
same autoantibody pattern as human patients.  
MHC, which is the single biggest genetic determinant in organ specific 
autoimmunity in man, may have an effect also in mice, and more particularly, in 
Aire deficient mice. It is known that the phenotype varies in different strains of Aire 
deficient mice (Jiang et al. 2005). Therefore, if the H2 haplotypes of the Aire 
deficient mice were studied after crossing the mice into different autoimmune 
susceptible backgrounds, such as those predisposing to T1D (H2g7), thyroiditis 
(H2k), or encephalitis (H2s), one would expect to see different phenotypes in these 
mice. One could expect for example higher levels of autoantibodies against the 
thyroid gland in the H2k mouse as well as a thyroid phenotype, whereas the H2g7 
mice would probably have autoantibodies against the pancreas in addition to a more 
severe diabetic phenotype. However, whether additional phenotypes would arise and 
what role H2 plays in Aire deficient mice has not yet been revealed. What exactly 
accounts for the dramatic differences in organ specific autoimmunity in Aire 
deficient mice of the different strains is not known. Nevertheless, the differences 
between the phenotypes and the range of organs targeted by autoantibodies in the 
Aire deficient mice in the B6, Balb/c and NOD strains points at the involvement of 
additional factors than just Aire involved in molding the autoimmune phenotype. 
Just as the phenotype of APECED patients differs from one “outbred” individual, or 
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population of patients to another, so does the phenotype of inbred mice from one 
strain to the other. 
Anderson et al. (Anderson et al. 2002) showed that Aire controls the expression of 
insulin in the thymus, but we did not detect insulin autoantibodies in our Aire 
deficient mice. Aire deficient mice do not develop autoimmune diabetes either, 
unlike APECED patients. This is in agreement with our results showing lack of 
autoantibodies against insulin, GAD and IA-2 in Aire deficient mice. None of the 
other disease components typical for APECED have been described in the Aire 
deficient mice either. We assume that the tissue reactivity reported by others 
(Anderson et al. 2002; Ramsey et al. 2002; Jiang et al. 2005) in Aire knock-out mice 
is targeted against some unknown organ specific or common antigens.  
We also tested for common, or systemic, autoantigens. Elevated levels of anti-
nuclear antibodies in the Aire knock-out mice were not found, thus these are 
unlikely candidates for the targets of the reported autoantibodies. Weak anti-nuclear 
antibodies had been reported in some Italian patients with APECED (Perniola et al. 
2000). Nine out of the 10 patients tested positive for low titre ANA (Perniola et al. 
2000). However, other studies show that ANA are not typical for APECED 
(personal communications, Aaro Miettinen). Therefore, the role of ANAs in 
APECED remains to be clarified. 
Other studies supporting our findings were that α-fodrin antibodies were found in 
Aire deficient mice (Kuroda et al. 2005). Anti-α-fodrin antibodies have not been 
described in APECED patients and interestingly, expression of α-fodrin is not under 
the control of Aire in the thymus. This may be because α-fodrin is a ubiquitous 
protein, unlike other known APECED antigens. Also this difference between Aire 
knock-out mice and APECED patients is in agreement with our results and further 
supports the view that the targets of autoimmunity are different in these species. 
Another such Aire-independent antigen is pancreas specific protein disulphide 
isomerase (PDIp) (Niki et al. 2006), though this protein is more specific and 
therefore, reasons as to why this is a target for autoantibodies in mice and not in 
humans is more difficult to speculate. 
Observations concerning the autoantibodies against different tissues in the Aire 
deficient mice showed that the genetic background had a strong effect on the 
spectrum of autoantibodies (Anderson et al. 2002; Jiang et al. 2005; Kuroda et al. 
2005). In humans, genetic background may have an effect as well, as for example 
Iranians rarely have candidiasis. However, they also have a different disease 
mutation than Finns, who have nearly 100% candidiasis. Therefore it is not easy to 
say whether the differences in the phenotypes of patients are due to genetic 
background or mutation. In mice, it seems that differences in phenotype between the 
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different models are related to strain rather than the construct used (i.e. where the 
“mutation is introduced” in Aire). 
Our study indicates that even though Aire knock-out mice have a well characterized 
defect in central tolerance, they do not develop autoimmunity against organs 
typically affected in the patients with APECED. Differing autoantigens in patients 
with APECED and in Aire deficient mice suggest that Aire may control a different 
set of genes in mice and in men. This may result from a number of reasons. For 
example, differences in chromosomal organization of target genes, in 
ubiquitinylation/methylation patterns, in promoter structures and in the mechanism 
of ectopic antigen presentation to T cells (Gotter et al. 2004) can be envisaged. The 
hierarchy of gene regulation may also differ between species. To find out the reason 
for these species differences, understanding of the molecular mechanism of AIRE 
dependent regulation of transcription (Gotter and Kyewski 2004) will be essential. 
Furthermore, a different panel of autoantigens suggests there are differences in the 
immunopathogenic mechanisms between man and mice, requiring further 
investigations. Finally, since the Aire deficient mice do not mimic the human 
APECED disease, caution should be applied when interpreting the data from 
analyses using the Aire mouse models. 
After completing our study concerning APECED autoantibodies in Aire deficient 
mice, we went on to screen for new autoantibodies in sera of the Ramsey Aire 
deficient mice (Ramsey et al. 2002) using cDNA library screening of a few different 
libraries (liver and hypoparathyroid gland). We found some new candidate target 
antigens in addition to NALP5 (discussed below). However, these studies are still 
ongoing. Importantly, our collaborative efforts have preliminarily shown that 
NALP5 is also found in some, individual Aire knock-out mice (unpublished data 
and Mohammad et al. personal communications), although not as frequently, or in as 
high titres as it is found in patients. If this is the case, NALP would be the first 
autoantibody reported to be common for Aire deficient mice and APECED patients 
and could help to elucidate molecular mechanisms leading to the loss of tolerance to 
NALP5 in the absence of Aire. It would be very interesting to study further why this 
autoantigen is shared between species, if most of the other APECED autoantibodies 
are different in mice and men. 
Our collaborative effort resulted in the discovery of NALP5 as an APECED 
autoantigen, associated with hypoparathyroidism (Alimohammadi et al. 2008). 
Hypoparathyroidism is a hallmark of APS-1 and affects more than 80% of the 
patients (Perheentupa 2002; Liston et al. 2004). Earlier, the calcium-sensing receptor 
(CaSR) had been suggested as an autoantibody for APECED (Gavalas et al. 2007), 
but other groups were not able to detect antibodies in patient sera against CaSR 
(Gylling et al. 2003; Soderbergh et al. 2004). It is quite exciting that a pattern 
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recognizing protein is the target of immune attack, although as with the other 
APECED autoantigens, why loss of tolerance specifically against this protein occurs 
is a mystery. Identification, finally, of a parathyroid specific autoantigen is 
important for improved serological diagnosis of APECED, and could help to provide 
better understanding of the molecular pathology of APECED. 
Recently, a group of neutralizing, IgG autoantibodies against type 1 interferons 
(IFN) were discovered as “new” autoantibodies in APECED patients. This was a 
very exciting finding, as these antibodies are so APECED specific and were present 
in 100% of sera of the APECED patients tested. IFNs can act to halt viral replication 
and serve as danger signals by activating APCs, thus linking between innate and 
adaptive immunity. Autoantibodies against IFN-α and IFN-ω were the most 
common subtypes, and some Finnish patients also reacted with IFN-β and IFNλ1 
(=IL29). IFN autoantibodies preceded other APECED autoantibodies and in some 
cases, the IFN antibodies were predictive of development of clinical symptoms 
(Meager et al. 2006; Wolff et al. 2007). Studying these antibodies further will 
certainly answer some of the many questions which arise from these results, such as 
why APECED patients with such “general” autoantibodies only get candidiasis and 
not other infections as well? Furthermore, it will be interesting to find out whether 
Aire knock-out mice express autoantibodies against interferons as well. Anti-IFNs 
may also be evoked by changes in APCs, such as DCs (Meager et al. 2006), studied 
in the II publication of this thesis discussed below. IFN autoantibody production in 
APECED patients is suggested to be caused by increased production of IFNs in the 
thymus. This would somehow result in anti-IFN antibodies, which cause down-
regulation of IFN stimulated genes in patient blood cells (Kisand et al. 2008). 
Novel pituitary autoantibodies in APECED were also reported recently (Bensing et 
al. 2007; O'Dwyer et al. 2007). TDRD6 was reported as a major autoantigen in 
APECED, in 49% of APECED patients studied, although it is expressed mainly in 
testis. This study also indicates the presence of further target autoantigens in the 
anterior pituitary than TDRD6 and AADC, which have already been found  
(Bensing et al. 2007). Indeed, a study on the prevalence of pituitary antibodies in 
Finnish APECED patients showed that the pituitary can be “part of the multi-organ 
involvement of the disease”. This study identified enolase, a ubiquitous glycolytic 
enzyme, as a novel autoantigen. This antigen is not organ specific and as patients 
rarely develop hypopituaritism, why autoantigens against enolase would develop is 
not clear. The most interesting finding concerning enolase as autoantigen was that 
candidal enolase could also be targeted by these enolase autoantibodies, indicating 
cross-reactivity between it and pituitary enolase. This suggests that a mechanism in 
APECED autoimmunity could be molecular mimicry (O'Dwyer et al. 2007). 
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Figure 15. Conclusions from our study of APECED autoantibodies in Aire deficient 
mice. Autoantibodies against different autoantigens are expressed in Aire-/- 
mice compared to APECED patients. Aire may therefore control the 
expression of a different set of TSAs in mice than AIRE does in humans. 
None of these newly reported autoantibodies, except NALP5, have been reported to 
be found in Aire deficient mice yet. However, in a study of induced diabetes in Aire 
deficient mice, the mice did develop ICA antibodies (Hassler et al. 2008). Still, we 
await news of whether also these new autoimmune targets are human specific or are 
also found in mice. Furthermore, it will be interesting to find out whether these 
autoantibodies are found in different mouse strains and at which age the antibodies 
develop, in order to try to answer the question of which comes first, autoimmunity 
or autoantibodies. 
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2 What is the role of AIRE in peripheral DCs? 
Our studies (II) revealed that APECED patient moDCs are functionally impaired: 
the transcriptional response of cytokine genes to pathogens was drastically reduced. 
Patient moDCs showed typical DC morphology and expressed DC marker proteins 
CD86 and HLA class II DR, as analyzed by FACS and Q-RT-PCR. When analyzing 
other typical markers of DCs by Q-RT-PCR, an interesting difference was noted in 
the expression of DC-SIGN (DC-specific ICAM-grabbing non-integrin) which was 
weakly, yet not significantly up-regulated in AIRE-deficient moDCs. This pattern 
recognition, adhesion and pathogen uptake receptor (Geijtenbeek et al. 2000; 
Geijtenbeek et al. 2000), functions as one of the major receptors for C. albicans 
enhancing its internalization (Cambi et al. 2003). However, expression of several 
other genes involved in cellular responses to C. albicans (Donini et al. 2007; 
Goodridge et al. 2007) was similar in APECED and control cells, and their 
expression was not altered either during C. albicans stimulation. Therefore, our 
studies were unable to shed light on why APECED patients are prone to candidiasis. 
An important goal we had in our study was the analysis of the transcript profiles of 
APECED patients (carrying the same homozygote FinnMajor mutation) versus healthy 
controls. Our results showed that patients differ in many respects from controls. The 
expression of a number of genes important for DCs was reduced in APECED 
moDCs. Several genes were up- or down-regulated in both unstimulated and C. 
albicans stimulated patients moDCs. Significantly more genes were repressed in 
patients: 5.9% in non-stimulated and 2.5% C. albicans-stimulated moDCs, than 
were activated: under 0.5% both before and after stimulation.  
Our genome-wide expression analysis showed that a number of interesting genes 
were down-regulated in APECED moDCs, for example NFκB1, important for DC 
activation and maturation (Kieran et al. 1990; Chaussabel et al. 2003), CD58 (LFA-
3) an MHC antigen mediating cell adhesion and T cell activation (Sanchez-Madrid 
et al. 1982; Suciu-Foca et al. 2005) and ITGB2 (also called CD18 or LFA-1) also 
important in the interactions of DCs with target cells (Sanchez-Madrid et al. 1982; 
Nagafuchi et al. 2007). These genes could at least partly contribute to the observed 
aberrations in the response to stimuli by APECED versus control cells. Expression 
levels of typical APECED autoantigen genes were not significantly different 
compared to controls, whereas those of most cytokine genes tested were down-
regulated in APECED DCs. AIRE has been shown to regulate cytokine expression 
in the thymus (Ruan et al. 2007) 
Importantly, the cytokine production was decreased in APECED moDCs, especially 
in response to microbial stimulus. We used three stimuli: live C. albicans, LPS, and 
Sendai virus, and all of them resulted in significantly reduced levels of DC cytokine 
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production. This would imply that patient moDCs respond weakly to microbial 
stimuli. Further, since cytokine synthesis is connected with the maturation of DCs 
(Veckman et al. 2004) the results could indicate that APECED patients have some 
impairment in their DC maturation processes as well. An important observation in 
support of this is that some differences in the gene expression profiles of moDCs 
were seen already at the immature stage in moDCs of APECED patients. Reduced 
expression of several genes and gene sets, such as those involved in cytokine 
activity, host defence response and cell-cell signalling were seen already in 
unstimulated patient moDCs. This could suggest that immature patient moDCs have 
a lowered tolerogenic capacity. 
The ability for antigen uptake of APECED moDCs is likely to be normal since 
DEC-205 and other uptake receptors were expressed at the levels comparable to 
controls. The antigen presenting capacity of APECED moDCs appeared normal, 
since the expression of  HLA class II genes was normal, or even weakly up-
regulated in APECED moDCs both at mRNA and protein level. Perniola et al. 
(Perniola et al. 2008) studied patient monocyte and leucocyte effector mechanisms 
and found nothing abnormal in those in response to e.g. C. albicans. This is in line 
with our finding of the DCs being the cell type defective in APECED. Brännström et 
al. (Brannstrom et al. 2006) studied the role of AIRE in defence against candidiasis. 
They saw a proliferation in patient T cells in response to Candida antigens probably 
due to clonal expansion of Candida recognizing T cell clones. They also 
investigated the capacity of patient DCs to internalize yeast cell wall zymosan and 
found a defect in this process. Many receptors and other molecules are involved in 
binding and internalization of C. albicans. Thus, the defect in the internalization and 
activation of Aire deficient DCs may be due to multiple pathways or one common 
effect (Brannstrom et al. 2006). Since we did not see altered levels in either mannose 
or lectin receptors, nor of e.g. dectin-1 either, identification of the pathway 
dysregulated in the absence of Aire needs to be studied further, in a more systematic 
fashion. Interestingly, Brännström et al. also noted a possible defect in monocyte 
maturation in APECED patients and hypothesized that this may affect the 
communication between APCs and effector T cells, just as our studies proposed. 
Using pathway analysis in order to observe changes in groups of genes too small on 
the individual gene level to be noted, we found a decrease in several 
immunologically relevant pathways in patient moDCs. Our results fit in well with 
previous findings on the role of AIRE in the maturation of DCs (Sillanpaa et al. 
2004) and the role of DCs in peripheral activation of T cells (Ramsey et al. 2006). 
The cytokine pathway was down-regulated, in accordance with our cytokine 
analyses. Cell-cell signalling was also down-regulated. A decrease in DC function, 
leading to deteriorate DC – target cell communication could, in turn, lead to 
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diminished lymphocyte activation and an impaired T cell response. On the other 
hand, since APECED patients are not more prone to infections other than those 
caused by C. albicans, these findings are slightly puzzling.  
We compared our human moDC array results with those of Johnnidis et al. 
(Johnnidis et al. 2005) arrays performed on thymic medullary epithelial cells 
(MECs) from Aire deficient and wt mice. Individual gene comparison did not show 
the same genes to be up-or down-regulated in both data sets. However, when the 
data sets were compared using our in-house pathway analysis, we found some 
shared differentially regulated functional categories. Aire knockout mouse MECs 
and human AIRE-deficient DCs both had down regulated cytokine activity, 
inflammatory response, G-protein-coupled receptor binding, chemotaxis, taxis, 
chemokine activity and chemokine receptor binding. Interestingly, in Aire-deficient 
mice, pathways involving T cell activation and proliferation as well as MHC class II 
biosynthesis were up-regulated, whereas only few pathways were found to be up-
regulated in APECED moDCs (mRNA processing, antigen processing and 
presentation, MHC protein complex). These differences in gene expression profiles 
likely result – at least to some extent – from differences in species and cell types 
compared. Yet, they could also be partly due to an apparently different role of AIRE 
in central vs. peripheral tolerance and in the mechanisms in humans vs. mice.  
A few other studies have addressed gene expression patterns in AIRE/Aire deficient 
and control cells. One study (Sillanpaa et al. 2004) compared the expression profiles 
of AIRE-positive and -negative monocytic U937 cell lines. Expression of the tissue-
specific antigens under control of AIRE in the thymus was not detected in the U937 
cells, again suggesting that the role of AIRE in the periphery may be different from 
that in the thymus. Array data presented by another group (Anderson et al. 2005) on 
mTECs from Aire deficient mice showed alterations in the expression of several 
genes involved in antigen processing and presentation. Aire deficient mice showed 
less effective antigen presenting capacity and chemokine expression was found to be 
up-regulated by Aire. We also observed a possible decrease in antigen presentation 
and in chemokine expression in the absence of AIRE. However, since our 
observation was in a different cell type and species, these two findings are not 
necessarily linked. However, it was not clear from the study by Anderson et al. 
whether the antigen presentation of splenic DCs from Aire-deficient mice was less 
effective as compared to wild type mice. On the contrary, Ramsey et al. (Ramsey et 
al. 2006) showed that peripheral DCs from Aire deficient mice were more effective 
activators of naïve T cells. Additionally, they reported that the number of DCs in the 
spleen, lymph nodes and blood of these mice was increased. They propose that the 
inappropriate T cell response in APECED could be due to overexpression of 
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costimulatory molecules on DCs, which is quite contrary to our findings, which 
suggest lack of sufficient target cell activation by DCs. 
DC maturation and DC – Treg interactions are important for immune response and 
tolerance (Hubert et al. 2007). We found some genes (ITGB2 and CD58 or LFA3) 
involved in DC-Treg interplay (Grossman et al. 2004; Suciu-Foca et al. 2005; 
Wethmar et al. 2006; Nagafuchi et al. 2007; Varga et al. 2007) to be down-regulated 
in patient moDCs. These findings of impaired DC function are in concordance with 
the findings of Kekäläinen et al. (Kekalainen et al. 2007). They suggested that the 
defect in AIRE-deficient regulatory T cells (Tregs) in humans could be due to 
impaired DCs stimulated Treg development. Defects found in both DCs and Tregs 
could implicate that there is a defect in the interplay between these two cell types. A 
study exploring the possibility that routing of antigens from mTECS may decide 
whether the cells become Tregs or not, showed that interactions of Tregs with 
mTECs do affect their development (Aschenbrenner et al. 2007). Therefore, one 
possibility is that the role of Aire in the thymus may additionally influence 
peripheral tolerance by affecting the development of Tregs. 
IFN over-production by peripheral DCs has not been observed and DCs were shown 
to produce normal levels of IFN stimulated genes in a recent study (Kisand et al. 
2008). However, increased serum levels of CXCL10, TNF-α and IL-6 were noted. 
As our patient DCs produced very low levels of CXCL10, the source of this 
chemokine in the patient sera is most likely other cell types than DCs (Kisand et al. 
2008). 
So far, it seems that more genes are positively regulated than negatively regulated by 
Aire. According to one study, the genes IL-1R1 and MHC class II were suppressed 
by Aire, among other genes not reported yet, as they are still being studied. These 
findings are only partly in agreement with our studies, as we saw suppression of 
cytokines in the absence of AIRE, but up-regulation of MHC class II (Sato et al. 
2004). Clearly, further studies on larger study samples are needed in order to reach a 
consensus on these, and several other issues concerning AIRE function. 
A study in line with our findings concerning a role for Aire in the periphery was that 
Aire deficient mice showed induced susceptibility to induced diabetes (Hassler et al. 
2008), although, strangely, highest levels were found in mice heterozygous for Aire 
(Aire+/-). We have worked on a project concerning injection of insulin into Aire+/+ 
and Aire-/- mice, in order to monitor differences in tolerance to insulin in the mice, 
but these studies have not yet been completed (Vaarala et al. unpublished data). 
Finally, functional defects in DCs, especially defects in DC maturation, have been 
shown to be involved in other, more common autoimmune diseases, like T1D 
(Angelini et al. 2005), SLE (Monrad et al. 2007), and arthritis (Laborde et al. 2007). 
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Findings concerning the monogenic disease APECED and its causative gene AIRE 
have indicated that well-functioning peripheral and central tolerance are important in 
preventing autoimmunity in humans.  
 
Figure 16. Our comparison of DCs from healthy donors with DCs from APECED 
patients showed that patient DCs have defects in cytokine production and 
other immunologically relevant pathways. This may result in a reduced 
function of patient DCs. 
Our observations support a role for AIRE in the maintenance of peripheral tolerance 
regulated by dendritic cells. Ours are the first results to show that AIRE plays a role 
in DC responses to microbial stimuli in humans. Additionally, our findings 
emphasize the need for further functional studies related to peripheral tolerance and 
how it is regulated in APECED patients. Revealing the functions of AIRE will help 
us understand the fundamental molecular mechanisms controlling the development 
of immune tolerance.  
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3 AIRE/Aire does not affect the development of γδ T cells and γδ T 
cells do not participate in the autoimmunity in APECED in mice 
or in men 
Our results show that in the absence of Aire γδ T cells develop in normal numbers and 
display a normal TCR repertoire in all of the tissues studied. γδ T cells do not resemble 
activated cells in Aire-/- mice and did not seem to participate in the pathological tissue 
infiltrates and thus, the immunopathology associated with Aire-deficiency. We conclude 
that the development of γδ T cells is not dependent on Aire function 
However, there are many ways in which loss of Aire function could affect γδ T cell 
development and why we set out to look at γδ T cells. Some of the molecules 
participating in γδ T cell selection might be controlled by Aire, like the thymic 
stromal element which has been shown to be needed for the positive selection of 
skin-associated γδ T cells (Xiong et al. 2004). Aire may be involved in the 
expression or function of nonclassical antigen-presenting molecules linked to 
antigen recognition by some γδ T cell subsets, or it may regulate the expression of 
cofactors, such as cytokines, important for γδ T cell maturation. Expression of Aire 
in the periphery and extrathymic selection, or maturation of γδ T cells could be 
linked, too, even though these mechanisms are not well-understood. Yet another 
interesting option is that the disruption of orderly αβ T cell maturation might be 
indirectly reflected on γδ T cell commitment. Recently, it was reported that 
CD4+CD8+ αβ  thymocytes may be able to regulate the maturation of precursors into 
γδ T cell lineages by an unknown mechanism (Silva-Santos et al. 2005). For 
example, in mice lacking TCR β, the development of γδ T cells is also disturbed, 
even though γδ T cells have no built-in need for TCR β chain expression. 
Interactions between thymocytes like these at different developmental stages may 
transfer abnormalities of one lineage onto others. 
The thymic TCR γ repertoire was remarkably similar in both Aire-/- and wt mice and 
the same CDR3 lengths were dominant in almost all mice. This suggests that despite 
the disruption of Aire-regulated ectopic transcription, whatever the antigens 
important to γδ T cell selection are, they were present in normal amounts.  
There was no sign of γδ TCR+ clonal expansions in the salivary glands, which would 
be expected in an antigen-driven local immune response. This last finding of ours 
makes it unlikely that γδ T cells would play a pathogenic role in APECED. Further, 
it suggests that the presumed immunoregulatory function of γδ T cells does not play 
a protective role in Aire-/- mice. The function of γδ T cells has been shown to take 
place in peripheral tissues, not in the secondary lymphoid tissues. Also other 
regulatory subsets suppress autoreactive T cells within the affected tissue, and such 
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findings have also been reported in Aire-/- mice (Kekalainen et al. 2007). We did not 
find significant numbers of γδ T cells in the target tissues and this is inconsistent 
with such local suppression. 
γδ T cells could be recruited to participate in the immunopathology of Aire deficient 
mice or the autoimmune disease of APECED patients. Although the functional 
significance of γδ T cells is still poorly known, in most cases the early γδ T cell 
response is proinflammatory, whereas at later stages, immunoregulatory functions 
dominate (Hayday and Tigelaar 2003). Therefore, γδ T cells could have either a 
pathogenetic or a protective role in APECED. Earlier studies have not shown defects 
of immunoregulation in Aire deficient mice, and experiments in which normal 
regulatory T cells were transferred to Aire deficient mice were not able to reverse 
the immunopathology. Yet, γδ T cells have not been studied separately, and defects 
in them could have been hidden by the normal function of other regulatory subsets. 
Since γδ T cells interact with DCs, it would have been possible that defects in DCs 
cause a defect in γδ T cells, or vice versa, thus leading to autoimmunity. Insufficient 
activation of γδ T cells could also have explained differences between species. It still 
may explain some species differences, if different γδ T cell subsets or functions are 
affected in mice and men. We already showed that there are aberrations in APECED 
patients DCs (II). If, γδ T cells would also have been defective, this would probably 
have lead to severe autoimmunity, since two cell types are affected. However, as γδ 
T cells function normally despite absence of Aire, γδ T cells may “take over” some 
of the tasks of the incapacitated DCs. How well γδ T cells can “cover” antigen 
presentation in mice and men may differ, thus leading to a difference in the severity 
of autoimmunity. 
The data on human γδ T cells showed substantial variation. This is not uncommon in 
human studies. Six female APECED patients in our study had a high frequency of 
circulating γδ T cells. However, our analysis of all the patients together was not able 
to confirm a link between sex and γδ T cell frequency. Moreover, we could not link 
this finding to disease severity or any specific disease component. One possible 
explanation could be that, given the association of γδ T cells with epithelial tissues, 
the increased frequency of γδ T cells in some patients could be associated with a 
local process such as the candidiasis, which affects the patients with variable 
severity.  
It would be interesting to study further the different subsets of γδ T cells in 
APECED patients and Aire deficient mice, but as so little is still known about γδ T 
cells in general, such analyses may not bring much new knowledge before the basic 
characteristics of γδ T cell are more clearly defined. 
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To summarize, our data underlines the difference in the developmental pathway and 
the function of αβ and γδ T cells. In the absence of Aire, the αβ T cell population 
shows several signs of dysregulation, but no such aberrations were observed in the 
γδ T cell population. The autoimmune pathology in Aire-/- mice does not seem to be 
driven by γδ T cells. Therefore, our results not only shed light on the role of γδ in 
APECED and the role of Aire on γδ T cells, but more generally, support the view 
that the thymic selection process and the molecules and antigens involved in it are 
different for αβ and γδ T cells. 
 
Figure 17. Our study on the γδ T cells in Aire deficient mice and in APECED patients 
showed that Aire does not affect the development of γδ T cells. Expression of 
self-antigens to γδ Tcells during their development may therefore be under 
the control of some other gene/s than Aire. 
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5 CONCLUSIONS 
The three studies included in this thesis have addressed different aspects of the 
function of Aire and tolerance. This approach was chosen because different 
strategies are needed in trying to solve an issue as complicated as the breakdown of 
tolerance – otherwise this key question would not have remained unanswered for so 
long. It is quite difficult, if not impossible, to study the function of a gene without 
access to the cells or organs in which the gene in expressed. Therefore, cell and 
animal models provide vital tools for revealing functions which cannot be, and 
would not be ethical to be studied in patients. 
In the first part of this thesis, we wanted to characterize the Aire deficient mice 
further and focused on a typical characteristic of APECED: autoantibodies. 
Autoantibodies typical for human APECED were not found in Aire deficient mice, a 
model constructed to mimic the human APECED disease. Thus, since 
autoantibodies still are present in the knock-out mice, they must be targeted against 
other than the human APECED antibody homologues. Even though the Aire 
deficient mouse is a very valuable tool in studying the role of AIRE/Aire, 
differences between the phenotype of the mice and the APECED patients are quite 
large and this must be kept in mind when interpreting the results from the mice. The 
species difference is also very interesting in itself; why are the mechanisms of 
immunopathology in the mouse different from those in humans? 
Findings concerning new autoantibodies expressed in both species, such as NALP5, 
may help shed light on both the reasons for species differences concerning 
autoantibodies as well as the mechanisms for why they are generated in the first 
place. Why autoantibodies are generated and the question “which is the hen and 
which is the egg – immune destruction or autoantibodies?” also remains 
unanswered.   
Next, we focused on human DCs. Since so many mouse models had been published 
and many groups were working on them, and because we have access to these rare 
patients, we wanted to address the unanswered question of the role of Aire in the 
periphery. Our main findings were that DCs of APECED patients show defects in 
response to microbial stimulus, and a decrease in cytokine production. Gene 
expression profiles of cells isolated from patients were different from those in cells 
isolated from healthy controls. In the patients the pathways involved in 
immunological functions were down-regulated, also indicating aberration in DC 
function. Still, which DC subsets are involved, how exactly DC functions are 
defected, how badly defective are their communication skills with target cells, with 
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which target cells and what about the situation in mice, all remain to be specified. 
Also the mystery of why solely CMC is a plague for APECED patients and other 
infections are not more common as well remains unsolved. 
Finally, we studied γδ T cells in both Aire deficient mice and in APECED patients, 
in order to find out whether Aire in involved in their development, as it is so 
important in the development of αβ T cells. We found that γδ T cells develop 
independently of Aire, as the numbers and characteristics of the γδ T cells were not 
altered in mice. Although we saw some variation in patient cell numbers, the cells 
themselves did not appear to be defected either. Therefore, γδ T cells do not seem to 
be involved in the peripheral damage or regulation of autoimmunity in APECED. 
However, since so much is still unknown concerning γδ T cells on the whole, there 
will be a whole lot to be found out about γδ T cell biology yet. 
Taken together, our studies show that there are substantial differences in the 
breakdown of tolerance between mice and men, and that Aire does play a role in 
peripheral tolerance, effecting DCs but not γδ T cells.  
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